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Chapter 1A
General Introduction
Sex Difference in Adipose Tissue Biology: 
Gonadal and Adrenal Steroid Perspectives
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Chapter 1A
1. Introduction
Excessive or abnormal fat accumulation in the body causes overweight 
and obesity. The latest report by the World Health Organization revealed that 
the prevalence of obesity worldwide has almost tripled from 1975 to 2016 and 
that 39% of adults were overweight and 13% or over 650 million were obese in 
2016 (1). Obesity is a risk for many noncommunicable diseases such as insulin 
resistance and type 2 diabetes mellitus, cardiovascular diseases, hypertension, 
and also some types of cancer (1,2). Studies have demonstrated that chronic 
obesity leads to adipose tissue dysfunction and systemic low-grade inflammation. 
Intriguingly, this obesity-induced inflammation likely causes disrupted energy 
homeostasis, resulting in insulin resistance and other metabolic diseases, such 
as cardiovascular diseases and hypertension (1,3)
Although women in most ethnic groups have a higher prevalence of 
obesity than men, women in their reproductive age have a lower incidence of 
metabolic diseases than men. This sex difference is attenuated after women 
become postmenopausal (4-7). The relatively higher metabolic risk of men and 
postmenopausal women is correlated with the distribution of adipose tissue to 
the visceral part of the body, called visceral obesity. In other words, the subcuta-
neous fat accumulation pattern of premenopausal women is associated with a 
lower metabolic risk (8,9). Hence, it is important to study the mechanisms that 
contribute to the sexual dimorphism in adipose tissue biology since it may lead 
to a better sex-specific treatment option for combating this obesity pandemic. 
Moreover, insight about how the sex differences in adipose tissue distribution 
is regulated might reveal novel treatment modalities to combat obesity and the 
associated metabolic complications.
Differences in gonadal and adrenal steroid levels and responses to those 
steroids play an important role in the sexually dimorphic pathophysiology 
of obesity and metabolic diseases. It is evident that males are more prone to 
metabolic consequences of chronic stress than females (10,11). As a response 
to stress, glucocorticoid (GC) is synthesized and secreted under the control of 
the hypothalamic-pituitary-adrenal (HPA) axis (12). The hypothalamus and the 
anterior pituitary also regulate the sex steroid synthesis of the gonads, termed 
the hypothalamic-pituitary-gonadal (HPG) axis (13,14). The HPA and HPG 
axes are interconnected at many levels which could partly account for the sex 
difference in metabolic alterations. For example, sex steroids interfere with the 
negative feedback of the HPA axis and with the expression and function of the 
GC receptor (GR) (11). On the other hand, administration of corticosterone in 
female mice to reach maximal concentrations that occur in response to stress 
suppressed estradiol-induced LH secretion and completely blocked the ovarian 
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cycle (15). Activation of the HPA axis in male rats by repeated immersion in cold 
water (chronic stress) gradually reduced serum testosterone levels and disrupted 
spermatogenesis (16).
Other mechanisms could also contribute to sex difference in obesity 
and adipose tissue metabolism, such as epigenetic modifications, e.g. DNA 
methylation, histone modifications, small single-stranded non-coding RNA 
[microRNA (miRNA)] interference; the presence of sex chromosomes (X- and 
Y-chromosomes in males, only X-chromosomes in females); and perinatal and 
pubertal development of the brain, known as the organizational effect of sex 
steroids (5,17,18). However, these topics are outside the focus of this chapter 
that will focus on the effects of sex steroids after puberty, the principal difference 
between males and females at reproductive age. The majority of studies in 
humans and rodents on the effects of sex steroids on metabolism and energy 
homeostasis have focused on the effects of estrogens and androgens in both sexes 
(19,20). The contribution of progesterone, another female sex hormone crucial 
for the luteal phase of the reproductive cycle and during pregnancy, to sex 
differences in energy metabolism has barely been investigated.
This chapter will provide an overview of sex differences in adipose tissue 
function and distribution, and the roles of gonadal and adrenal steroids therein. 
In addition, this chapter will touch upon the mechanisms by which gonadal 
and adrenal steroid hormones affect adipose tissue function and distribution in 
various clinical conditions associated with disturbances in gonadal and adrenal 
steroids.
2. Adipose tissue function, characteristics, and distribution
For a long time, adipose tissue had been considered only a passive organ 
for storing excess calories as triglycerides (TGs) and providing energy-rich 
substrates to the body when needed. However, it is currently known that adipose 
tissue is not merely a passive bystander, but secretes a plethora of bioactive 
products, termed adipokines, which regulate whole-body homeostasis and reflect 
its adaptation in physiological and pathological states (21). This section will 
discuss the types and distribution of adipose tissue as well as its metabolic and 
secretory functions, with a focus on sex differences in these properties. Other 
auxiliary functions of adipose tissue, which will not be discussed in detail, 
include cushioning mechanical stress such as in palms, buttocks, and soles, and 
providing thermal insulation for the body since thermal conductivity of adipose 
tissue is only about 40–50% of that of lean tissues (22).
10
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2.1 Types and distribution of adipose tissues
Adipose tissue has traditionally been categorized into two types which 
serve opposite roles: lipid-storing white adipose tissue (WAT) and thermogenic 
lipid-burning brown adipose tissue (BAT). Many studies have demonstrated 
a high degree of plasticity in adipose tissues. WAT can become brown-like by, 
for example, chronic exposure to cold or sustained adrenergic stimulation. This 
process is called browning and the resulting adipose tissue is called beige (or brite 
[brown-in-white]) adipose tissue (23,24). In contrast, BAT can be ‘whitened’ by 
multiple factors, e.g. acclimation to chronic warm temperatures and β-adrenergic 
signaling impairment (25). 
To store excess energy in WAT, adipose tissue can expand in size 
(enlargement of existing adipocytes, called hypertrophy) and/or increase cell 
number (forming new adipocytes from the resident progenitor cells, called 
hyperplasia). Hypertrophic expansion is considered detrimental since the 
enlarged adipocytes reach a limit of oxygen diffusion, resulting in hypoxia, 
inflammation, fibrosis, adipose tissue dysfunction, and subsequently insulin 
resistance (26-29). Hyperplastic expansion is considered a healthy adaptation 
and occurs together with proper angiogenesis – formation of new vasculature 
to supply the growing adipocytes (21,30). Adipogenesis and angiogenesis are 
reciprocally regulated by peroxisome proliferator-activated receptor-γ (PPARγ) 
and vascular endothelial growth factor (VEGF). Reducing PPARγ activity by a 
dominant-negative PPARγ results in reduced preadipocyte differentiation and 
inhibits angiogenesis and an immunologic inhibition of VEGF blocks vessel 
formation and inhibits adipocyte differentiation (31), showing that these two 
processes are reciprocally regulated.
Concerning body fat distribution, WAT can generally be divided into 
two anatomical depots: subcutaneous depots, e.g. abdominal subcutaneous and 
gluteofemoral depots for humans or anterior (axillary) and posterior (inguinal) 
subcutaneous depots for rodents; and visceral depots, e.g. omental, mesenteric, 
gonadal, and retroperitoneal depots (32,33). Depot difference in WAT expansion 
is evident in rodent and human studies. In mice fed a high-fat diet (HFD), 
subcutaneous WAT expands more significantly by hyperplasia while visceral 
WAT shows a greater hypertrophic expansion. Indeed, adipose progenitor cells, 
responsible for adipogenesis, are more abundant in the subcutaneous depot than 
the visceral depot of mice (34). Likewise, adipocyte progenitor cells isolated from 
a subcutaneous depot of mice differentiated better by a standard in vitro culture 
protocol and express higher levels of pro-adipogenic genes and lower levels of 
anti-adipogenic genes than cells isolated from a murine visceral depot (35).
11
1
General Introduction: Sex Differences in Adipose Tissue Biology
Also in humans, obese subjects have more preadipocytes in their 
abdominal subcutaneous WAT than in their omental visceral WAT. Isolated 
preadipocytes from the subcutaneous depot also differentiated more efficiently 
into mature adipocytes and expressed higher levels of adipogenic transcription 
factors than those isolated from the visceral depot (36,37). In morbidly obese 
subjects [body mass index (BMI) > 40 kg/m2], the amount of visceral fat in 
insulin-resistant individuals is negatively correlated with insulin sensitivity: 
insulin-resistant obese subjects have significantly higher waist circumference 
and visceral fat accumulation than insulin-sensitive obese persons (27). Overall, 
visceral fat accumulation is associated with an increased risk of metabolic 
complications of obesity and clinical practice guidelines support measurement of 
waist circumference (a reasonable proxy for visceral obesity) as an indicator for 
the risk to develop metabolic diseases (38-41). A brief summary of adipose tissue 
expansion and its adaptive mechanisms is presented in Table 1. Of note, some 
characteristics will be discussed in following sections of this chapter.
2.1.1 Sex difference in adipose tissue distribution
Throughout life, women typically have a higher percentage of body fat 
than men at an equivalent BMI (42-44). Body composition also shows many 
sex-dependent characteristics including regional distribution. Women tend to 
accumulate body fat around hips and thighs, called a gynoid or pear-shaped 
pattern, whereas men accumulate fat around the abdomen, termed an android 
or apple-shaped pattern (8,9,44). Subsequently, women and female rodents have 
relatively more subcutaneous WAT and less visceral WAT than age-matched men 
and male rodents (19,45-47). One of the possible mechanisms accounting for this 
sex difference is that women have a higher activity of lipoprotein lipase (LPL) 
in subcutaneous WAT than men (48). LPL is the enzyme involved in hydrolysis 
of TGs to yield fatty acids that can be taken up by adipocytes. Upon uptake, the 
fatty acids will be re-esterified with glycerol into TGs and stored in the adipocyte 
(see section 2.3 for more detail). The sex-dependent pattern of fat distribution 
is apparent after pubertal development, indicating a role of sex steroids in fat 
accumulation (49). Moreover, this sex-dependent fat accumulation diminishes at 
an older age; in other words, women gain more visceral fat, and thus their body 
fat distribution becomes android-like, after menopause (50,51).
Inflammation in adipose tissues typically precedes systemic metabolic 
inflammation and occurs when proper adipogenesis is limited (52). This is 
especially the case in visceral depots, the predominant fat depot of males. A 
mouse study demonstrated that female mice had a higher ratio of adipose 
progenitor cells to adipocytes in gonadal and inguinal WATs than male mice (53). 
12
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Fed a HFD for 14 weeks, males expanded the gonadal depot only by hypertrophic 
expansion accompanied by an accumulation of macrophages and other immune 
cells, whereas females expanded the gonadal depots by both hyperplasia and 
hypertrophy. This difference coincided with more weight gain and a worse 
metabolic profile in males than in females after the HFD challenge (53). Other 
studies also confirmed that females had less intra-abdominal fat accumulation 
than males although both sexes consumed an equal amount of HFD. These 
sex-differential effects were absent when the female sex steroids were depleted by 
ovariectomy. Treatment with 17β-estradiol (E2) in the HFD-fed ovariectomized 
mice restored the visceral deposition to the amount of non-ovariectomized 
females.In addition, gonadal adipocytes were larger in males and ovariectomized 
females than in non-ovariectomized females and E2-treated ovariectomized 
females, suggesting protective properties of E2 on hypertrophic expansion (54, 
55). Another study in male and female mice demonstrated that an obesogenic 
(high-fat and high-sugar) diet resulted in greater diet-induced obesity, higher 
mesenteric fat accumulation, and a worse metabolic profile in males. Intrigu-
ingly, E2 treatment feminized and attenuated the diet-induced disturbances of 
male mice (56). Altogether, these data in humans and rodents suggest direct 
effects of sex steroids on adipose tissues, which will be discussed in more detail 
in section 3.
2.2 Adipogenic programming
Adipogenesis is a complex process in which multipotent mesenchymal 
stem cells commit to the adipogenic lineage after which these preadipocytes 
differentiate into lipid-containing mature adipocytes (Figure 1). White 
adipocytes and classical brown adipocytes (as found in interscapular BAT depots 
in rodents and human infants) are derived from different progenitor lineages. 
Brown adipocytes and skeletal myoblasts arise from the paired box 7 (Pax7)- and 
myogenic factor 5 (Myf5)-expressing progenitors. The transcriptional regulator 
PR domain-containing 16 (Prdm16) controls the differentiation towards brown 
adipocytes, whereas myogenic factors, i.e. Myf5 and the myogenic differentiation 
(MyoD), repress Prdm16 and promote myoblast differentiation (57,58). White 
and beige adipocytes are derived from Pax7- and Myf5-negative progenitors, but 
activation of the transcription factor early B-cell factor 2 (Ebf2) commits the 
progenitor cells to a beige adipocyte lineage. Of note, Prdm16 is an Ebf2-target 
gene and brown adipocytes also express Ebf2 (59). On the contrary, the transcrip-
tional regulator zinc finger protein (Zfp423) is critical for white preadipocyte 
commitment since Zfp423 can bind and repress Ebf2 transcriptional activity, 
allowing preadipocytes to differentiate to white adipocytes (60).
14
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Figure 1  Adipogenesis and progenitor lineage
Classical white and brown adipocytes are derived from different progenitors. Adipogenic 
programming is modulated by distinct transcription factors, listed by the arrows in the diagram.
15
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The general program of differentiation into mature lipid-containing 
adipocytes is regulated by the transcription factor PPARγ (the master regulator 
of adipogenesis) and the transcription co-activators CCAAT/enhancer-binding 
protein α and β (C/EBPα and C/EBPβ) (61). White preadipocyte differentiation is 
promoted by the transducin-like enhancer of split 3 (TLE3), whereas beige and 
brown preadipocyte differentiation is promoted by Prdm16 (62). During differen-
tiation, committed preadipocytes arrest in growth, accumulate lipids, and form 
functional insulin-responsive mature adipocytes. Early differentiated adipocytes 
express PPARγ, C/EBPα or C/EBPβ, fatty acid binding protein 4 (FABP4, also known 
as adipocyte protein 2 [aP2]), and the insulin-responsive glucose transporter 4 
(GLUT4) (30). Continuous activation of PPARγ promotes terminal differenti-
ation by inducing a variety of differentiation-dependent target genes. Mature 
adipocytes then express the genes important for adipose tissue function, such 
as LPL, adipose triglyceride lipase (ATGL), hormone-sensitive lipase (HSL), 
perilipin, adiponectin, and leptin, as well as all of the early differentiation 
markers (30,63).
The key regulator important for brown and beige adipocyte differenti-
ation is the transcriptional coactivator protein PPARγ coactivator 1α (PGC1α). 
PGC1α co-activates PPARγ and other transcriptional factors to initiate a broad 
program of mitochondrial biogenesis, including the induction of expression of 
the gene encoding the thermogenic uncoupling protein 1 (UCP1), a protein in 
the inner mitochondrial membrane that allows protons to leak independently 
of ATP synthesis and dissipate energy of substrate oxidation as heat, a unique 
function of brown and beige adipocytes (64,65). The thermogenic function of 
BAT is discussed in more detail in section 2.5. Upon prolonged cold exposure or 
β-adrenergic stimulation, white adipocytes can also transdifferentiate into beige 
adipocytes by upregulating Prdm16 and PGC1α (61,66), and thereby having a 
beneficial contribution to energy metabolism.
2.3 Lipid metabolism in adipose tissue
As an energy reservoir in postprandial or positive energy balance 
conditions, WAT depots store excess nutrient calories as TG by uptake of fatty 
acids from plasma or de novo lipogenesis. In prolonged fasting or high energy 
demand conditions, on the other hand, white adipocytes lipolyze the stored TGs to 
supply fatty acids and glycerol as energy substrates to the circulation to be used 
by other tissues (67). The balance in lipid storage and breakdown determines 
adipose tissue mass. Principle enzymes and substrates for lipid metabolism in 
white adipocytes are illustrated in Figure 2.
16
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During physiological substrate-rich conditions, e.g. after meals, an 
increase in plasma insulin levels not only promotes glucose uptake but also 
stimulates fatty acid uptake and lipogenesis in white adipocytes (68). For the 
uptake, adipocytes obtain fatty acids from two TG-rich lipoproteins, namely 
chylomicrons (enterocyte-derived lipoproteins that transport exogenous [dietary] 
fats) and very low-density lipoproteins (VLDL, endogenous lipoproteins secreted 
by the liver). The fatty acids are hydrolyzed from the TG-rich lipoproteins by 
LPL after which they can be taken up through fatty acid transport proteins 
(FATP) or fatty acid translocase (FAT, also known as CD36). In the adipocytes, 
these fatty acids are activated to fatty acyl-CoAs and sequentially esterified with 
glycerol-3-phosphate to form TGs that are subsequently packed and stored in 
lipid droplets (67-69).
De novo lipogenesis contributes only marginally to the TG content of 
adipocytes. This pathway is less active in adipocytes than in the liver and is 
less important in humans than in rodents (68,70). An increase in intracellular 
substrate concentrations, for example by insulin stimulation, stimulates de novo 
lipogenesis in adipocytes by inducing the transcription factors carbohydrate 
response element-binding protein (ChREBP) and sterol regulatory element-
binding protein 1c (SREBP1c), which subsequently induce many lipogenic 
genes such as those that encode for acetyl-CoA carboxylase 1 (ACC1), fatty acid 
synthase (FASN), and stearoyl-CoA desaturase 1 (SCD1) (71-73).
When the body lacks energy, e.g. upon prolonged fasting, or requires 
extra metabolic supplies, e.g. during exercise, lipolysis in adipocytes is induced. 
In this process that involves multiple lipases, a complete breakdown of one 
molecule of TG generates three fatty acid molecules and one molecule of glycerol 
as substrates for direct utilization in other tissues or for gluconeogenesis in the 
liver. The first fatty acid is cleaved from TG by ATGL or, to a minor extent, by 
HSL. The remaining diacylglycerol is hydrolyzed into monoacylglycerol and a 
second fatty acid by HSL. Monoacylglycerol lipase (MGL) cleaves the remaining 
monoacylglycerol into a third fatty acid and glycerol (67,74). Likely various 
transporters such as FABP4 facilitate the export of fatty acids, while aquaporin 
7 (AQP7) facilitates the transport of glycerol out of adipocytes (75,76).
At basal conditions, proteins such as perilipins coat the surface of lipid 
droplets preventing them from lipase action (67,77). When lipolysis is required, 
systemic cues such as the sympathetic nervous system and the HPA axis can 
regulate lipase activities in many ways. The sympathetic outflow products 
catecholamines bind to β-adrenergic receptors and initiate signaling cascades 
to inactivate the protecting effect of perilipins and promote the translocation of 
HSL to the lipid droplets. GCs, produced in response to activation of the HPA 
axis, promote lipolysis in adipocytes by inducing the transcription of the lipolytic 
enzymes ATGL and HSL (67,74,77,78).
18
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2.4 Secretory function of adipose tissue
Besides the well-known function as an energy reservoir, adipocytes 
produce and secrete various adipokines that function as autocrine, paracrine, 
and endocrine signaling molecules. Various systemic functions of adipokines 
are known, such as regulation of systemic energy homeostasis, endothelial 
function, insulin sensitivity, and inflammation. More than 600 adipokines have 
been discovered, including adiponectin, adipsin, apelin, bone morphogenetic 
protein 4 (BMP4), BMP7, dipeptidyl peptidase 4 (DPP4), fibroblast growth factor 
21 (FGF21), interleukin-1β (IL-1β), IL-6, leptin, lipocalin 2, omentin, resistin 
[for rodents], retinol binding protein 4 (RBP4), tumor necrosis factor α (TNFα), 
and visfatin (79-81). Leptin and adiponectin are the two most studied adipokines 
which regulate feeding behavior and whole-body insulin sensitivity and will 
therefore be discussed in more detail below.
2.4.1 Leptin
Leptin was the first identified adipokine in 1994 (82), but its physiological 
roles had already been known since 1950, when an autosomal inherited mutation 
was identified in an obese mouse strain (83). This mutation, and later the gene, 
was originally called obese (ob). Another gene mutation, which turned out to 
encode the leptin receptor, was identified in 1966 in an obese and early-onset 
diabetic (db) mouse strain (84). The leptin-deficient ob/ob mice and the leptin 
receptor-deficient db/db mice are among the most used animal models of obesity 
and metabolic diseases since the shared phenotypes of these two models include 
profound obesity, hyperphagia, reduced energy expenditure, hyperglycemia and 
hyperinsulinemia (which leads to insulin resistance or diabetes depending on 
age and strain), and hyperlipidemia (85).
Leptin is a 167-amino acid protein produced mainly in adipose tissues, 
with WAT producing significantly more leptin than BAT. Lep mRNA expression 
is however detected in many other tissues as well, including skeletal muscles, 
stomach, placenta, and ovaries (86). Under healthy physiological conditions, 
excess nutrient calories promote an expansion of adipose tissues which induces 
leptin production and secretion. Thus plasma leptin concentrations reflect 
energy status and total fat mass. Leptin binds to the leptin receptors on neurons 
in various brain regions, including energy-control centers in the hypothalamus. 
Here, leptin promotes satiety signals to reduce food intake and accelerate 
energy expenditure in peripheral tissues through sympathetic nervous system 
activation. In addition, leptin also regulates lipid metabolism in WAT since 
sympathetic activation induces lipolysis and reduces de novo lipogenesis. While 
plasma leptin concentrations are positively correlated with the total amount of 
body fat, the leptin-induced inhibition of food intake is blunted in many obese 
subjects, indicating that obesity may reflect a leptin-resistant state (87-90).
19
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2.4.2 Adiponectin
Adiponectin, a 247-amino acid adipokine that has a higher plasma level 
(µg/mL) than other conventional factors, e.g. insulin and leptin (ng/mL), was 
discovered in the mid 90’s by many research groups giving this protein different 
names: Acrp30 (adipocyte complement-related protein of 30 kDa), AdipoQ, apM1 
(adipocyte most abundant gene transcript 1), and GBP28 (gelatin-binding protein 
of 28 kDa) (91-94). Adiponectin is generally accepted as an adipocyte-specific 
marker produced by BAT and WAT (95,96). However, Adipoq mRNA expression 
has been detected beyond adipose tissue depots under some specific conditions, 
e.g. lipopolysaccharide-induced muscle inflammation (97,98). 
Adiponectin displays many metabolically favorable effects and 
circulating adiponectin concentrations decline with increasing BMI, increasing 
waist circumference, and insulin resistance (89,99,100). Within morbidly obese 
individuals (BMI > 40 kg/m2), the insulin-resistant group exhibits lower serum 
adiponectin levels than the insulin-sensitive group. Thus, lower circulating 
adiponectin concentration together with adipose tissue inflammation appears 
a good predictor of insulin resistance (27). Adiponectin is also associated with 
an hyperplastic expansion of adipose tissue (99). Since plasma leptin concen-
trations increase and adiponectin concentrations decrease in obese subjects, 
the adiponectin/leptin ratio is considered a reliable indicator for assessing 
subclinical insulin resistance, metabolic disorders, and adipocyte dysfunction 
(95,99,101,102).
Another unique characteristic of secreted adiponectin is that it circulates 
in higher-order complex forms: the high-molecular-weight (HMW) form consisting 
of 12–18 adiponectin molecules; the low-molecular-weight (LMW) hexamer 
form; and the trimer form. Distribution of adiponectin complexes contributes 
to distinct biological effects and HMW adiponectin is considered the active form 
of this adipokine. As a result, the HMW/total adiponectin ratio is considered 
another predictor for insulin sensitivity (103,104).
2.4.3 Extragonadal steroid synthesis
In addition to adipokines, WAT depots are an important source of extra- 
gonadal estrogen biosynthesis, through aromatization of intracellular androgens 
by the enzyme aromatase (CYP19A1) (105). Aromatase can convert testosterone 
(the main circulating male sex hormone) to E2 (the main circulating female sex 
hormone), or androstenedione (a weak androgen) to estrone (a weak estrogen). 
The aromatization of androgens in adipose tissues contributes substantially to 
circulating estrogen levels, especially in obese men and postmenopausal women 
(106,107). Moreover, aromatization might contribute to local effects of sex 
20
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steroids on adipose tissue. An imbalance in the testosterone/E2 ratio in obese 
men causes metabolic syndrome and hypogonadism, which will be discussed 
further in section 3.3.
GCs (cortisol for humans or corticosterone for rodents) can be converted 
from their inactive 11-keto steroid precursors (cortisone or 11-dehydrocorticos-
terone, respectively) by the reductase activity of the enzyme 11β-hydroxysteroid 
dehydrogenase type 1 (11β-HSD1) in adipose tissues. The active GCs act locally 
to promote preadipocyte differentiation, adipocyte hypertrophic expansion, and 
hence adipose tissue and systemic insulin resistance, rather than contributing 
to an increase in circulating GC levels (108). Interestingly, 11β-HSD1 reductase 
activity is higher in preadipocytes from visceral depots than in those from 
subcutaneous depots of male mice, supporting a role of local activation of GCs in 
visceral obesity (109).
2.5 Thermogenic function of BAT
BAT is a thermogenic organ that dissipates nutrient energy as heat 
through its classical mitochondrial protein UCP1. It was originally recognized 
that BAT was present and actively functioning only in human infants, small 
mammals, and hibernating animals to maintain body temperature without 
thermogenic shivering of skeletal muscles. Likewise, the concept has been that 
BAT in humans regresses within the first years of life, resulting in an absence of 
BAT in adults (110). Although the existence of activated BAT in healthy adults 
had been suggested in the positron emission tomography/computed tomography 
(PET/CT) imaging since 2002 (111), direct evidence of cold-activated glucose 
uptake in BAT together with UCP1-immunoreactive brown adipocytes was 
confirmed in 2009 (112-115). After the rediscovery of active BAT in adults, BAT 
has gained much attention from researchers as activating BAT is suggested a 
promising tool to combat the obesity pandemic.
Under physiological conditions, exposure to low ambient temperatures 
stimulates cutaneous thermoreceptors to transmit sensory signals to the thermo-
center preoptic area of the hypothalamus. Subsequently, the hypothalamic 
network provides signals to stimulate the sympathetic premotor neurons that 
hence activate 1) cutaneous vasoconstriction (to reduce heat loss), 2) non-shivering 
thermogenesis in BAT, and 3) shivering in skeletal muscles (116). In humans, 
repeated exposure to cold (cold acclimation), e.g. 2 hours/day and 5 days/week for 
4 weeks, increases BAT mass and the oxidative capacity of BAT. Furthermore, 
the prevalence of BAT detected by PET/CT imaging is higher during winter than 
other seasons and negatively correlates with outdoor temperatures (117,118).
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Cold exposure induces sympathetic nerves in BAT to secrete norepineph-
rine that stimulates BAT thermogenesis through β-adrenergic receptors (β-ADR). 
Although all three types of β-ADRs (β1, β2, and β3) are expressed in human and 
murine BAT, to date only treatment with β3-ADR agonists, but not with non- 
specific β-ADR agonists, has resulted in increased BAT activity, suggesting that 
β3-ADR mediates BAT thermogenesis (119-121). A single dose of propranolol 
(a competitive non-selective β-ADR antagonist) given to patients with a strong 
BAT activity signal in PET/CT imaging suppressed BAT activity in most cases 
(122,123). Since propranolol binds β1- and β2-ADRs with high affinity but has a 
lower binding affinity for β3-ADR (124), the suppression of BAT activity after 
administration of propranolol may indicate less specificity in β-ADR subtypes 
regulating human BAT activity.
The acute adrenergic response of BAT enhances lipolysis through the 
activation of ATGL and HSL, and the fatty acids released in this process 
stimulate UCP1 activity (125). In addition, cold exposure stimulates the uptake 
of glucose and fatty acids in BAT, resulting in a decrease in circulating glucose 
levels and also reductions in plasma free fatty acid and TG concentrations 
(126). After the fatty acids are imported into brown adipocytes, they are most 
likely first esterified into TG and incorporated into lipid droplets after which 
they are hydrolyzed to be metabolized for uncoupling thermogenesis (126). This 
was confirmed by the presence of significantly defective BAT thermogenesis in 
ATGL-deficient mice upon an acute cold exposure (127), underscoring the need of 
intracellular TG. Figure 3 illustrates the current hypothesis on lipid metabolism 
in brown adipocytes for UCP1 thermogenesis.
Interestingly, not only the transcription of genes and activation of 
enzymes involved in substrate turnover are upregulated, UCP1 transcription 
and protein abundance in BAT are also increased upon cold exposure, called 
adaptive thermogenesis (Figure 3) (126,128-130). Prolonged cold exposure also 
induces browning of inguinal WAT in mice, with subsequent upregulation of Ucp1 
mRNA and protein expression (59,66,128). This inducible browning process was 
observed in all WAT depots, but was much more pronounced in subcutaneous 
depots than in visceral depots (131). 
2.5.1 Sex difference in BAT abundance and function
In general, research has revealed that women and female rodents have 
a greater BAT mass and/or higher prevalence of metabolically active BAT 
and have greater inducible browning of their WAT depots than men and male 
rodents (132,133). A retrospective study determining the prevalence of BAT 
by PET/CT imaging found that BAT was detectable in 328 out of 4,842 (6.8%) 
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Figure 3  Activation of BAT thermogenesis and lipid metabolism in brown adipocytes
Acute thermogenic responses by β3-adrenergic stimulation include activation of (1) intracellular 
lipolysis, (2) fatty acid uptake, and (3) glucose uptake. Altogether, these processes increase 
intracellular free fatty acid availability for mitochondrial UCP1 thermogenesis. Prolonged cold 
exposure also induces adaptive thermogenesis by (4) upregulating Ucp1 mRNA expression.
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participants and significant determinants for BAT activity included, besides 
low outdoor temperatures (seasonal variation), young age, low-to-normal BMI, 
absence of diabetes, and female sex (118). Of note, the influence of sex on BAT 
prevalence declined with age (118). Also in rodents, female rats have a higher 
BAT mass (relative to body mass), higher total and mitochondrial protein 
content in BAT with larger mitochondria with more cristae, and higher BAT 
UCP1 protein expression than male rats under normal housing conditions at 
22°C and ad libitum fed with chow diet (134,135). Circulating sex steroids are 
likely one of the most important regulators of BAT differentiation and activity 
(136). In cultured brown adipocytes isolated from BAT of mice or rats, treatment 
with E2 or progesterone stimulated while testosterone inhibited mitochondrial 
biogenesis signaling and brown adipocyte differentiation (137,138).
Under caloric restriction conditions (e.g. 60% caloric intake of the ad 
libitum fed animals for 100 days), female rats showed a greater deactivation 
of BAT thermogenesis to reduce energy expenditure than male rats, and hence 
females are better able to protect other metabolically active organs, advanta-
geous for survival in food-limited conditions, than males (139). When fed a HFD 
for 8 weeks, female rats maintained a higher expression of proteins involved in 
thermogenesis (e.g. UCP1, PGC1α) and fat oxidation, and a lower expression 
of proteins involved in fat synthesis (e.g. FASN, ACC1) in BAT than male rats, 
again suggestive for increased protective adaptations of female BAT, also under 
energy-excess conditions (140). Another study, in which rats had been exposed 
to a high-fat, high-sugar diet for 100 days followed by a chow diet for 70 days, 
confirmed that female rats had a higher BAT mass (relative to body mass), higher 
total and mitochondrial protein in BAT, higher Ucp1 and Adrb3 (β3-ADR) mRNA 
expression, and a greater weight loss during the chow diet state than male rats. 
This study confirms a higher functional capacity of BAT in females during an 
overweight state (134).
3. Effects of sex and stress steroids on adipose tissues
This section will review the effects of sex- and stress-steroids on the 
distribution and function of adipose tissues. Such effects have mainly been 
addressed by administration of the biological hormones or their agonists/
antagonists to humans and rodents, as wells as ex vivo treatment of adipose 
tissue-derived cells and stable adipocyte cell lines. Also, the removal of the 
sex steroid producing gonads (gonadectomy) and animals deficient in specific 
steroid receptors are commonly used methods and models to study the role of 
sex steroids. A brief summary of the effects of sex- and stress-steroids on adipose 
tissues is presented in Table 2 and will be discussed in more detail below.
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3.1 Estrogens
Estrogens are female sex hormones, the effects of which at target organs 
are classically mediated by the nuclear estrogen receptors (ERs): ERα and ERβ. 
Upon binding to ER, the estrogen-ER complex interacts with estrogen response 
elements and other transcription factors, and hence stimulates or inhibits target 
gene expression (19). Estrogens can also bind to membrane-associated ERs, such 
as the G protein-coupled ER (GPER, formerly known as GPR30), and initiate 
rapid non-genomic actions (141). In premenopausal women, E2 is the main 
circulating estrogen produced by ovaries during the menstrual cycle.
Estrogen deficiency after menopause is associated with many metabolic 
risks, such as obesity, metabolic syndrome, type 2 diabetes mellitus, and 
cardiovascular diseases. Postmenopausal estrogen therapy has beneficial effects 
against these metabolic risks. However, individualized treatment formula, route 
of administration, dosage, and duration should be considered because thrombo-
embolism, a major harmful consequence of the hormone treatment, needs 
to be monitored and evaluated (19,142,143). Estrogens also regulate energy 
homeostasis via the central nervous system, mainly through activation of ERα 
in many brain regions, which is beyond the scope of this chapter. The net central 
effect of estrogens is towards a negative energy balance by inhibiting feeding 
behavior and promoting energy expenditure through sympathetic nervous 
system activation, and hence BAT thermogenesis [see for a comprehensive 
review (144)].
Concerning adipose tissue expansion and distribution, estrogens promote 
the subcutaneous gluteofemoral or gynoid/pear-shaped fat distribution, which is 
associated with low metabolic risks. Postmenopausal women shift towards the 
visceral or central/android/apple-shaped fat distribution and increase their body 
weight and fat mass. Hormone replacement therapy in early postmenopausal 
women counteracts weight gain, prevents the central fat distribution, and 
increases gluteofemoral fat accumulation (145,146). Interestingly, administra-
tion of E2, in combination with an antiandrogen, for gender-affirming hormone 
therapy in transwomen (male-to-female transgender persons) resulted in a 
marked increase in subcutaneous fat deposition at the abdominal area, hip, and 
thigh, but only a slight increase in visceral fat deposition (147).
Studies in rodents also confirm this effect of estrogens on fat distribu-
tion. Female rats have more subcutaneous fat and less visceral fat than male 
rats. Ovariectomy increased visceral fat deposition in females and E2 treatment 
of ovariectomized females reversed the fat distribution to that of ovary-intact 
females. In addition, E2 treatment of castrated males also increased the subcuta-
neous fat percentage (148). Male and female mice with estrogen deficiency such 
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as aromatase knockout (ArKO) mice, which cannot synthesize endogenous 
estrogens due to targeted disruption of the aromatase gene, had heavier gonadal 
and infrarenal fat pads than their wild-type (WT) littermates. E2 replacement 
in female ArKO mice restored the fat pad mass to those of WT animals (149).
To study whether ERα or ERβ is involved in the effects of estrogens 
on adipose tissues, studies with ERα knockout (ERαKO) male and female mice 
showed that these animals had an increased WAT mass, especially the gonadal 
WAT (150). Studies comparing ERαKO, ERβ knockout (ERβKO), and double ERs 
knockout (ERαβKO) mice showed that ERαKO and ERαβKO, but not ERβKO 
females had increased overall fat mass and circulating leptin levels. In addition, 
treatment of ovariectomized females with E2 resulted in a reduction in gonadal 
fat mass in WT and ERβKO, but not in ERαKO or ERαβKO mice (151,152). 
Adipocyte-specific deletion of ERα led to visceral obesity and adipose tissue 
inflammation in both sexes of mice, but more severe metabolic disturbances 
were observed in male mice (153). These animal studies underscore that the 
fat-reducing effect of estrogens is mediated through ERα, which is in accordance 
with a finding in humans that adipose tissues of obese women had lower ERα 
mRNA levels than those of non-obese women (154).
Recent studies revealed that GPER may also regulate adipose tissue 
function and expansion, but the findings are still contradictory and warrant 
further studies. One study found that female but not male GPER knockout 
(GPERKO) mice were protected from HFD-induced obesity without significant 
changes in food intake and energy expenditure. GPER deficiency did not affect 
the metabolic phenotypes of chow-fed male and female mice (155). In contrast, 
another study found that chow-fed GPERKO males had increased visceral and 
subcutaneous fat mass, elevated circulating proinflammatory cytokine levels, 
and reduced adiponectin levels, without changes in food consumption or physical 
activity (156).
Regarding adipokine production, plasma adiponectin levels are in general 
higher in women than in men (157). Postmenopausal women, nevertheless, 
have higher circulating total and HMW adiponectin levels than premenopausal 
women (158,159). Total and HMW adiponectin concentrations were negatively 
correlated with E2 levels and insulin resistance status (158). Although estrogen 
status alone cannot fully explain adiponectin levels in all mentioned conditions, 
a higher adiponectin level remains a significant determinant for lower risk of 
insulin resistance in postmenopausal women, confirming the anti-diabetic effect 
of adiponectin (159). Gender-affirming hormone therapy in transwomen not 
only increased total fat mass but also serum leptin and adiponectin concentra-
tions (160,161). In addition, in vitro stimulation of WAT explants or isolated 
adipocytes from subcutaneous WAT of women confirmed a direct stimulatory 
effect of E2 on leptin secretion and on LEP mRNA expression (162). Likewise, 
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E2 directly reduced adiponectin production and secretion in cultured 3T3-L1 
adipocytes (163).
Also female mice have higher plasma adiponectin levels, greater HMW/
total adiponectin ratio, and better insulin sensitivity than male mice (104,163). 
Ovariectomy increases while E2 treatment in ovariectomized mice decreases 
plasma adiponectin levels (163). Another study found that E2 treatment reduced 
body weight and abdominal fat mass and attenuated insulin resistance of female 
mice with HFD-induced obesity. Circulating leptin levels were elevated while 
adiponectin levels were unchanged by HFD, yet E2 treatment reduced the 
circulating levels of both leptin and adiponectin. Most likely, this is mediated 
through a different mechanism since E2 treatment did not affect Adipoq 
mRNA expression in WAT of the HFD-fed females while it reduced Lep mRNA 
expression (164).
The finding that E2-treated obese mice had improved insulin sensitivity 
but decreased circulating adiponectin levels is contradictory to a general 
observation that adiponectin levels decline in obese and insulin-resistant state, 
whereas leptin levels increase proportionally to fat mass and correlate with 
insulin resistance (81). Another study in ovariectomized mice found that E2 
treatment reduced fat mass, adipocyte size, and serum leptin and adiponectin 
levels, but increased the adiponectin/leptin ratio which was in parallel with an 
improved glucose tolerance (165). This discrepancy in adiponectin levels and 
insulin sensitivity in each estrogen condition is likely caused by physiological 
adaptations of adipose tissue, modes of adipose tissue expansion, or alterations 
of circulating adiponectin isoforms, which require further investigation to draw 
a firm conclusion.
3.2 Progestogens
Progestogens are steroid hormones synthesized in ovaries, adrenal 
glands, and the placenta. Progesterone, the natural endogenous progestogen, is 
essential for the development of female reproductive organs in the luteal phase 
of female reproductive cycle, when it prepares the endometrium for possible 
implantation of a fertilized egg, and for maintenance of pregnancy. The classical 
signaling pathway of progestogens is through binding to the nuclear progesterone 
receptors (PRs), subsequently interacting with progesterone response elements, 
and initiating transcription of PR target genes. In addition, progestogens can 
also signal through non-classical pathways by binding to other receptors, e.g. 
membrane-associated receptors (mPRs), which belong to the progestin and 
adipoQ receptor (PAQR) family, and the PR membrane component (PGRMC) 1 
and 2 (166). Furthermore, progesterone can be converted into the neuroactive 
metabolite allopregnanolone which acts through the membrane-associated 
GABA type A (GABAA) receptor (166).
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Clinical observations propose a lipogenic effect of progestogens. A 
longitudinal study in pregnant women found that weight gain during pregnancy 
was positively correlated with plasma progesterone levels but not with E2 levels 
or amount of dietary intake (167). Women using depot-medroxyprogesterone 
acetate (DMPA), a progestogen-only injectable contraceptive, gained more 
weight than women without hormonal contraceptives. This weight gain was 
contributed to an increase in fat mass with a more central distribution (168). 
Of note, although DMPA has the highest affinity to PR, it can also bind to GR 
and AR albeit with low affinity, and thus DMPA also has some androgenic and 
glucocorticoid effects (169). Furthermore, progestogen-only contraceptive users 
usually have elevated plasma insulin concentrations after a glucose challenge, 
suggesting progestogen-induced insulin resistance (170).
Progesterone administration to rats had no effect on body weight and 
fat mass of male rats, but led to increased body weight and inguinal fat mass in 
female rats without affecting the intra-abdominal fat mass. Activity and mRNA 
expression of lipogenic enzymes were also upregulated in the inguinal WAT 
of female rats (171,172). An in vitro progesterone treatment of rat adipocytes, 
obtained from parametrial fat pads of females, confirmed the lipogenic effects 
of progesterone since it dose-dependently upregulated Srebp1c and Fasn mRNA 
expression (173). However, an in vitro study using cultured adipocytes isolated 
from subcutaneous and omental WATs of women, showed inconsistent effects of 
progesterone on adipocyte differentiation and lipid accumulation (174).
Concerning adipokine production, progesterone administration in rats 
resulted in upregulated Lep mRNA but downregulated Adipoq mRNA expression 
in inguinal WAT of females. The effect of progesterone on the adipokine 
mRNA expression was abolished when mifepristone (RU486, a potent PR and 
GR antagonist) was co-administered, suggesting a PR-regulated mechanism. 
Of interest, progesterone did not alter Lep and Adipoq mRNA expression in 
retroperitoneal WAT of females or in inguinal, epididymal, and retroperitoneal 
WATs of males, and did not affect circulating levels of leptin and adiponectin 
in both sexes (171). However, prolonged treatment with progesterone increased 
adiponectin production but did not affect leptin production in 3T3-L1 adipocytes 
(175). Hence, these depot- and sex-specific effects of progesterone on adipokine 
production warrant further investigation, especially since this female sex steroid 
is less well studied than the other major hormone, E2.
3.3 Androgens
Androgens are male sex hormones which are not only required for male 
reproductive system development and secondary male sex characteristics, but 
are also involved in energy/metabolic homeostasis. Testosterone is the main 
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circulating androgen for adult men and male rodents, synthesized in testes. At 
target organs, testosterone can be converted to E2 by the enzyme aromatase, 
e.g. in WAT, or to the more potent androgen derivative dihydrotestosterone 
(DHT) by the enzyme 5α-reductase in, for example, male reproductive organs, 
hair follicles, liver, and many brain regions. Principal actions of testosterone 
and DHT are mediated by the androgen receptor (AR). Apart from the gonads, 
adrenal glands also produce androgen precursors, so-called adrenal androgens, 
i.e. dehydroepiandrosterone (DHEA), DHEA sulfate, and androstenedione, 
which are found in plasma of both sexes after the adrenarche, i.e. maturation of 
adrenal steroidogenesis (20,176).
Male hypogonadism, i.e., men with low testosterone levels, is associated 
with visceral obesity, metabolic syndrome, and an increased incidence of type 2 
diabetes mellitus (177,178). Testosterone replacement therapy for male hypogo-
nadism reduces fat mass and improves the metabolic profile (177). In contrast, 
androgen deprivation therapy (so-called chemical castration) for patients with 
prostate cancer leads to increases in body weight, total fat mass, and insulin 
resistance (179,180). The mentioned studies suggest that androgen deficiency 
in men contributes to obesity and the metabolic syndrome. On the other hand, 
obesity itself is also considered a cause of male hypogonadism since leptin and 
obesity-induced proinflammatory cytokines have been shown to suppress the 
HPG axis and testicular testosterone production (181). Nutritional intervention 
for weight reduction or bariatric surgery (surgical treatment for severely obese 
patients) leads to increased plasma testosterone concentrations (182). Therefore, 
it should be concluded that obesity and testosterone deficiency are bidirectionally 
regulated.
Regarding fat distribution, testosterone treatment as a gender-affirming 
hormonal therapy for transmen (female-to-male transgender persons) resulted 
in a reduced subcutaneous fat deposition and a slight increase in visceral fat 
accumulation, resembling the male fat distribution pattern (147). In healthy 
men, testosterone administration dose-dependently affects total fat mass. 
Low serum testosterone concentrations increase fat mass while supra-physio-
logical concentrations reduce fat mass, but the changes in fat mass are evenly 
distributed between the visceral and subcutaneous depots (183). In men with 
hypogonadism, treatment with testosterone alone or in combination with 
finasteride (a 5α-reductase inhibitor for blocking peripheral conversion of 
testosterone to DHT) both resulted in an increase in lean body mass; decreases 
in waist circumference and total fat mass; improvement of physical performance; 
and decreased levels of leptin, insulin, inflammatory markers, and plasma lipid 
concentrations (184,185). These studies suggest a beneficial effect of testosterone 
on the metabolic profile in men, including a decrease in visceral adiposity.
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However, a study in abdominally obese men found that testosterone 
decreased whereas DHT increased visceral fat mass, while subcutaneous fat 
mass was unaffected by either treatment. Testosterone but not DHT increased 
glucose disposal under fixed hyperinsulinemic conditions, decreased fasting 
plasma glucose levels, and improved plasma lipid profiles, suggesting a complex 
mechanism rather than only a direct activation of AR (186). These studies 
are suggestive for (local) effects of E2 because DHT cannot be converted into 
E2 whereas testosterone can. Indeed, testosterone treatment to hypogonadal 
men led to increased plasma concentrations of both testosterone and E2. 
Moreover, this treatment restored the reduced mRNA expression of AR, ERα, 
and CYP19A1 in adipose tissue of hypogonadal men to those in eugonadal men 
(187). Importantly, an elegant study in healthy men revealed that the fat mass 
reducing effect of testosterone disappeared when an aromatase inhibitor was 
co-administered with testosterone. This co-administration resulted in a greater 
total fat mass than at baseline. In other words, estrogen deficiency may in fact be 
the main cause of increased body fat in hypogonadal and obese men (188). These 
studies illustrate the complex hormonal regulation of adipose tissue function 
and a potential estrogenic effect of testosterone through ERα in male adipose 
tissues.
Studies in male mice demonstrate some contradictory effects of castration 
on fat masses. For example, one study showed that castration led to an increased 
gonadal fat mass (189), whereas other studies showed no significant effect of 
castration on retroperitoneal, gonadal, and subcutaneous fat masses (47,190). 
Surprisingly, specific activation of AR by DHT and combined treatment of 
testosterone and an aromatase inhibitor in castrated mice resulted in an 
increased retroperitoneal fat mass, but neither testosterone treatment alone nor 
E2 treatment negatively affected the fat mass (190). However, the AR knockout 
(ARKO) mouse model revealed that ARKO males have increased fat mass, 
elevated serum leptin levels, and reduced physical activity, but the effects on 
insulin sensitivity, leptin sensitivity, adiponectin levels, and food intake were 
inconsistent (191-193). A possible explanation of the inconsistent phenotypes 
is the markedly reduced testosterone level and thus aromatase-synthesized E2 
in ARKO mice because AR is crucial for testicular testosterone production and 
ARKO males had atrophic testes. In fact, male mice with adipose-specific AR 
deficiency showed normal body weight and adiposity with unaffected serum 
testosterone and E2 levels, but an increase in intra-adipose E2 levels and 
hyperleptinemia, yet without leptin resistance. The increased leptin production 
is likely E2-driven (194).
Concerning adipokine synthesis, androgen deprivation in healthy men 
induced by gonadotropin-releasing hormone (GnRH) antagonist treatment led 
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to elevated plasma leptin and adiponectin concentrations, whereas testosterone 
administration suppressed the plasma concentrations of both adipokines (195). 
Likewise, testosterone treatment in transmen also resulted in reduced serum 
concentrations of leptin and adiponectin (160,161). In vitro stimulation of WAT 
explants or isolated adipocytes from subcutaneous WAT of men confirmed that 
DHT inhibited LEP mRNA expression and decreased leptin secretion. Moreover, 
the inhibitory effect of DHT on leptin synthesis was attenuated upon cotreatment 
with an AR antagonist, suggesting an AR-mediated mechanism (162). In male 
mice, castration resulted in elevated levels of total and HMW adiponectin, 
whereas testosterone treatment in castrated males reduced the circulating 
adiponectin levels. In addition, testosterone or DHT treatment in cultured 
adipocytes confirmed a direct inhibitory effect of testosterone on adiponectin 
secretion (196,197).
In contrast to men, hyperandrogenism in women, e.g. women with 
polycystic ovary syndrome (PCOS), is associated with increased total fat mass 
and insulin resistance, but without a difference in regional fat distribution 
compared to BMI-matched female controls (198). Another study however showed 
that women with PCOS had increased visceral fat accumulation and decreased 
insulin sensitivity, features which were also observed in normal-weight PCOS 
subjects (199). Interestingly, recent studies revealed that the reduced insulin 
sensitivity of PCOS women was associated with low serum adiponectin levels, 
hypertrophic morphology of adipocytes, and an increased waist/hip ratio, but not 
with androgen excess (200,201). Also in mice, continuous administration of DHT 
in prepubertal females resulted in a disturbed metabolic phenotype that included 
increased body weight, enlarged adipocytes in gonadal and inguinal WAT depots, 
impaired glucose tolerance, elevated leptin levels, and reduced adiponectin levels 
(202). Intriguingly, female mice with global loss of AR signaling were protected 
against the ovarian and metabolic consequences of DHT treatment, indicating 
that AR-mediated androgen actions are crucial for the pathogenesis of PCOS in 
the rodent DHT model (203).
3.4 Glucocorticoids
GCs are synthesized in adrenal glands under the control of the HPA 
axis, as a crucial stress response mechanism. GCs regulate energy substrate 
metabolism in many aspects, namely by inducing hepatic gluconeogenesis, 
reducing glucose uptake in skeletal muscles and adipose tissues, promoting 
lipolysis in adipose tissues, inhibiting insulin secretion from pancreatic β cells, 
and stimulating glucagon secretion from pancreatic α cells (204). Endogenous GC 
synthesis is different among mammal species. Due to a lack of the steroidogenic 
enzyme CYP17A1 (functioning as 17α-hydroxylase or 17,20-lyase) in adrenal 
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glands of mice and rats, corticosterone is the main endogenous GC for rodents, 
whereas cortisol is the main endogenous GC for humans (12,205). At target 
tissues, GCs bind the GR or the mineralocorticoid receptor (MR), depending on 
their expression profile and function in each target tissue.
Synthetic GCs, such as dexamethasone, prednisolone, and hydrocorti-
sone, are commonly prescribed medications due to their immunosuppressive 
properties. Weight gain is one of the most common side effects of synthetic GCs 
with a prevalence of 70% based on a self-reported population-based study, or at 
a hazard ratio of 2.4 based on an outpatient rheumatology clinic study (206,207). 
In patients with Cushing syndrome (clinical manifestation of pathological 
hypercortisolism), overweight/obesity is the most prevalent phenotype, present 
in 57–100% of patients, with a preferential pattern towards visceral rather 
than subcutaneous fat accumulation (208). The GC-induced visceral obesity 
can be explained by several mechanisms, especially with respect to the effects 
of GCs on WAT. First, GR mRNA expression levels and the binding capacity 
for GC in WAT homogenates are higher in omental tissues than in abdominal 
subcutaneous tissues (48,209). Second, intra-adipose cortisol levels are higher 
in omental WAT than in subcutaneous WAT, independent of serum cortisol 
level. This can be explained by an increased turnover rate and local generation 
of GC in adipose tissues, controlled by the 11β-HSD enzymes (209,210). The 
reductase 11β-HSD1 activates cortisone to cortisol, whereas the hydrogenase 
11β-HSD2 deactivates cortisol to cortisone. Both enzymes are present and 
functioning in WAT, but only the reductase activity and HSD11B1 mRNA 
expression are positively correlated with adipocyte size and total fat mass. 
Actually, GC treatment indirectly promotes the reductase activity by providing 
the cofactor NADPH for 11β-HSD1 activity in adipocytes from omental depots 
only. Direct effects on HSD11B1 mRNA expression or 11β-HSD1 protein levels, 
however, remain inconclusive (209,210). Third, LPL activity was higher while 
norepinephrine-induced lipolysis was lower in abdominal WAT of Cushing 
patients than in those of non-Cushing obese subjects, suggesting GC-induced 
lipid accumulation in the visceral depot. Of note, lipogenic and lipolytic activities 
in femoral WAT of Cushing patients were unaffected (211).
Concerning direct effects of GCs on lipid metabolism, dexamethasone 
(a potent GR agonist with a very weak binding to the MR) treatment of rat 
adipocytes directly stimulated lipolysis in a dose-dependent manner and this 
effect was abolished by RU486 (a potent GR and PR antagonist). Likewise, 
dexamethasone treatment of rats resulted in increased plasma levels of glycerol 
and free fatty acids, confirming the lipolytic effect of GCs. Epididymal fat of 
dexamethasone-treated mice also showed higher lipolytic activity and greater 
levels of HSL and ATGL mRNA expression and protein content (212). An in 
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vitro stimulation of 3T3-L1 adipocytes with corticosterone confirmed the direct 
lipolytic effect of GCs and the GC-induced basal lipolysis in adipocytes that had 
been chronically exposed to GCs (213).
However, the direct lipolytic effect of GCs alone cannot explain the 
increase in visceral fat accumulation in Cushing patients. Indeed, GCs have 
another crucial function in adipose tissues, namely promoting adipogenesis. 
Corticosterone treatment in rats showed that corticosterone increased in fat 
mass and number of adipocytes in the visceral depot but not the subcutaneous 
depot, indicating depot-dependent adipogenic recruitment (213). Of interest, 
among many compounds used in a standard cocktail for 3T3-L1 adipocyte 
differentiation, dexamethasone is the most crucial compound in the initial stage 
of differentiation, as without it adipogenesis is not induced (214). Likewise, in 
human preadipocytes obtained from abdominal subcutaneous adipose tissues of 
healthy subjects, knockdown of GR by small interfering RNA (siRNA) completely 
blocked the adipogenic action of cortisol, whereas knockdown of MR did not 
affect the differentiation (215). Hence, all studies suggest that GR plays a more 
important role than MR for the adipogenic action of GCs.
Regarding adipokine production, plasma leptin levels were elevated 
in patients with Cushing syndrome compared to non-obese subjects or obese 
subjects without endocrine diseases. Curative resection of adrenal tumors 
reduced plasma leptin levels while a dexamethasone challenge in healthy 
individuals increased plasma leptin levels (216). Cortisol treatment of cultured 
human adipocytes also resulted in increased LEP mRNA expression and leptin 
secretion. A siRNA knockdown of the gene encoding GR but not MR reduced the 
stimulatory effect of cortisol on leptin production, showing that GR is also the 
receptor involved in the stimulatory effect of GCs on leptin production (215). 
Likewise, dexamethasone treatment in cultured rat adipocytes also led to an 
upregulated Lep mRNA expression (217). 
The effects of GCs on adiponectin are different. Non-obese Cushing 
patients had a lower plasma adiponectin concentration than non-obese control 
subjects, but obese Cushing patients had the same low level of plasma adiponectin 
concentration as the obese control subjects. Hydrocortisone injection in healthy 
individuals confirmed the inhibitory effect of GCs on adiponectin production 
(218). Also in cultured human subcutaneous adipocytes, dexamethasone directly 
suppressed adiponectin secretion (219). In contrast, another study found that 
cortisol treatment of cultured human adipocytes isolated from abdominal 
subcutaneous depots induced ADIPOQ mRNA expression and adiponectin 
secretion. Knockdown of GR by siRNA reduced the stimulatory effect of cortisol 
on adiponectin production, whereas knockdown of MR had no effect (215). The 
contradictory effect of GC on adiponectin production warrant further studies.
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The HPA axis has been shown to exhibit sexually dimorphic regulation 
and activity. For example, many stress-induced psychiatric disorders, such as 
depressive and anxiety disorders, are more prevalent and severe in women than 
in men (220). Also in rodent studies, female rats have higher baseline levels and 
higher stress-induced levels of corticosterone and adrenocorticotropic hormone 
(ACTH; the pituitary hormone that stimulates the adrenal glands to synthesize 
and secrete GCs) than male rats (221,222). However, there are only a limited 
number of studies addressing sex differences in GC-induced alterations in 
adipose tissue function. In male mice, cotreatment of corticosterone and DHT 
potentiated, whereas cotreatment of corticosterone and the AR-antagonist 
enzalutamide attenuated GR responses in WAT (223). Another recent study 
showed that the GC-induced obesity and hypertrophic expansion of visceral fat 
depots in ovariectomized rats were attenuated by E2 treatment (224). Further 
studies are required to elucidate if the GC-induced metabolic derangements, 
including effects on adipose tissues, are sex-dependent.
4. Conclusion
Males and females display differences in adipose tissue distribution 
and functions that contribute to differences in the risk to develop obesity 
and obesity-related comorbidities. Differences in sex steroid hormone levels 
contribute significantly to these differences. However, studies in human and 
animal models also revealed that sex steroids have sex-dependent effects 
on adipose tissues. Recent studies showing that sex steroid hormone levels 
influence the metabolic effects of glucocorticoids, underline the need for more 
studies to gain a full understanding of the molecular mechanisms regulating 
these sex-dependent effects. Additional studies are also needed since sex- 
dependent effects of sex steroids and glucocorticoids have largely been overlooked 
with respect to their clinical implications, for instance, sex differences in 
the effects of pharmacological GCs. Better understanding of sex-dependent 
regulation of adipose tissues will facilitate the development of novel sex-specific 
therapeutic strategies to combat the obesity pandemic.
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1. Introduction
Adipose tissue can be generally categorized into two main types with 
opposite function: energy-storing white adipose tissue (WAT) and energy-burning 
brown adipose tissue (BAT), reviewed in chapter 1A. Upon cold stimulation, 
BAT utilizes energy-rich substrates, mainly fatty acids, to fuel thermogenesis, 
a mitochondrial process in which the activity of uncoupling protein 1 (UCP1) is 
pivotal. Upon confirmation of the presence of active BAT in adult humans in 2009 
(1-3), BAT has become a “hot organ” for metabolic research. Induced utilization 
of excess calories through BAT activation is considered a promising strategy for 
obesity treatment (4). As discussed in chapter 1A, studies in humans and rodents 
have shown that females generally have a higher BAT prevalence and activity 
than males (5-7). The thermogenic function of BAT is part of the whole-body 
thermal homeostasis. This chapter will therefore provide an overview of body 
temperature regulation and highlight the role of BAT herein. In addition, this 
chapter will discuss whether thermoregulation is sex-dependently modulated.
2. Body temperature regulation
Humans and rodents are endotherms whose core body temperature (Tc) 
is tightly controlled at ~37°C in a narrow range, e.g. 35.4–37.8°C for humans (8). 
This is because cellular proteins are irreversibly denatured at a Tc above 42°C 
and cellular reactions slow down at a Tc below the normal range, resulting in, for 
instance, fatal cardiac failure at Tc ~27°C (9,10). In general, core temperatures, 
e.g. in the brain and the thoracoabdominal compartment, are usually higher than 
peripheral temperatures, e.g. skin temperatures (Tsk) measured at the limbs. 
Heat is transferred between the core and the periphery via the circulation, which 
is an important regulator of body thermal homeostasis (10). To achieve optimal 
thermoregulation, the body integrates three main components for autonomic 
responses: afferent (input) sensing, central integration, and efferent (output) 
responses (9,11), see Figure 1 for a schematic overview.
The skin serves as the principal sensory organ since it contains sensory 
nerve endings of afferent sensory neurons located in the dorsal root ganglia (DRG) 
(11). The neuronal receptive endings contain temperature sensors (or thermo-
receptors) that belong to the transient receptor potential (TRP) superfamily 
of cation channels of which the voltage-dependent receptors are affected by 
different temperatures. Examples of these sensors include the heat-sensitive 
channel TPRV1, the warm-sensitive channel TRPM2, and the cool-sensitive 
channel TRPM8 (12,13). Via these sensors, information about the Tsk is directed 
to the thermosensory neurons: first-order neurons in the DRG, second-order 
neurons in the dorsal horn (DH) of the spinal cord, and third-order neurons in 
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Figure 1  Overview of autonomic thermoregulation
Abbreviations (from input to output): Tsk, skin temperature; DRG, dorsal root ganglia; DH, 
dorsal horn of the spinal cord; LPB, lateral parabrachial nucleus of the pons; POA, preoptic 
area of the anterior hypothalamus; DMH, dorsomedial hypothalamic nucleus; rRPa, rostral 
raphe pallidus nucleus in the medulla oblongata; VH, ventral horn; IML, intermediolateral cell 
column of the spinal cord; PVG, paravertebral ganglia; BAT, brown adipose tissue; CVC, 
cutaneous vasoconstriction; and Tc, core body temperature.
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the lateral parabrachial nucleus (LPB) of the pons. The LPB, in turn, transmits 
the signal to the preoptic area (POA) of the anterior hypothalamus, the master 
thermoregulatory sensorimotor integration area (9,11). Of note, warm and cool 
signals are transmitted through separate populations of afferent neurons that 
project to distinct populations of neurons in POA to distinguish between warm 
and cool sensory inputs (14).
The warm-activated neurons and cold-activated neurons in the POA 
are interconnected to integrate the signals from the LPB, and hence transmit 
inhibitory or excitatory signals to the dorsomedial hypothalamic nucleus [DMH, 
the key regulator for body temperature, body weight, and metabolic function 
(15)] in the posterior hypothalamus and/or to the rostral raphe pallidus nucleus 
(rRPa) in the medulla oblongata. The DMH contains BAT sympathoexcitatory 
neurons and shivering promoting neurons, while the rRPa contains cutaneous 
vasoconstriction (CVC) premotor neurons, BAT sympathetic premotor neurons, 
and skeletal muscle shivering premotor neurons. In other words, cold exposure 
leads to excitatory commands to the DMH and the rRPa that stimulate the 
cold-defensive responses such as a reduction in heat loss by peripheral vasocon-
striction and inductions in heat production by skeletal muscle shivering and 
BAT activation. By contrast, warm exposure inhibits the excitatory commands 
to the DMH and the rRPa (9,11).
For vasoconstriction and BAT thermogenesis during cold exposure, 
signals from the premotor neurons in the rRPa are transmitted through the 
preganglionic neurons in the intermediolateral cell column (IML) of the spinal 
cord, which synapse onto the postganglionic neurons in the paravertebral 
ganglia (PVG), and in turn stimulate the effector organs, cutaneous blood vessels 
or BAT depots. For shivering, the involuntary somatic premotor neurons in the 
rRPa drive the α- and γ-motoneurons in the ventral horn (VH) of the spinal cord to 
initiate repeated skeletal muscle contractions (11). Although shivering leads to 
rapid, maximal heat production during cold stress, it is a more energy-consuming 
process than BAT activation, even when the cold is rather mild. Hence, shivering 
thermogenesis is initiated only when the energy-inexpensive vasoconstriction is 
at its maximum. Non-shivering BAT thermogenesis is enhanced and preferred 
during habitual/prolonged cold conditions (9,16,17). For example, mice exposed 
to 4°C for 3 weeks had ~4-fold induction in UCP1 mRNA and protein expression 
in their BAT, compared to mice housed at 21°C (18). Rats housed at 10°C for 3 
weeks also had higher oxidative activity in BAT, as well as a larger BAT depot, 
indicating a more metabolically active BAT compared to BAT of rats kept at 
27°C (19). These rodent findings underscore the importance of non-shivering 
thermogenesis in BAT for chronic cold-defensive responses.
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In contrast, warm exposure leads to peripheral vasodilation for heat 
dissipation, through inhibition of the sympathetic CVC tone. In hot conditions, 
warm-activated neurons also activate the sympathetic outflow through 
sympathetic cholinergic nerves that induce active vasodilation of peripheral 
vessels and perspiration of eccrine sweat glands, resulting in evaporative heat 
loss. When the ambient temperature (Ta) exceeds Tc, evaporative cooling is the 
only possible mechanism for heat dissipation (9,11,20).
After thermal effectors have responded to external cues, e.g. changes in 
Ta or Tsk, temperature sensors in internal organs recheck the adjusted Tc, and 
send a feedback signal to the POA in order to optimize the thermoregulatory 
circuit (11,21). In fact, only changes in Tc initiate the autonomic thermoregulatory 
responses and sensory information from Tc contributes more than Tsk to 
the autonomic responses (22). Furthermore, physiological thermoregulatory 
mechanismsalso involve behavioral adaptations, e.g. changing body posture or 
clothing [reviewed in (23)], which are beyond the scope of this chapter.
3. Sex difference in thermoregulation
Studies in humans and rodents have revealed sex differences in several 
of the thermoregulatory control mechanisms. A remarkable sex difference is 
the sex hormone-driven alterations in Tc. Women during the luteal phase of the 
menstrual cycle and women taking hormonal contraceptives have a 0.3–0.5°C 
higher Tc than men and women during the follicular phase (24,25). Of note, 
the Tc fluctuation during reproductive cycles is also observed in mice (26). This 
fluctuation in Tc in females is mediated by progesterone, resulting in decreased 
firing rates of warm-sensitive neurons and increased firing rates of cold-sensitive 
neurons in the POA (27). In addition, a study comparing the thermoeffector 
responses between the early follicular phase and the midluteal phase found 
that Tc at which women started shivering, sweating, and displaying cutaneous 
vasodilation were all increased in the luteal phase, confirming the set point 
altering effects of progesterone (28). Interestingly, estrogen seems to counteract 
this effect of progesterone on the temperature set point since the Tc of women 
taking combined estrogen-progestin (a synthetic progesterone) contraceptives 
was ~0.5°C lower than Tc of women taking progestin-only contraceptives (29).
An important factor for thermoregulation is body composition, an anthro-
pometric feature that is profoundly different between men and women. A higher 
body surface area (BSA) directly results in a higher rate of heat loss, whereas 
body mass positively correlates with the rate of heat production and storage. 
The BSA-to-mass ratio thus dictates the net heat transfer from the body to its 
surroundings (30,31). With similar adiposity, women generally have a larger 
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BSA but a smaller body mass than men, indicating a higher heat loss and a 
lower heat production capacity compared to men. Therefore, the sex difference 
in body composition, with women having in general a higher BSA-to-mass ratio 
than men, suggests that women have a higher basal rate of heat loss than men 
(30-32). Intriguingly, a recent study found that the BSA-to-mass ratio was 
almost the sole determinant for heat-dissipating responses during an exercise 
with matched heat-loss requirements and that women favored dry heat loss 
(vasodilation) whereas men depended more on evaporative heat loss (sweating) 
(33).
The thermoeffector responses, e.g., adaptations of cutaneous vessels, 
sweating, and BAT thermogenesis, have been shown to display a certain degree 
of sex-dependent regulation. A human study in which the researchers infused 
warm or cold saline to manipulate Tc while keeping Tsk constant found that the 
average Tc at which women started vasoconstriction, sweating, and shivering 
were all ~0.3°C higher than the Tc in men (34). However, the inter-threshold 
range of shifting from vasoconstriction to sweating was ~0.2°C, which was equal 
in both sexes (34).
Concerning direct effects of sex hormones on vascular tones, 17β-estradiol 
(E2) directly causes rapid vasodilation by estrogen receptor (ER)-stimulated 
production of nitric oxide, an endothelium-derived relaxing factor, in vascular 
walls (35). The effects of progesterone and testosterone on blood vessels have 
also been studied, but the findings are contradictory. For example, while acute 
testosterone treatment increased vasodilation, chronic testosterone treatment 
led to impaired vascular relaxation and augmented vasoconstriction (36,37).
Studies have shown sex differences in sweating. Men had a greater 
maximal sweat rate than women when they were locally infused with 
acetylcholine, without a difference in cutaneous blood flow or the number of 
active sweat glands (38,39). Furthermore, although the acetylcholine-induced 
sweat rate was increased in physically trained subjects, the sweat rate remained 
higher in the physically trained men than in trained women (38). The same 
sex difference was also found when volunteers were exposed to a controlled 
whole-body heating protocol. Although men had a higher maximal sweat rate 
than women, the change in Tc and the Tsk at which sweating started, as well as 
cutaneous vasodilation measured by cutaneous vascular conductance, did not 
differ between the sexes (39). 
As reviewed in chapter 1A, BAT is more prevalent and active in females 
than in males (5-7,40) and studies have demonstrated that the female sex 
hormones E2 and progesterone stimulate while the male sex hormone testos-
terone inhibits BAT activities (41,42). In addition, E2 can directly influence the 
central nervous system through ERα in the ventromedial hypothalamus (VMH), 
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which subsequently activates the rRPA, resulting in sympathetic nervous 
system activation, and hence BAT activation (43,44). Female mice lacking ERα 
in the VMH-specific steroidogenic factor-1 neurons had a reduction in sympathetic 
outflow activity and impaired BAT thermogenesis, confirming the direct E2- 
activated BAT thermogenesis in the VMH (45).
4. Thermal perception: a matter of sex?
In terms of thermal perception, thermal comfort is not only the sensation 
of Ta, but also a subjective interpretation of an individual how satisfied he/she is 
with Ta. Of interest, research has shown that women are more sensitive to and 
more often dissatisfied to fluctuations in Ta than men (46-50). In other words, 
women have a smaller comfort range of Ta than do men, though the findings have 
not always been statistically significant (50,51). This sex-dependent thermal 
preference has been nicely demonstrated in mouse studies. For instance, if mice 
were allowed to choose to reside at either 20, 25, or 30°C, females preferred to 
spend more time in the 30°C cage and less time in the 20°C cage, compared to 
males (52,53). One of the possible mechanisms for this sex difference in thermal 
sensation is the sensitivity of the cool-sensitive TRPM8. Females had higher 
sensitivity (lower threshold) and greater signal transmission of TRPM8 in the 
DRG neurons than males. The sex-dependent effects in TRPM8 were lost upon 
removal of E2 and testosterone from the culture media (54), implicating a role 
for sex steroids in thermal sensation.
5. Conclusion
Optimal control of Tc is achieved by coordination of thermal somato- 
sensory organs, central integrating centers in the hypothalamus, and thermo- 
effector organs. Sex differences in thermoregulation are evident in multiple 
aspects, such as anthropometric characteristics and effects of sex hormones on 
BAT. However, it is still largely unknown whether sex hormones are involved in 
the differences in thermal perception. Also, whether the different sensitivities to 
Ta in males and females are causative for the sex differences in thermoeffector 
responses requires more dedicated investigations. 
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Males and females display differences in adipose tissue distribution 
and function, as well as in thermoregulation, as reviewed in Chapters 1A and 
1B. Yet, the mechanisms that underlie this sex dimorphism are not completely 
understood. So far, most human and rodent studies have studied the role of the 
sex steroids estrogens and androgens in adipocyte metabolism, proliferation, and 
function. However, little is known whether other factors, such as glucocorticoids 
and sensory input, contribute to sex differences in white adipose tissue (WAT) 
and brown adipose tissue (BAT) function and whether these factors modulate 
the actions of sex steroids on adipose tissue.
This thesis therefore aims to investigate intrinsic and glucocorticoid- 
induced sex differences in adipose tissue function. In addition, this thesis aims 
to unravel the role of sex hormones in thermal perception, as this might be an 
important factor in controlling sex differences in BAT activity. 
Chapter 2 presents a study on the effects of treatment with high-dose 
corticosterone (the endogenous rodent glucocorticoid) on whole-body glucose 
metabolism and adipose tissue adaptation in male and female mice. WAT and 
BAT are studied by morphological, molecular, and functional approaches. One 
of the aims of this study was to investigate whether biological sex modulates 
the adverse metabolic consequences caused by the intensive glucocorticoid 
treatment.
Chapter 3 focuses on sex differences in mouse BAT transcriptome with 
the aim to identify molecular mechanisms that contribute to sex differences in 
BAT morphology and activity. In addition, the effects of the less studied female 
sex hormone progesterone on cultured adipocytes were analyzed to gain insight 
into its regulatory role in BAT activity.
Chapter 4 demonstrates another aspect of BAT regulation, namely 
a sensory input for BAT activation. Because exposure to cold (an ambient 
temperature lower than the thermoneutral zone) is a major driver of BAT 
thermogenesis for maintaining an optimal body temperature, this study 
explored whether the thermal preference between young adult male and female 
mice differs. Since sex hormones are important physiological regulators of the 
temperature set point in the central nervous system, gonadectomy was performed 
to study the role of sex steroids herein.
Chapter 5 is a translational and confirmatory study on the thermal 
preference in young adult men and women. In this study, the water-filled cooling 
blanket was used as a body-cooling instrument since this is a common method for 
studying BAT activity. The temperature at which participants started shivering, 
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was used as the primary outcome since this is a sensitive and quantitative 
assessment for evaluating cold perception threshold in humans.
Chapter 6 provides a general discussion about the findings of the studies 
presented in this thesis and incorporates some recent updates on interactions 
between sex and stress hormones influencing adipose tissue function. Finally, 
conclusions and some future perspectives are provided.

Chapter 2
Sex Difference in Corticosterone-Induced 
Insulin Resistance in Mice
Kasiphak Kaikaew1,2, Jacobie Steenbergen1, Theo H. van Dijk3, Aldo Grefhorst1,4, 
Jenny A. Visser1
1 Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands
2 Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
3 Department of Laboratory Medicine, University Medical Center Groningen, Groningen, the Netherlands
4 Department of Experimental Vascular Medicine, Amsterdam University Medical Centers, Location AMC, 
Amsterdam, the Netherlands
Endocrinology (2019) 160: 2367–2387
2
62
2
Chapter 2
Abstract
Prolonged exposure to glucocorticoids (GCs) causes various metabolic 
derangements. These include obesity and insulin resistance, as inhibiting glucose 
utilization in adipose tissues is a major function of GCs. Although adipose tissue 
distribution and glucose homeostasis are sex-dependently regulated, it has 
not been evaluated whether GCs affect glucose metabolism and adipose tissue 
functions in a sex-dependent manner. In this study, high-dose corticosterone 
(rodent GC) treatment in C57BL/6J mice resulted in nonfasting hyperglycemia 
in male mice only, whereas both sexes displayed hyperinsulinemia with normal 
fasting glucose levels, indicative for insulin resistance. Metabolic testing using 
stable isotope-labeled glucose techniques revealed a sex-specific corticosterone- 
driven glucose intolerance. Corticosterone treatment increased adipose tissue 
mass in both sexes, which was reflected by elevated serum leptin levels. 
However, female mice showed more metabolically protective adaptations of 
adipose tissues than did male mice, demonstrated by higher serum total and 
high-molecular-weight adiponectin levels, more hyperplastic morphological 
changes, and a stronger increase in mRNA expression of adipogenic differentia-
tion markers. Subsequently, in vitro studies in 3T3-L1 (white) and T37i (brown) 
adipocytes suggest that the increased leptin and adiponectin levels were mainly 
driven by the elevated insulin levels. In summary, this study demonstrates 
that GC-induced insulin resistance is more severe in male mice than in female 
mice, which can be partially explained by a sex-dependent adaptation of adipose 
tissues.
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Introduction
Glucocorticoids (GCs) are steroid hormones produced by the adrenal 
gland. External stressors such as infection, trauma, food deprivation, and 
physical or psychological stress enhance the activity of the hypothalamic- 
pituitary-adrenal (HPA) axis and trigger the adrenal gland to secrete an 
endogenous GC: cortisol for humans or corticosterone for rodents (1). 
Exogenous synthetic GCs are widely prescribed for a number of 
autoimmune diseases and allergic reactions due to their immunosuppressive 
properties (2). However, prolonged exposure to elevated endogenous GCs, 
such as in Cushing syndrome, or to exogenous GCs leads to various metabolic 
derangements, such as progressive weight gain, truncal obesity due to expansion 
of the visceral white adipose tissue (WAT), loss of subcutaneous WAT mass, and 
development of insulin resistance that might result in diabetes mellitus (2-5). 
These effects are largely attributable to the role of GC in the control of glucose 
homeostasis, as they promote hepatic glucose production (gluconeogenesis) and 
inhibit glucose utilization in WAT and skeletal muscles (1,4).
The HPA axis is controlled in a sexually dimorphic manner: female 
rodents have higher basal and stress-induced corticosterone levels with a less 
robust negative feedback on the HPA axis than do males (6,7). The fact that 
the concentrations of corticosteroid-binding globulin, the glycoprotein that binds 
80% of circulating corticosterone, are higher in females than in males likely 
contributes to this sex difference (6,8). Sex steroid hormones are also involved in 
the sex-dependent control of the HPA axis (6,7). In adult male rats, castration 
and estradiol treatment increase responsiveness of the HPA axis to external 
stressors whereas ovariectomy and androgen replacement in female rats 
decrease this response (7).
Intriguingly, adipose tissue distribution and function show many sex- 
dependent characteristics as well. Concerning WAT distribution, females have 
relatively more subcutaneous WAT and less visceral WAT than do males (9,10). 
Females also have a relatively higher activity of the metabolically active brown 
adipose tissue (BAT) and have more brown-like adipocytes in their WAT depots 
(11,12). Furthermore, glucose metabolism has been shown to differ between 
males and females, with female mice being more insulin sensitive and glucose 
tolerant than male mice (13).
Despite these sex differences in HPA axis regulation, adipose tissue 
distribution, and glucose homeostasis, high-dose GC- or stress-induced adverse 
effects have only been studied in male rodents (14,15). Whether the metabolic 
consequences of exposure to high-dose GC differ between males and females is 
still unknown. To address this knowledge gap, we have studied the effects of 
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2-week high-dose corticosterone on whole-body glucose metabolism and adipose 
tissue function in both male and female C57BL/6J mice.
Materials and Methods
Animals, housing conditions, and corticosterone treatment
Eight-week-old C57BL/6J mice (24 males and 24 females) were obtained 
from Charles River Laboratories (Maastricht, Netherlands). Upon arrival, mice 
were group housed (three mice per cage) at room temperature (RT; ~22°C) on 
a 12-hour light/12-hour dark cycle (lights on at 8:00 AM). Chow food pellets 
(801722 CRM (P), Special Diets Services, Essex, UK) and water were available 
ad libitum. We provided tissue papers (Tork extra soft facial tissue, SCA Hygiene 
Products, Zeist, Netherlands) as nesting material and woodchips (Lignocel BK 
8/15, J. Rettenmaier & Söhne GmbH, Rosenberg, Germany) as bedding material. 
All experimental procedures were approved by the Animal Ethics Committee at 
Erasmus MC, Rotterdam, Netherlands.
After 10 to 14 days of acclimatization, a corticosterone pellet [50 mg 
of corticosterone (Sigma-Aldrich, Zwijndrecht, Netherlands) and 50 mg of 
cholesterol] or a vehicle pellet (100 mg cholesterol) was implanted subcutane-
ously at the dorsal region of the neck under isoflurane (Teva Pharmachemie, 
Haarlem, Netherlands) anesthesia and carprofen (Rimadyl Cattle, Pfizer, Pfizer 
Animal Health, Capelle aan den IJssel, Netherlands) analgesia. Subsequently, 
mice were single housed and enrolled in experiment 1 or 2.
Experiment 1: nonfasting glucose monitoring and endpoint blood and tissue 
collection
For experiment 1, mice were weighed on day 0 (before pellet implan-
tation) and on days 3, 5, 7, 10, and 12 after pellet implantation at 1:00 PM. At 
the same time, their nonfasting blood glucose (NFBG) level was determined by 
tail-tip bleeding using a glucometer and test strips (FreeStyle Freedom Lite, 
Abbott, Hoofddorp, Netherlands). On day 12, we weighed the food pellets and 
transferred the mice to a new cage with similar conditions. On day 14 at 8:00 AM, 
the mice and food pellets were weighed again, the NFBG was measured, and the 
bedding material was collected for further processing. Next, we transferred the 
mice to clean cages with similar conditions except for the presence of food pellets. 
At 1:00 PM (after 5 hours of fasting), the fasting blood glucose (FBG) level was 
determined and the mice were euthanized by cardiac puncture under isoflurane 
anesthesia. Thymus involution was confirmed in the corticosterone-treated mice. 
Blood was stored immediately at 4°C and various tissues (e.g., BAT, WATs, 
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quadriceps femoris muscle, and liver) were dissected, weighed, and snap-frozen 
in liquid nitrogen or fixed in 4% paraformaldehyde (PFA) in PBS at RT. The 
inguinal (also known as posterior subcutaneous) WAT (iWAT) and gonadal 
WAT (gWAT) depots were cut in half. One half of iWAT was snap-frozen; one 
half of gWAT was further divided and snap-frozen or fixed as described above. 
The other half of iWAT and gWAT was washed in PBS and preincubated in 
DMEM/F12 medium (catalog no. 21331020, Gibco, Life Technologies Europe, 
Bleiswijk, Netherlands) with 2% fatty acid–free BSA (FF-BSA; catalog no. 
03117057001, Roche Diagnostics, Mannheim, Germany) at RT for subsequent 
ex vivo stimulation.
Serum (obtained after an overnight clotting at 4°C) and snap-frozen 
tissues were stored at −80°C until analyses. After 24-hour fixation in PFA at 
RT, tissues were stored in 70% ethanol until histological analysis. Feces was 
collected from the bedding material, air-dried, weighed, crushed, and extracted 
with ethanol for fecal corticosterone measurement, as described previously (16).
Experiment 2: intraperitoneal glucose tolerance test
For experiment 2, mice were weighed and their NFBG was determined 
on days 0 (before pellet implantation), 7, and 14 at 8:00 AM. Next, food pellets 
were removed and the mice were fasted until 1:00 PM when their FBG was 
determined and one blood spot (~6 µL) was collected on filter paper (TFN 180 g/m2, 
Sartorius Stedim Biotech, Göttingen, Germany) for fasting blood insulin (FBI) 
measurement. Additionally, on day 14 mice were subjected to an intraperitoneal 
glucose tolerance test (IPGTT). For this, the mice received an IP injection of 2 g/kg 
glucose [20% glucose solution, which contains 95% D-(+)-glucose (Sigma-Aldrich) 
and 5% [U-13C6]-D-glucose (Cambridge Isotope Laboratories, Andover, MA)]. 
Blood glucose levels were determined and two blood spots (~3 µL for glucose 
kinetic analysis and ~6 µL for insulin measurement) were collected on filter paper 
at 5, 15, 30, 45, 75, and 120 minutes after glucose injection. After the experiment, 
mice were euthanized by cervical dislocation under isoflurane anesthesia. Blood 
spots were air-dried for 2 hours and stored at −20°C (for insulin measurement) 
or at RT (for glucose extraction).
Insulin stimulation of WAT explants
Pieces of iWAT and gWAT preincubated with 2% FF-BSA in DMEM/
F12 (from experiment 1) were cut into small pieces of ~20 mg and incubated 
in DMEM/F12 medium containing 2% FF-BSA (Roche Diagnostics) with or 
without 1 µM insulin (Sigma-Aldrich) at 37°C in a humidified incubator with 5% 
CO2 for 2 hours (refreshed once with fresh solution after 1 hour of incubation). 
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Subsequently, tissues were washed twice in cold PBS and stored at −80°C until 
protein extraction.
Adipose tissue histology and adipocyte size quantification
PFA-fixed gWAT, anterior subcutaneous (also known as axillary) WAT 
(aWAT), and BAT were embedded in paraffin. After manually sectioned with 
a microtome, 8-µm-thick WAT and 5-µm-thick BAT sections were mounted on 
glass slides and stained with hematoxylin and eosin.
Representative photos from three random sections of gWAT and aWAT 
from each animal were taken with a digital imaging system (Nikon Eclipse 
E400 and Nikon Digital Sight DS-L1, Nikon Corporation, Tokyo, Japan). To 
quantify adipocyte size, we used an automated mode of Adiposoft, a plug-in of 
Fiji (advanced distribution of ImageJ) software for accurately analyzing number 
and size of adipocytes (17).
Circulating hormone and adipokine quantification by ELISA
Serum and fecal concentrations of hormones and adipokines of the 
mice from experiment 1 were determined according to the manufacturers’ 
protocols. Serum total and high-molecular-weight (HMW) adiponectin levels 
were measured with a mouse HMW and total adiponectin ELISA kit (18). Serum 
leptin was measured with a mouse/rat leptin ELISA kit (19). Serum and fecal 
corticosterone levels were determined with a corticosterone ELISA kit (20).
The insulin concentrations in the blood spots collected in experiment 2 
were determined as previously described (21) using a rat insulin ELISA kit (22) 
with the Mouse Insulin Standard (90020, Crystal Chem, Zaandam, Netherlands). 
In brief, a completely filled blood spot on filter papers (6-mm diameter) was 
punched out and eluted in guinea pig anti-insulin in sample diluent overnight at 
4°C, followed by the standard procedure of the ELISA kit.
Derivatization and gas chromatography–mass spectrometry measurements of 
glucose
Extraction of glucose from the filter paper blood spots, derivatization of 
the extracted glucose, and gas chromatography–mass spectrometry (GC-MS) 
measurements of the glucose derivatives were done according to the analytical 
procedure described before (23). In short, a disk was punched out of the blood 
spots, glucose was extracted from the disk by incubating it in ethanol/water 
(10:1 v/v), and glucose was derivatized to its pentaacetate ester. Samples were 
analyzed by GC-MS (Agilent 5975C inert MSD, Agilent Technologies, Amstelveen, 
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Netherlands) with separation of derivatives on 30-m × 0.25-mm interior diameter 
(0.25-µm film thickness) capillary columns (ZB-1701, Phenomenex, Utrecht, 
Netherlands) and with positive-ion chemical ionization with methane. Measured 
by GC-MS, the fractional isotopomer distribution (M0 to M6) was corrected for 
the fractional distribution due to natural abundance of 13C by multiple linear 
regression as described by Lee et al. (24), to obtain the excess fractional distribu-
tion of mass isotopomers (M0 to M6) due to the dilution of administrated [U-13C6]-
D-glucose; that is, M6 represents the fractional contribution of the administered 
tracer and was used in the calculations of blood glucose kinetics.
Calculation of blood glucose metabolism
Tracer concentrations were calculated as the product of the blood glucose 
concentration and the fractional contribution of the tracer at that time point (t): 
[13C6-glucose]t = (M6)t·[glucose]t. To determine the effects of the IPGTT on glucose 
metabolism in mice, we used an adapted minimal model for glucose metabolism 
after an oral glucose tolerance test (25). This adapted model is presented in 
Fig. 1A and was used in SAAM II software (version 2.3, The Epsilon Group, 
Charlottesville, VA). To generate sufficient input data for this model, measured 
data of blood glucose, blood insulin, and tracer concentrations were fitted to 
the following formula to calculate the concentration (C) of these metabolites at 
multiple time points (t): Ct = Cb + C(1)0∙e
−k(1)t + C(2)0∙e
−k(2)t − C(3)0∙e
−k(3)t , where b 
indicates the basal value and 0 indicates the estimated value at time point 0. The 
bioavailability (F) of the bolus was estimated from the tracer curve as follows:
F = 1 − [ C(3)0k(1)k(2)C(1)0k(2)k(3) + C(2)0k(1)k(3) ] .
The glucose kinetic parameters were calculated using the compartmental 
model and the relevant equations (26-28), as presented in Fig. 1. In this model, 
k1 and k2 are rate constants for the glucose flux from the accessible plasma pool 
to the inaccessible tissue pool and vice versa, whereas k3 is the rate constant for 
the insulin flux from the accessible plasma pool to the inaccessible tissue pool, 
and they are different from the rate constants k(1), k(2), and k(3) used to describe 
the plasma glucose vs time curve above. We adapted the volume of the accessible 
glucose pool from literature; that is, 150 mL/kg was suggested by Tissot et al. 
(29) and Gastaldelli et al. (30) for humans. The insulin-independent glucose 
utilization was set to three times the insulin-dependent glucose utilization 
under basal conditions as was also used for humans (31,32). Furthermore, under 
basal conditions the independent utilization flux was estimated at 45% of the 
endogenous glucose production (EGP). The fractional turnover rates (k0 through 
k4) were estimated within the model.
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Fig. 1  Compartmental model and formulas used for calculating blood glucose kinetics
(A) Kinetic model used to calculate the kinetic parameters of glucose metabolism upon an 
IPGTT in mice. Upon injection into the IP compartment, the injected glucose passes the 
liver to contribute to the accessible plasma glucose pool (Qp) and to the inaccessible tissue 
glucose pool (Qt). Additionally, glucose produced/released by tissues such as the intestine and 
liver also contribute to Qp. As such, two rates of appearances can be distinguished, namely 
that of exogenous injected glucose (Raexo) and of endogenous glucose (Raendo). The Qp is in 
equilibrium with Qt via two rate constants (k1 and k2). Disposal of glucose (U) from the Qp can 
be divided in insulin-independent glucose-dependent disposal (Uiig) and insulin-independent 
constant disposal (Uiic). Disposal from the Qt is the sum of insulin-dependent constant disposal 
(Uidc) and insulin-dependent disposal (Uidi). As with glucose, this model also presumes two 
compartments for insulin, namely the accessible plasma insulin pool (Ip) and the inaccessible 
tissue insulin pool (It). (B) The formulas for assessing glucose metabolism indexes and kinetic 
parameters. HOMA-IR, an acceptable surrogate index for insulin resistance when applying a 
mouse-specific constant (26,27), was calculated relative to a median of the vehicle-treated 
male mice. β-Cell response was estimated as changes in plasma insulin levels relative to 
changes in glucose levels (28). Subscript b refers to a basal level, subscript 0 refers to an 
estimated value at time point 0, and Vg indicates the volume of the accessible pool.
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In vitro adipocyte culture
The white preadipocyte cell line 3T3-L1 (33) and the brown preadipocyte 
cell line T37i [(34); a gift provided by Dr. M. Lombès, Inserm U1185, France] 
were used to study direct effects of corticosterone and/or insulin on adipocytes. 
3T3-L1 preadipocytes were cultured with basal medium [3T3-BM: DMEM 4.5 
g/L glucose with L-glutamine and 25 mM HEPES (21063029, Gibco) supple-
mented with 10% fetal bovine serum (FBS; Gibco) and 100 IU/mL penicillin/100 
µg/mL streptomycin (P/S; Gibco)]. Two days after reaching full confluence 
(differentiation day 0), 3T3-L1 cells were differentiated with differentiation 
medium 1: 3T3-BM containing 0.5 mM 3-isobutyl-1-methylxanthine, 0.25 µM 
dexamethasone and 1 µg/mL insulin (all from Sigma-Aldrich). Starting from day 
4, cells were maintained in differentiation medium 2 (3T3-BM containing 1 µg/
mL insulin) that was refreshed every 2 to 3 days until full differentiation on day 
12. T37i preadipocytes were cultured with basal medium [T37i-BM: DMEM/F12 
with L-glutamine (21041025, Gibco) supplemented with 10% FBS, P/S, and 20 
mM HEPES (Gibco)]. Two days after reaching full confluence (differentiation 
day 0), T37i cells were differentiated by adding 2 nM triiodothyronine and 20 nM 
insulin (both from Sigma-Aldrich) to T37i-BM. This medium was refreshed every 
2 to 3 days until full differentiation on day 9.
Before corticosterone and insulin stimulation, the differentiating cells 
were steroid-starved for 24 hours by replacing FBS with dextran-coated charcoal-
treated FBS [prepared by incubating 100 mL of FBS twice with 0.1 g of dextran 
T250 (Pharmacia, Uppsala, Sweden) and 1 g of activated charcoal (C5510, 
Sigma-Aldrich) for 30 minutes, centrifuged, and sterile-filtered]. Three hours 
before stimulation, the differentiated cells were starved in starvation medium: 
DMEM (for 3T3-L1) or DMEM/F12 with 20 mM HEPES (for T37i) supplemented 
with P/S and 0.2% dextran-coated charcoal-treated FBS. Subsequently, the cells 
were stimulated for 24 hours in starvation medium containing 1 µL/mL ethanol 
vehicle control, 1 µM corticosterone, 0.2 µM insulin, or 1 µM corticosterone and 
0.2 µM insulin (both from Sigma-Aldrich). After stimulation, the cells were 
used to determine their glucose uptake or immediately stored at −80°C until 
RNA isolation or protein extraction. In the latter case, cultured media were also 
collected, centrifuged, and stored at −20°C for adipokine measurement by ELISA.
Radioactive glucose uptake
For the glucose uptake studies, the 24-hour corticosterone- and/or 
insulin-treated cells were washed with PBS and stimulated with 0, 20, or 100 
nM insulin in 0.1% FF-BSA (03117057001, Roche Diagnostics) in PBS for 15 
minutes. Next, 0.05 µCi of 2-[1-14C]-deoxy-D-glucose (PerkinElmer, Waltham, 
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MA) in 0.1% FF-BSA was added to the medium. After an additional 5-minute 
incubation, the cells were washed twice with cold PBS, lysed with 0.2% SDS 
solution (Merck, Hohenbrunn, Germany), and protein content in cell lysates 
was quantified using Advanced protein assay reagent (Cytoskeleton, Denver, 
CO). Cell lysates were transferred to a scintillation glass vial and homogenized 
in a scintillation cocktail (Optiphase Hisafe 3, PerkinElmer Health Sciences, 
Groningen, Netherlands). Radioactivity was detected with a liquid scintillation 
analyzer (Tri-Carb 2910TR, Packard, PerkinElmer) and reported in counts per 
minute normalized to protein content.
Gene expression analysis
RNA was isolated from mouse tissues and cultured cells using the 
TriPure Isolation Reagent (Roche Diagnostics) according to manufacturer’s 
instructions. Contaminating genomic DNA was removed using RQ1 RNase-Free 
DNase (Promega Corporation, Madison, WI). Purified RNA was quantified with 
a NanoDrop 8000 Spectrophotometer (Thermo Fisher Scientific, Wilmington, 
DE). Reverse transcription was performed using the Transcriptor high-fidelity 
cDNA synthesis kit (Roche Diagnostics). Quantitative PCR was performed using 
FastStart Universal SYBR Green Master (Rox) (Roche Diagnostics) with a 
QuantStudio 7 flex real-time PCR system (Applied Biosystems, Life Technologies, 
Carlsbad, CA). Expression of the tested genes was normalized to the indicated 
housekeeping genes using the 2−∆∆CT method. Sequences of the primers for all 
genes are listed in Table 1.
Protein extraction
Protein was extracted from the insulin-stimulated WAT explants by 
mincing the tissues with a micropestle in lysis buffer containing 50 mM HEPES, 
150 mM NaCl, 10 mM EDTA, 2 mM Na3VO4, 20 mM NaF, 1% Triton X-100, 
phosphatase inhibitor (P5726, Sigma-Aldrich), and protease inhibitor (cOmplete, 
Roche Diagnostics). After centrifugation to remove debris, lysates were collected. 
For the cultured adipocytes, cells were lysed in the aforementioned lysis buffer 
and sonicated for 10 seconds. Protein concentrations were quantified relatively to 
BSA (Sigma-Aldrich) using the Advanced protein assay reagent (Cytoskeleton).
Western blot analysis
Protein extracts were diluted in Laemmli sample buffer (Bio-Rad Labora-
tories, Veenendaal, Netherlands) with 50 mM dithiothreitol and denatured 
at 95°C for 5 minutes. A total of 15 µg of protein was electrophoresed on an 
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Table 1  Primer Sequences
Gene Forward (5′→3′) Reverse (5′→3′)
Adamts1 TGCTCCAAGACATGCGGCTCAG TGGTACTGGCTGGCTTCACTTCC
Adipoq GCACTGGCAAGTTCTACTGCAA GTAGGTGAAGAGAACGGCCTTGT
Cebpb ACGACTTCCTCTCCGACCTCT CGAGGCTCACGTAACCGTAGT
Chrebpb TCTGCAGATCGCGTGGAG CTTGTCCCGGCATAGCAAC
Fkbp5 ATTTGATTGCCGAGATGTG TCTTCACCAGGGCTTTGTC
Foxo1 CTTCAAGGATAAGGGCGACA GACAGATTGTGGCGAATTGA
Irs1 CGATGGCTTCTCAGACGTG CAGCCCGCTTGTTGATGTTG
Irs2 GTGGGTTTCCAGAACGGCCT ATGGGGCTGGTAGCGCTTCA
Klf15 GCGAGAAGCCCTTTGCCT GCTTCACACCCGAGTGAGAT
Lep ACCCCATTCTGAGTTTGTCC TCCAGGTCATTGGCTATCTG
Nr3c1 CCGGGTCCCCAGGTAAAGA TGTCCGGTAAAATAAGAGGCTTG
Nr3c2 ATGGAAACCACACGGTGACCT AGCCTCATCTCCACACACCAAG
Pck1 ATGTGTGGGCGATGACATT AACCCGTTTTCTGGGTTGAT
Pcx GGGATGCCCACCAGTCACT CATAGGGCGCAATCTTTTTGA
Pparg GAAAGACAACGGACAAATCACC GGGGGTGATATGTTTGAACTTG
Slc2a1 GACCCTGCACCTCATTGG GATGCTCAGATAGGACATCCAAG
Slc2a2 CCAGTACATTGCGGACTTCCTT CTTTCCTTTGGTTTCTGGAACTTT
Slc2a4 GTGACTGGAACACTGGTCCTA CCAGCCACGTTGCATTGTAG
Tsc22d3 CAGCAGCCACTCAAACCAGC ACCACATCCCCTCCAAGCAG
Ucp1 GGCCTCTACGACTCAGTCCA TAAGCCGGCTGAGATCTTGT
Actb AAGGCCAACCGTGAAAAGAT GTGGTACGACCAGAGGCATAC
B2m ATCCAAATGCTGAAGAACGG CAGTCTCAGTGGGGGTGAAT
Gapdh TGTCCGTCGTGGATCTGAC CCTGCTTCACCACCTTCTTG
Rn18s GTAACCCGTTGAACCCCATT CCATCCAATCGGTAGTAGCG
8% acrylamide gel and blotted onto a nitrocellulose membrane. Membranes 
were blocked in 3% skim milk powder in PBS for 1 hour at RT and incubated 
overnight at 4°C with an Akt antibody [1:1,000 (35)] or a phosphorylated Akt 
(Ser473) antibody [1:2,000 (36)] in PBS containing 0.1% Tween 20 and 5% BSA. 
Next, membranes were washed and incubated for 1 hour at RT with an IRDye 
800CW goat anti-rabbit secondary antibody [1:10,000 (37)] in PBS containing 
0.1% Tween 20 and 3% skim milk powder. The Akt and phosphorylated Akt 
immunoreactivities were detected with an Odyssey infrared imaging system 
(LI-COR, Biotechnology, Bad Homburg, Germany) and were quantified using 
Image Studio Lite software (version 5.2, LI-COR).
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Statistical Analysis
Data were analyzed and graphs were plotted in GraphPad Prism for 
Windows (version 6, GraphPad Software, San Diego, CA) and IBM SPSS Statistics 
for Windows (version 24, IBM Corp., Armonk, NY). Unless otherwise indicated, 
differences between groups were analyzed by two-way ANOVA with Tukey 
post hoc test when the interaction of factors was significant or with Bonferroni 
test if the interaction was not significant. P < 0.05 was considered statistically 
significant [abbreviations for P values: PC for corticosterone treatment, PI for 
insulin treatment, and PS for sex, PT for time (duration) of treatment]. When 
analyzing the IPGTT data, the area under the curve (AUC) was calculated 
normalized to the fasting level of each animal (26,38). Unless specified, data and 
graphs are shown as mean ± SEM.
Results
Corticosterone increases nonfasting glucose concentrations only in male mice
Corticosterone treatment for 2 weeks differentially affected body weight 
(BW) of male and female mice (experiment 1). The corticosterone-treated 
male mice were only 1.2 g heavier than vehicle-treated male mice whereas 
the corticosterone-treated female mice were 3.5 g heavier than vehicle-treated 
female mice (repeated three-way ANOVA: PS×C×T < 0.001; Fig. 2A). Relative to 
BW at implantation, the corticosterone-treated female mice gained more weight 
than did the other three groups (PS×C = 0.002; Fig. 2B). While vehicle-treated 
female mice consumed more food (relative to BW) than did vehicle-treated male 
mice, corticosterone treatment significantly increased the 24-hour food intake to 
a comparable amount in both sexes (PS < 0.001, PC < 0.001; Fig. 2C). The 24-hour 
fecal output was higher in female than in male mice, was increased by corticos-
terone treatment (PS < 0.001, PC < 0.001; Fig. 2D), and was positively correlated 
with food intake (r = 0.93, P < 0.001; data not shown). Serum corticosterone 
levels (at time of euthanization) and fecal corticosterone levels (2-day average 
levels between days 12 and 14 of treatment) were measured and confirmed 
that corticosterone-treated mice had significantly higher corticosterone levels 
in serum and feces than did vehicle-treated mice (PC < 0.001; Fig. 2E and 2F). 
Moreover, the corticosterone-treated male mice tended to have higher corticoste-
rone levels than corticosterone-treated female mice, but levels in vehicle-treated 
mice were not different between males and females (Fig. 2E and 2F).
73
2
Sex Difference in GC-Induced Insulin Resistance
Corticosterone treatment differentially affected NFBG of male and female 
mice. Corticosterone increased NFBG of male mice by approximately twofold 
whereas it had no effect on NFBG of female mice (repeated three-way ANOVA: 
PS×C×T = 0.02; Fig. 3A). Measurement of 5-hour FBG after the 2-week treatment 
period revealed that female mice had a lower FBG than did male mice, and 
corticosterone treatment reduced the FBG in both sexes, but more pronounced 
in female mice (PS = 0.01, PC = 0.008; Fig. 3B). These data suggest that corticos-
terone treatment disturbs glucose homeostasis more severely in male than in 
female mice because only corticosterone-treated male mice presented with an 
elevated NFBG.
Fig. 2  Effects of corticosterone treatment on BW and energy balance of mice
(A) BW of ad libitum-fed mice before (day 0) and after (days 3 to 14) pellet implantation 
(repeated three-way ANOVA: PS < 0.001, PC = 0.11, PT < 0.001, PS×C = 0.29, PS×T = 0.02, 
PC×T < 0.001, PS×C×T < 0.001). (B) BW changes after 2-wk treatment relative to BW before 
pellet implantation (PS = 0.002, PC < 0.001, PS×C = 0.002). (C) Daily food intake and (D) fecal 
production relative to BW, determined during days 12 and 14 of treatment (food intake, PS < 
0.001, PC < 0.001, PS×C = 0.06; fecal output, PS < 0.001, PC < 0.001, PS×C = 0.20). (E) Serum 
corticosterone levels (level at time of euthanization: PS = 0.14, PC < 0.001, PS×C = 0.06). 
(F) Fecal corticosterone levels (average level during days 12 to 14: PS = 0.13, PC < 0.001, 
PS×C = 0.05). Unless stated, statistical significance was determined by two-way ANOVA. 
* P < 0.05, (*) P < 0.10 (tendency to significance), for sex difference between mice with the 
same treatment; # P < 0.05, for effect of corticosterone treatment in mice of the same sex, by 
post hoc test.
74
2
Chapter 2
Differential effects of corticosterone on glucose tolerance in male and female mice
To investigate the differential effects of high-dose corticosterone on blood 
glucose homeostasis in male and female mice in more detail, mice were subjected 
to an IPGTT on day 14 in the second experiment. Also in this experiment, 
corticosterone treatment differentially affected BW of male and female mice 
(data not shown) and increased NFBG only in male mice (NFBG day 14: PS×C 
< 0.001; Fig. 4A). Compared with the vehicle-treated mice of the same sex, 
corticosterone treatment reduced the 5-hour FBG by 28.1% ± 7.4% in male mice 
and by 7.6% ± 4.6% in female mice (unpaired t test: P = 0.04; Fig. 4A). FBI was 
elevated in both sexes after 7 and 14 days of corticosterone treatment, and the 
effect was more pronounced in male than in female mice (PS×C < 0.01 for both 
days; Fig. 4B). Likewise, corticosterone treatment increased the homeostatic 
model assessment of insulin resistance (HOMA-IR) values more profoundly in 
male mice than in female mice (PS×C < 0.05 for both days; Fig. 4C). These data 
underscore that corticosterone-induced insulin resistance is more pronounced in 
male than in female mice.
After the IP administration of glucose, peak glucose levels of corticos-
terone-treated male mice were lower than in vehicle-treated males. However, 
corticosterone-treated male mice showed a delayed glucose clearance, and 
glucose levels did not return to baseline levels (Fig. 4D and 4E). As a result, 
baseline-corrected AUC values were slightly but not significantly increased in 
the corticosterone-treated males (PS×C = 0.03; Fig. 4F). In contrast, in corticos-
terone-treated female mice the blood glucose levels were blunted, resulting in a 
Fig. 3  Sex-dependent effects of corticosterone treatment on glucose homeostasis
(A) NFBG levels during days 3 to 14 of treatment (repeated three-way ANOVA: PS < 0.001, 
PC < 0.001, PT < 0.001, PS×C <0.001, PS×T = 0.02, PC×T < 0.001, PS×C×T = 0.02; two-way ANOVA 
at each time point: PS < 0.05 every time point, PC = 0.69 for day 3, PC < 0.05 for days 5 to 14, 
PS×C < 0.05 every time point). (B) FBG levels determined on day 14 of treatment (PS = 0.01, 
PC = 0.008, PS×C = 0.19). Unless stated, statistical significance was determined by two-way 
ANOVA. * P < 0.05, for sex difference between mice with the same treatment; # P < 0.05, for 
effect of corticosterone treatment in mice of the same sex, by post hoc test.
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Fig. 4  Sex-dependent effects of corticosterone treatment on glucose clearance
(A) Nonfasting and 5-h FBG levels (NFBG day 7, PS = 0.003, PC = 0.008, PS×C = 0.06; FBG 
day 7, PS = 0.22, PC = 0.01, PS×C = 0.60; NFBG day 14, PS < 0.001, PC < 0.001, PS×C < 0.001; 
FBG day 14, PS = 0.08, PC = 0.009, PS×C = 0.07). F indicates the 5-h fasting period on days 
0, 7, and 14. (B) Five-hour FBI levels and (C) HOMA-IR calculated from FBG and insulin 
levels before (day 0) and after (days 7 and 14) pellet implantation (FBI day 7, PS < 0.001, 
PC < 0.001, PS×C = 0.009; FBI day 14, PS = 0.001, PC < 0.001, PS×C = 0.002; HOMA-IR day 7, 
PS < 0.001, PC < 0.001, PS×C = 0.04; HOMA-IR day 14, PS = 0.01, PC < 0.001, PS×C = 0.04). 
(D) Blood glucose levels, (E) changes in blood glucose levels over individual baseline values, 
(F) baseline corrected AUCs of glucose levels, (G) blood insulin levels, (H) changes in blood 
insulin levels over individual baseline values, and (I) baseline corrected AUCs of insulin levels 
after IP glucose administration in the 2-wk vehicle- or corticosterone-treated mice are shown 
(AUC glucose levels, PS < 0.001, PC = 0.16, PS×C = 0.03; AUC insulin levels, PS < 0.001, PC < 
0.001, PS×C < 0.001). (J) β-Cell response to the IPGTT (PS = 0.04, PC < 0.001, PS×C = 0.12). 
Statistical significance was determined by two-way ANOVA. * P < 0.05, (*) P < 0.10 (tendency 
to significance), for sex difference between mice with the same treatment; # P < 0.05, for effect 
of corticosterone treatment in mice of the same sex, by post hoc test.
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significantly reduced baseline-corrected AUC value (Fig. 4D–4F). Blood insulin 
levels after IPGTT were markedly different between the groups, mainly due to 
the elevated baseline FBI upon corticosterone treatment (Fig. 4G). Interestingly, 
the rise in blood insulin levels upon glucose injection was greater in the corticos-
terone-treated male mice than in the other three groups (PS×C < 0.001; Fig. 4H 
and 4I). Calculated from the glucose and insulin AUC, the β-cell response was 
largely increased by corticosterone treatment and was higher in female mice 
than in male mice (PS = 0.04, PC < 0.001; Fig. 4J).
Using the enrichment of blood [U-13C6]-D-glucose (Fig. 5A), the effects 
of corticosterone treatment on the glucose clearance rate (GCR) and the EGP 
at baseline (before glucose injection) can be calculated. The GCR was higher in 
female mice than in male mice, and corticosterone treatment tended to sex-de-
pendently affect GCR, namely a reduction in male and an increase in female 
mice (PS×C = 0.04; Fig. 5B). The EGP was reduced by corticosterone treatment 
in male but was unaffected in female mice (PS×C = 0.006; Fig. 5C). The factors 
contributing to blood glucose levels after the injected bolus can also be assessed. 
First, the bioavailability of the injected glucose was reduced by corticosterone 
treatment, but sex-independently (PC < 0.001; Fig. 5D). Second, detailed analysis 
of the clearance of the injected glucose revealed that the glucose-mediated flux, 
the insulin-mediated flux, and the independent flux were in general reduced 
by corticosterone treatment in both male and female mice (AUC total flux: PC 
< 0.001; Fig. 5E and 5F). Interestingly, the percentage contribution of each 
flux was sex-dependently altered by corticosterone treatment, shifting toward 
insulin-mediated flux for male mice but toward independent flux for female 
mice (PS×C < 0.05 for all fluxes; Fig. 5G). Finally, the insulin sensitivity index 
(insulin-mediated glucose clearance) was markedly reduced by corticosterone 
treatment, and female mice had a greater insulin sensitivity index than did male 
mice (PS < 0.001, PC < 0.001; Fig. 5H). This finding once again underscores that 
corticosterone-induced insulin resistance is more pronounced in male mice than 
in female mice.
Sex-differential effects of corticosterone on WAT morphology
Adipose tissue is one of the glucose-consuming tissues, and we previously 
reported marked effects of corticosterone treatment on adipose tissue depots 
in male mice (39). Because the current data suggest that glucose clearance is 
differentially affected by corticosterone treatment in male and female mice, we 
next investigated the effects of corticosterone on male and female adipose tissues 
in more detail. Corticosterone treatment altered many aspects of WAT and BAT 
morphology and function with some clear differences between male and female 
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Fig. 5  Glucose kinetic parameters from stable isotope-labeled glucose analyses
(A) Blood [U-13C6]-D-glucose levels with model-fitted line plots after IP stable isotope-labeled 
glucose administration in the 2-wk vehicle- or corticosterone-treated mice. This plot was 
used for calculating following glucose kinetic parameters. (B) Glucose clearance rate and 
(C) endogenous glucose production at basal state (before glucose administration; GCR, PS 
< 0.001, PC = 0.42, PS×C = 0.04; EGP, PS = 0.003, PC = 0.06, PS×C = 0.006). (D) Bioavailability 
of the injected glucose in the accessible pool of the minimal mouse model (PS = 0.18, PC < 
0.001, PS×C = 0.18). (E) Stacked area plots demonstrating utilization of the injected glucose, 
separated into independent, glucose-mediated, and insulin-mediated fluxes. (F) AUCs of 
total glucose utilization (AUC total flux: PS = 0.08, PC < 0.001, PS×C = 0.26). (G) Relative 
percentages of each glucose utilization flux (PS×C < 0.05 for all fluxes). (H) Insulin sensitivity 
reflecting the clearance of injected glucose by endogenous insulin secretion (PS < 0.001, PC < 
0.001, PS×C = 0.10). Statistical significance was determined by two-way ANOVA. * P < 0.05, for 
sex difference between mice with the same treatment; # P < 0.05, for effect of corticosterone 
treatment in mice of the same sex, by post hoc test.
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mice. The visceral depot gWAT had a substantially greater mass in vehicle-
treated male mice than in vehicle-treated female mice. This sex-dependent 
pattern disappeared after corticosterone treatment as corticosterone-treated 
male and female mice had a comparable gWAT mass (PS×C = 0.001; Fig. 6A). 
Two subcutaneous depots, iWAT and aWAT, also gained more mass upon 
corticosterone treatment, but there was no significant sex difference (PC < 0.001 
for both depots, PS×C = 0.04 for iWAT; Fig. 6B and 6C). Corticosterone treatment 
noticeably elevated the total WAT mass (the sum of the aforementioned WAT 
masses) without a significant sex difference (PS×C = 0.006; Fig. 6D).
Because the mode of WAT expansion (hypertrophy or hyperplasia) can 
explain WAT functions and adaptations, the histologies of gWAT (Fig. 6E) and 
aWAT (Fig. 6F) after corticosterone treatment were studied. Female mice had 
a remarkably smaller gWAT adipocyte size than did male mice, and corticos-
terone treatment enlarged gWAT adipocyte size in both sexes (PS < 0.001, PC < 
0.001; Fig. 6G). The cross-sectional area of aWAT adipocytes was also smaller 
in female mice than in male mice, and corticosterone treatment increased the 
aWAT adipocyte size in both sexes (PS = 0.008, PC < 0.001; Fig. 6H).
Corticosterone treatment induces significant changes in gene expression 
in a partly depot- and sex-dependent manner. The mRNA expression of Nr3c1 
encoding the glucocorticoid receptor (GR) in gWAT was lower in female mice 
than in male mice, whereas its expression in iWAT was higher in female mice 
than in male mice. Corticosterone treatment reduced Nr3c1 mRNA expression 
in both depots of both sexes (Table 2). The mRNA expression of the GR target 
genes Fkbp5 and Tsc22d3 was significantly induced by corticosterone treatment 
in both depots with a general trend of higher expression in corticosterone-treated 
male depots than in female depots (Table 2). Although corticosterone and sex 
of the mice did not affect the mRNA expression of Nr3c2 encoding the mineralo-
corticoid receptor (MR) in gWAT, its expression in iWAT was strikingly higher 
in vehicle-treated female mice than male mice. However, this sex-differential 
pattern in iWAT disappeared upon corticosterone treatment because it reduced 
Nr3c2 mRNA expression in female mice only (Table 2).
In gWAT, mRNA expression of the adipogenic transcription factors 
Cebpb and Pparg was generally elevated by corticosterone treatment in both 
sexes. In iWAT, expression of both transcription factors tended to be higher in 
female mice than in male mice (Table 2). ADAMTS1, an extracellular protein 
secreted from mature adipocytes, together with Adamts1 mRNA expression 
has been considered a marker of the hyperplastic limitation in WAT because it 
inhibits the generation of new adipocytes from adipocyte precursor cells (40). In 
gWAT, female mice had a lower Adamts1 mRNA expression than did male mice, 
and corticosterone treatment induced its expression in both sexes. However, 
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Fig. 6  Sex differences in WAT mass and morphology upon corticosterone treatment
(A–D) gWAT, iWAT, aWAT, and total WAT mass relative to BW of the 2-wk vehicle- or corticos-
terone-treated mice (gWAT, PS = 0.12, PC < 0.001, PS×C = 0.001; iWAT, PS = 0.33, PC < 0.001, 
PS×C = 0.04; aWAT, PS = 0.93, PC < 0.001, PS×C = 0.07; total WAT mass, PS = 0.80, PC < 0.001, 
PS×C = 0.006). (E and F) Hematoxylin and eosin–stained gWAT and aWAT. Experimental group 
abbreviations: FC, female corticosterone; FV, female vehicle; MC, male corticosterone; MV, 
male vehicle. Scale bar, 100 µm. (G and H) gWAT and aWAT adipocyte sizes (gWAT, PS < 
0.001, PC < 0.001, PS×C = 0.12; aWAT, PS = 0.008, PC < 0.001, PS×C = 0.58).  Statistical signifi-
cance was determined by two-way ANOVA. * P < 0.05, (*) P < 0.10 (tendency to significance), 
for sex difference between mice with the same treatment; # P < 0.05, (#) P < 0.10 (tendency to 
significance), for effect of corticosterone treatment in mice of the same sex, by post hoc test.
corticosterone treatment induced Adamts1 mRNA expression by sevenfold in 
iWAT of male mice but did not significantly affect the expression in female mice 
(Table 2). Of note, Adamts1 mRNA expression in gWAT was on average 11-fold 
higher than in iWAT (data not shown).
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Sex-differential effects of corticosterone on adipokine secretion
Apart from energy storage as lipid droplets, adipose tissue depots secrete 
a number of adipokines into the circulation. Serum leptin concentrations were 
strongly elevated after corticosterone treatment in both male and female mice (PC 
< 0.001; Fig. 7A). The serum concentrations of total adiponectin were in general 
higher in female mice than in male mice and were increased upon corticosterone 
treatment, especially in female mice (PS×C = 0.005; Fig. 7B). Serum concentra-
tions of HMW adiponectin, the metabolically active adiponectin isoform, were 
also elevated by corticosterone treatment (PS×C = 0.004; Fig. 7C). The HMW/total 
adiponectin ratio did not differ between the sexes but was significantly higher 
after corticosterone treatment (PC < 0.001; Fig. 7D). The adiponectin/leptin 
(A/L) ratio, a promising index for assessing insulin sensitivity (41), was higher 
in vehicle-treated female mice than in male mice, but this sex difference was 
attenuated and reduced to a similar low A/L ratio after corticosterone treatment 
(PS×C = 0.007; Fig. 7E). The HMW adiponectin/leptin ratio showed a similar 
pattern (PS < 0.001, PC < 0.001, PS×C = 0.001; data not shown).
Fig. 7  Serum adipokine levels
(A) Serum leptin levels and (B and C) serum total adiponectin and HMW isoform levels of the 
2-wk vehicle- or corticosterone-treated mice (leptin, PS = 0.64, PC < 0.001, PS×C = 0.89; total 
adiponectin, PS < 0.001, PC < 0.001, PS×C = 0.005; HMW adiponectin, PS = 0.008, PC < 0.001, 
PS×C = 0.004). (D) Ratio of the HMW isoform to the total adiponectin levels (PS = 0.12, PC < 
0.001, PS×C = 0.37). (E) Ratio of adiponectin to leptin levels, illustrated on a logarithmic scale 
(PS < 0.001, PC < 0.001, PS×C = 0.007). Statistical significance was determined by two-way 
ANOVA. * P < 0.05, for sex difference between mice with the same treatment; # P < 0.05, for 
effect of corticosterone treatment in mice of the same sex, by post hoc test.
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The changes in leptin concentrations were also reflected by changes in 
gene expression. Corticosterone treatment induced Lep mRNA expression in 
gWAT and iWAT of both sexes, which was more pronounced in corticosterone- 
treated male mice than in female mice (Table 2). In contrast, corticosterone 
treatment reduced Adipoq mRNA expression in both depots of both sexes. 
Furthermore, female mice tended to have a higher Adipoq mRNA expression in 
iWAT than did male mice (Table 2). Note that Lep mRNA expression in gWAT 
was on average fivefold higher whereas Adipoq mRNA expression was 0.7-fold 
lower than in iWAT (data not shown).
Corticosterone treatment reduces BAT activity in both male and female mice
In both male and female mice, corticosterone treatment increased BAT 
mass (PC < 0.001; Fig. 8A) and induced lipid accumulation and unilocular 
rearrangement in BAT (Fig. 8B). The mRNA expression of Ucp1, a classical 
BAT thermogenic gene, was reduced by corticosterone treatment in both sexes 
(Table 3). Although corticosterone treatment tended to reduce mRNA expression 
of Nr3c1 without a sex-dependent pattern in BAT, it significantly induced 
expression of the GR target genes Fkbp5 and Tsc22d3 in both sexes, albeit less 
pronounced in female mice than in male mice (Table 3). The mRNA expression 
of Nr3c2 was lower in female mice than in male mice without an obvious effect 
by corticosterone treatment (Table 3).
Lep mRNA expression in BAT of female mice tended to be lower than that 
of male mice, and corticosterone treatment strongly induced the expression in 
both sexes by >35-fold (Table 3). However, Adipoq mRNA expression in BAT was 
not significantly affected by corticosterone treatment in both sexes (Table 3).
Elevated concentrations of leptin and adiponectin are likely due to hyper- 
insulinemia, not a direct effect of corticosterone
To investigate whether the elevated serum leptin and adiponectin levels 
upon corticosterone treatment are caused directly by corticosterone or indirectly 
as a result of the compensatory hyperinsulinemia, in vitro studies using 3T3-L1 
white adipocytes and T37i brown adipocytes were performed. In 3T3-L1 cells, 
corticosterone reduced whereas insulin induced Lep mRNA expression (Table 
4). Leptin production and secretion by 3T3-L1 cells were also significantly 
stimulated by insulin treatment (Table 4). Although both insulin and corticos-
terone reduced Adipoq mRNA expression in 3T3-L1 cells, cotreatment of insulin 
and corticosterone attenuated the inhibitory effect of corticosterone on Adipoq 
mRNA expression (Table 4). In contrast, insulin significantly increased whereas 
corticosterone reduced the total adiponectin production in 3T3-L1 cells, and 
adiponectin secretion tended to be increased by corticosterone only (Table 4).
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Fig. 8  BAT mass and morphology upon corticosterone treatment
(A) BAT mass relative to BW of the 2-week vehicle- or corticosterone-treated mice (PS = 
0.68, PC < 0.001, PS×C = 0.12). (B) Hematoxylin and eosin–stained BAT. Experimental group 
abbreviations: FC, female corticosterone; FV, female vehicle; MC, male corticosterone; MV, 
male vehicle. Scale bar, 100 µm. Statistical significance was determined by two-way ANOVA. 
# P < 0.05, for effect of corticosterone treatment in mice of the same sex, by post hoc test.
Table 3  mRNA expression in BAT
Genes Sig. M Veh M Cort F Veh F Cort
Thermogenic gene
  Ucp1 C,× 1.00±0.16 0.80±0.21 1.61±0.25 0.50±0.15 #
GR, MR, and GR-target genes
  Nr3c1 (C) 1.00±0.11 0.86±0.10 0.97±0.13 0.68±0.09
  Fkbp5 S,C,× 1.00±0.12 43.82±4.34 # 0.64±0.06 30.00±4.79 #,*
  Tsc22d3 C,× 1.00±0.08 5.05±0.35 # 1.36±0.13 3.89±0.41 #,*
  Nr3c2 S 1.00±0.07 0.89±0.11 0.59±0.12 * 0.76±0.15
Adipokine production
  Lep (S),C 1.00±0.36 38.56±7.49 # 0.12±0.03 23.54±4.55 #,(*)
  Adipoq – 1.00±0.10 0.98±0.14 1.23±0.15 0.82±0.09
Glucose transport
  Irs1 – 1.00±0.21 1.19±0.11 2.10±0.78 1.12±0.21
  Slc2a1 – 1.00±0.15 1.23±0.19 0.74±0.09 1.00±0.15
  Slc2a4 – 1.00±0.17 1.00±0.13 0.84±0.08 1.10±0.10
  Chrebpb × 1.00±0.19 0.63±0.13 0.44±0.07 (*) 0.92±0.18
Gene expression was normalized to Actb and Rn18s expression and expressed relative to the 
vehicle-treated male mice. Sig. indicates significant effects (P < 0.05) analyzed with two-way 
ANOVA. Symbols in parentheses [e.g., (C)] indicate a tendency to significance (P < 0.10).
Abbreviations: C, corticosterone treatment; S, sex; ×, interaction of corticosterone treatment 
and sex. * P < 0.05, (*) P < 0.10 (tendency to significance), for sex difference between mice 
with the same treatment; # P < 0.05, for effect of corticosterone treatment in mice of the same 
sex, by post hoc test.
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In T37i cells, corticosterone reduced whereas insulin strongly induced 
Lep mRNA expression (Table 4). Likewise, leptin production and secretion by 
T37i cells were stimulated by insulin treatment and cotreatment of corticos-
terone and insulin, while corticosterone treatment alone marginally reduced 
its production (Table 4). Although corticosterone reduced Adipoq and insulin 
did not alter Adipoq mRNA expression in T37i cells, cotreatment of insulin 
and corticosterone attenuated the inhibitory effect of corticosterone treatment 
(Table 4). Furthermore, whereas insulin treatment only increased intracellular 
adiponectin but did not affect the total production, corticosterone treatment 
reduced total adiponectin production but increased its secretion significantly 
(Table 4). Apart from adiponectin production in brown adipocytes, these data 
suggest that the elevated adipokine levels of corticosterone-treated mice were 
more likely caused by the high insulin level than by corticosterone treatment 
itself.
Corticosterone treatment reduces insulin-stimulated Akt phosphorylation in WAT
Insulin induces glucose uptake in WATs through Akt phosphorylation 
and subsequently GLUT4 translocation (42). To determine insulin signaling in 
WATs of vehicle- and corticosterone-treated mice, gWAT (a visceral depot) and 
iWAT (a subcutaneous depot) explants were stimulated with insulin and Akt 
phosphorylation was determined. Corticosterone treatment reduced baseline 
and insulin-stimulated Akt phosphorylation without a sex-dependent pattern 
in both gWAT and iWAT explants (repeated 3-way ANOVA: PC×I < 0.05 in both 
explants; Fig. 9).
Corticosterone reduces whereas insulin induces glucose uptake, but both 
cause insulin resistance in WAT
To address the effects of corticosterone treatment on adipose tissue glucose 
homeostasis, we assessed the adipose tissue mRNA expression of genes related 
to glucose transport. Corticosterone treatment did not affect mRNA expression 
of Irs1, the gene encoding the insulin receptor, in gWAT and BAT, but reduced 
its expression in iWAT (Tables 2 and 3). In gWAT, the mRNA expression of the 
glucose transporter 4 [Slc2a4 (Glut4)], an insulin-dependent glucose transporter, 
and the glucose transporter 1 [Slc2a1 (Glut1)], a basal glucose transporter, were 
in general increased by corticosterone treatment (Table 2). In iWAT, corticos-
terone treatment reduced Slc2a1 expression but tended to increase Slc2a4 
expression (Table 2). In contrast, corticosterone treatment did not significantly 
affect Slc2a1 and Slc2a4 mRNA expression in BAT (Table 3). Finally, we 
analyzed the expression of Mlxipl variant β (or called Chrebpb), a gene whose 
transcription is regulated by the carbohydrate-responsive element-binding 
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protein (ChREBP; also known as MLX interacting protein-like) because it can be 
considered a readout of intracellular glucose concentrations (43). Corticosterone 
treatment increased Chrebpb expression in gWAT and iWAT, but not in BAT, 
suggestive of an increased glucose uptake after corticosterone treatment in both 
WAT depots (Tables 2 and 3). Of note, Chrebpb expression in the iWAT depot 
was significantly induced by corticosterone treatment only in female mice due to 
the sex-differential baseline expression.
To determine whether the increased uptake of glucose in WAT upon 
corticosterone treatment is due to corticosterone per se and/or the high plasma 
insulin concentrations, we measured the insulin-stimulated glucose uptake in 
3T3-L1 and T37i cells pretreated for 24 hours with corticosterone and/or insulin. 
In 3T3-L1 cells, pretreatment with corticosterone (PC) inhibited whereas 
pretreatment with insulin (PI) stimulated basal glucose uptake (PPC×PI = 0.009; 
Fig. 10A). Note, however, that the co-pretreatment of corticosterone and insulin 
resulted in a 34% lower basal glucose uptake than did insulin pretreatment 
Fig. 9  Insulin-stimulated Akt phosphorylation in WAT explants
(A and B) Akt phosphorylation level in (A) gWAT and (B) iWAT of the vehicle- or corticoste-
rone-treated mice, ex vivo stimulated with insulin (gWAT, PS = 0.99, PC = 0.005, PI < 0.001, 
PS×C = 0.99, PS×I = 0.95, PC×I = 0.02, PS×C×I = 0.39; iWAT, PS = 0.91, PC = 0.004, PI < 0.001, PS×C 
= 0.45, PS×I = 0.97, PC×I = 0.02, PS×C×I = 0.57). Akt phosphorylation level was normalized to 
total Akt and expressed relative to the level of vehicle-treated male explants. A representative 
blot is shown of three biological samples per group. Statistical significance was determined 
by repeated three-way ANOVA with post hoc Tukey test: letters a,b, and c denote significant 
group differences (P < 0.05).
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alone. The insulin-stimulated glucose uptake pattern was affected by pretreat-
ment with corticosterone, pretreatment with insulin, and stimulatory insulin 
(SI) (repeated three-way ANOVA: PPC×PI×SI = 0.001; Fig. 10A). Pretreatment with 
corticosterone and insulin alone or in combination significantly inhibited the 
insulin-induced glucose uptake (Fig. 10A).
For T37i cells, the basal glucose uptake was decreased by pretreatment 
with corticosterone but increased by pretreatment with insulin (PPC = 0.05; PPI < 
0.001; Fig. 10B). The insulin-stimulated glucose uptake pattern was increased 
by stimulatory insulin, but it was not significantly altered by pretreatment 
with corticosterone or pretreatment with insulin, reflecting an insulin-sensitive 
state of the corticosterone- or insulin-pretreated T37i cells (repeated three-way 
ANOVA: PSI < 0.001; Fig. 10B). These data suggest that corticosterone and 
high-dose insulin induce insulin resistance mainly in white adipocytes, but not 
in brown adipocytes.
Fig. 10  Insulin-stimulated radioactive glucose uptake in corticosterone- and/or 
insulin-treated 3T3-L1 and T37i adipocytes
(A) Differentiated 3T3-L1 white adipocytes and (B) differentiated T37i brown adipocytes 
pretreated with corticosterone (PC) and/or insulin (PI) for 24 h were stimulated with insulin (SI) 
at the indicated concentrations for 15 min and subsequently 2-[1-14C]-deoxy-D-glucose was 
added to determine glucose uptake (3T3-L1, PPC = 0.03, PPI = 0.09, PSI < 0.001, PPC×PI = 0.60, 
PPC×SI = 0.08, PPI×SI < 0.001, PPC×PI×SI = 0.001; T37i, PC = 0.22, PPI = 0.16, PSI < 0.001, PPC×PI = 
0.77, PPC×SI = 0.46, PPI×SI = 0.17, PPC×PI×SI = 0.15). Data from three independent experiment were 
plotted in counts per minute, relative to protein content (µg) of each sample. Pretreatment 
condition abbreviations: CORT, corticosterone; CORT+INS, cotreatment with corticosterone 
and insulin; INS, insulin. Statistical significance was determined by repeated three-way 
ANOVA. + P < 0.05, (+) P < 0.10 (tendency to significance), for difference from baseline uptake 
of control condition; # P < 0.05, for effect of the stimulatory insulin from its baseline uptake, by 
post hoc Dunnett test.
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Effect of corticosterone treatment on gene expression in skeletal muscle
Not only adipose tissues, but also skeletal muscle is an important 
glucose-consuming organ that contributes to whole-body GCR, especially at the 
postprandial state, and GCs have been shown to reduce glucose uptake in the 
muscle by counteracting the effect of insulin (1,4). We therefore investigated 
whether corticosterone treatment affected the gene expression profile in skeletal 
muscle in a sex-dependent manner. The expressions of Nr3c1 (GR) and Nr3c2 
(MR) were not significantly different between male and female mice and were 
not affected by corticosterone treatment (Table 5). Corticosterone treatment 
significantly increased the mRNA expression of the GR target genes Fkpb5 and 
Tsc22d3 in both sexes (Table 5).
Another hallmark of GC excess is GC-mediated muscle atrophy by 
reducing muscle protein synthesis and degrading muscle proteins. Corticosterone 
treatment strongly upregulated the mRNA expression of the muscle atrophy- 
related genes Foxo1 and Klf15 in both male and female mice (Table 5).
Vehicle-treated female mice had a higher Irs1 mRNA expression than 
did vehicle-treated male mice, but corticosterone treatment reduced Irs1 mRNA 
expression to a similar level in male and female mice (Table 5). Whereas 
the expression of Slc2a1 and Slc2a4 mRNA was not significantly affected by 
corticosterone treatment, Chrebpb mRNA expression was remarkably elevated 
by corticosterone treatment in both sexes (Table 5).
Effect of corticosterone treatment on gene expression in liver
We also determined hepatic gene expressions of the vehicle- and 
corticosterone-treated mice because the liver is the central organ regulating 
whole-body glucose homeostasis, especially in the fasting state when hepatic 
gluconeogenesis is crucial to maintain euglycemia (1,4). Nr3c1 mRNA expression 
tended to be higher in female mice than in male mice but was not significantly 
affected by corticosterone treatment (Table 6). However, corticosterone 
treatment clearly induced Fkpb5 and Tsc22d3 mRNA expression in both sexes 
(Table 6). Regarding transcriptional regulation of genes encoding gluconeogenic 
enzymes, corticosterone treatment upregulated the mRNA expression of Pck1 
(phosphoenolpyruvate carboxykinase 1, also known as PEPCK) and Pcx (pyruvate 
carboxylase) in a sex-independent manner (Table 6).
Whereas Irs1 mRNA expression was not significantly affected by sex or 
corticosterone treatment, Irs2 mRNA expression was higher in vehicle-treated 
female mice than in male mice and was reduced by corticosterone treatment to 
a comparable level in both sexes (Table 6). Corticosterone treatment induced 
transcription of Slc2a2 (also known as Glut2), a major glucose transporter for 
hepatic glucose uptake, in male mice only (Table 6). Furthermore, corticosterone 
treatment increased Chrebpb mRNA expression in both sexes, but this increase 
tended to be higher in corticosterone-treated male mice than in female mice 
(Table 6).
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Table 5  mRNA expression in skeletal muscle
Genes Sig. M Veh M Cort F Veh F Cort
GR, MR, and GR-target genes
  Nr3c1 – 1.00±0.17 0.90±0.06 0.88±0.20 0.91±0.15
  Fkbp5 S,C,× 1.00±0.10 18.11±1.06 # 0.69±0.13 12.49±2.29 #,*
  Tsc22d3 C 1.00±0.20 3.99±0.67 # 1.07±0.21 4.30±0.95 #
  Nr3c2 – 1.00±0.10 1.36±0.29 1.22±0.34 1.21±0.13
Muscle atrophy
  Foxo1 C 1.00±0.13 12.80±2.11 # 1.30±0.30 14.25±3.46 #
  Klf15 C 1.00±0.18 2.70±0.63 # 1.22±0.24 2.23±0.36
Glucose transport
  Irs1 S,C,× 1.00±0.17 0.66±0.10 2.24±0.45 * 0.61±0.19 #
  Slc2a1 – 1.00±0.27 1.60±0.61 1.08±0.13 0.81±0.26
  Slc2a4 – 1.00±0.08 1.04±0.09 1.01±0.16 1.24±0.12
  Chrebpb C 1.00±0.35 13.06±1.22 # 0.80±0.06 18.04±10.57 #
Gene expression was normalized to Gapdh and Rn18s expression and expressed relative 
to the vehicle-treated male mice. Sig. indicates significant effects (P < 0.05) analyzed with 
two-way ANOVA. Abbreviations: C, corticosterone treatment; S, sex; ×, interaction of corticos-
terone treatment and sex. * P < 0.05, for sex difference between mice with the same treatment; 
# P < 0.05, for effect of corticosterone treatment in mice of the same sex, by post hoc test.
Discussion
This study demonstrates that a high-dose corticosterone treatment 
causes insulin resistance in both sexes of mice, but with a more severe phenotype 
in male than in female mice. Our results also show that corticosterone-treated 
female mice displayed a more protective feature in WAT expansion and adipokine 
secretion than did corticosterone-treated male mice.
The 2-week treatment with high-dose corticosterone induced an 
insulin-resistant state more potently in males than in females, which was 
confirmed by high FBI concentrations, and hence an increase in HOMA-IR 
levels. Moreover, in-depth analyses indicated that glucose metabolism was more 
disturbed in male mice than in female mice. First, the corticosterone-induced 
increase in FBI levels slightly decreased FBG levels only in female mice. Second, 
corticosterone treatment elevated NFBG levels in male mice but not in female 
mice, resembling the early pathognomonic postprandial hyperglycemia as a sign 
of GC-induced diabetes mellitus in humans (44). Third, the increases in glucose 
and insulin levels after an IPGTT were more severe in corticosterone-treated 
male mice than female mice.
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To gain insight into the underlying mechanisms of the corticosterone- 
induced insulin resistance, especially the resemblance of a postprandial-like state, 
we determined EGP and GCR using an IPGTT enriched with a stable isotope tracer 
[U-13C6]-D-glucose. In contrast to the more severe whole-body insulin resistance 
in the corticosterone-treated male mice, the high blood insulin concentrations 
upon corticosterone treatment resulted in lower glucose production in male mice 
but not in female mice. Because GCs stimulate and insulin suppresses hepatic 
gluconeogenesis, it is hard to separate the contribution of these two factors in 
the control of EGP. Quinn et al. (45) have shown that female mice have a higher 
hepatic susceptibility to GCs. Thus, more pronounced actions of GCs in female 
mice might overrule the inhibitory effect of insulin on EGP or, alternatively, 
the FBG levels of corticosterone-treated mice were at their lowest limit which 
requires EGP to prevent symptomatic hypoglycemia. Corticosterone treatment 
had opposite effects on GCR in male and female mice. GCR tended to increase 
in female mice but tended to decrease in male mice. These findings confirm 
that peripheral insulin resistance was more severe in corticosterone-treated 
males than in corticosterone-treated females because the elevated insulin levels 
Table 6  mRNA expression in liver
Genes Sig. M Veh M Cort F Veh F Cort
GR, MR, and GR-target genes
  Nr3c1 (S) 1.00±0.05 1.08±0.08 1.41±0.17 (*) 1.20±0.22
  Fkbp5 C 1.00±0.22 40.38±7.71 # 4.09±0.68 31.63±6.59 #
  Tsc22d3 C 1.00±0.01 5.27±0.57 # 1.55±0.25 4.50±0.51 #
  Nr3c2 - 1.00±0.09 1.00±0.16 1.15±0.13 1.22±0.31
Gluconeogenesis
  Pck1 C 1.00±0.13 2.30±0.33 # 1.26±0.18 2.23±0.23 #
  Pcx (×),C 1.00±0.05 1.92±0.25 # 1.03±0.06 1.41±0.15
Glucose transport
  Irs1 - 1.00±0.15 0.70±0.11 0.99±0.09 1.02±0.10
  Irs2 ×,S,C 1.00±0.09 0.55±0.02 # 1.88±0.05 * 0.74±0.07 #
  Slc2a2 ×,C 1.00±0.09 1.84±0.22 # 1.43±0.17 1.43±0.19
  Chrebpb (S),C 1.00±0.11 1.69±0.10 # 0.97±0.05 1.31±0.18 (#,*)
Gene expression was normalized to Actb and Rn18s expression and expressed relative to the 
vehicle-treated male mice. Sig. indicates significant effects (P < 0.05) analyzed with two-way 
ANOVA. Symbols in parentheses [e.g., (S)] indicate a tendency to significance (P < 0.10). 
Abbreviations: C, corticosterone treatment; S, sex; ×, interaction of corticosterone treatment 
and sex. * P < 0.05, (*) P < 0.10 (tendency to significance), for sex difference between mice 
with the same treatment; # P < 0.05, for effect of corticosterone treatment in mice of the same 
sex, by post hoc test.
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by corticosterone treatment should have increased GCR substantially in both 
sexes. Altogether, our data show that the sex-differential effects of high-dose 
corticosterone treatment on insulin sensitivity were mainly driven by the more 
pronounced insulin resistance of peripheral tissues in male mice.
Remarkably, we observed that BW of corticosterone-treated female mice 
in this study increased much more than that of corticosterone-treated male mice. 
This seems in contrast to the more severe insulin resistance in corticosterone- 
treated male mice, as weight gain usually links with an increase in insulin 
resistance (46,47). The more pronounced increase in BW in female mice could be 
explained by the well-known effect of GC-induced muscle atrophy (48). Because 
lean mass of male C57BL/6J mice at this age is in general 6 g heavier than 
that of female mice (49), corticosterone treatment could lead to a substantial 
reduction in muscle mass in male mice and thereby masking an increase in fat 
mass resulting in an unchanged total BW. Nevertheless, we observed that the 
fold increase in WAT mass was greater upon corticosterone treatment in female 
mice than in male mice, suggesting a sex-dependent expansion rate of WAT to 
GCs.
WAT stores lipid and can expand by enlarging cell size (hypertrophy), 
increasing cell number (hyperplasia), or a combination of both (50,51). 
Hypertrophic expansion is considered more detrimental than hyperplasic 
expansion, as hypertrophy is associated with reduced insulin sensitivity (50). 
Adipose tissue expansion generally shows a depot-related pattern; that is, 
subcutaneous WAT is more hyperplastic than visceral WAT (51). Our finding 
that corticosterone-treated female mice tended to have larger WAT depots but 
smaller adipocytes, together with a lower mRNA expression of Adamts1 and Lep, 
than do corticosterone-treated male mice suggests that female mice displayed 
more hyperplastic expansion in WATs than did male mice upon corticosterone 
treatment. This is in accordance with a previous study showing that corticos-
terone-induced adipocyte expansion was greater in ovariectomized female rats 
than in sham-operated female rats, which suggests a role for sex steroids in the 
sex difference in adipose depot expandability (52).
Besides its fundamental function as an energy reservoir, WAT secretes 
a number of adipokines that are essential mediators regulating systemic energy 
homeostasis and are also linked with the mode of expansion as previously 
discussed (50,53). We found that corticosterone treatment increased Lep 
expression in gWAT, iWAT, and BAT and increased circulating leptin levels in 
both sexes of mice, which was linked with an increased WAT mass and was in 
line with other studies (54). Moreover, the increased food intake after corticos-
terone treatment might indicate leptin resistance in the corticosterone-treated 
mice (53,54). Circulating levels of total and HMW adiponectin and A/L ratio are 
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considered reliable indicators for assessing adipocyte dysfunction and metabolic 
disorder because adiponectin levels decline in obesity and insulin resistance 
(41,50,55,56). Also in our study, both the A/L ratio and HMW adiponectin/
leptin ratio were reduced in the corticosterone-treated mice. Nevertheless, 
circulating levels of total adiponectin and HMW adiponectin were elevated upon 
corticosterone treatment, especially in female mice. In accordance with our 
data, a previous study in male mice showed that prednisolone treatment 
increased plasma adiponectin levels and the effect was more pronounced when 
administering prednisolone to the castrated mice (57). Expression of Adipoq 
in gWAT, iWAT, and BAT of corticosterone-treated mice, however, was lower 
or tended to be lower than that of the vehicle-treated mice. This contradictory 
effect on gene expression and total circulating protein level might be explained 
by the compensatory effect of insulin because our in vitro studies in cultured 
3T3-L1 white adipocytes and T37i brown adipocytes revealed opposite effects of 
insulin and corticosterone on the production and secretion of adiponectin. More 
comprehensive in vivo studies are needed to elucidate this counterregulatory 
effect of insulin and corticosterone on adipocyte adaptations.
Note that our finding on Adamts1 expression is different from a previous 
study that reported that dexamethasone-treated mice had a reduced ADAMTS1 
abundance in WAT (40). However, another study demonstrated that cortisol 
treatment of cultured preadipocytes, obtained from WAT of healthy women who 
had undergone hysterectomy, upregulated ADAMTS1 expression (58). These 
discrepancies may be caused by a different type, dosage, or duration of GC used 
among experiments. Unlike the endogenous GCs cortisol and corticosterone that 
can activate both GR and MR, dexamethasone is a potent GR activator with 
minimal mineralocorticoid effects (59), and Adamts1 is reported to be an MR 
target gene, at least in cardiomyocytes (60).
Concerning the IPGTT data, an absence in spike of blood glucose 
levels in corticosterone-treated female mice is unlikely caused by a technical 
error since [U-13C6]-D-glucose can be detected in the blood of the mice and the 
IPGTT was performed simultaneously in all groups of mice. We speculate that 
this unique blood glucose pattern in the corticosterone-treated female mice 
reflects an effective β-cell response to secrete insulin for handling the injected 
glucose. This is in general confirmed by a recent study by Gasparini et al. (61) 
in which it was shown that only female mice remained insulin-sensitive after 
4 weeks treatment with ~250 µg corticosterone per day in drinking water. 
Although insulin sensitivity was not assessed directly in our study, note that 
we found an increase in fasting insulin levels in both male and female mice 
whereas Gasparini et al. (61) found that corticosterone-treated female mice had 
an unchanged insulin concentration. This is likely due to a higher induction 
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of systemic corticosterone levels by the high-dose corticosterone treatment in 
our study. Further studies using hyperinsulinemic-euglycemic clamp, the gold 
standard method for assessing insulin sensitivity, are needed to elucidate the 
effect of chronic high-dose corticosterone treatment.
Another limitation of our study is the lack of data on energy expenditure 
of the animals, as we think that the increased food consumption can only 
partially explain the enhanced fat accumulation and weight gain of the 
corticosterone-treated mice. Thus, performing quantitative measurement of 
physical activity together with indirect calorimetry is needed in future studies 
on sex-dependent corticosterone effects.
A few studies have shown an apparent interaction of sex steroids with GC 
activity. For instance, estrogen depletion in female mice resulted in a GC-driven 
development of hepatic steatosis (45). The consequences of this on whole-body 
metabolism was not addressed in the aforementioned study, but another study 
revealed that corticosterone-induced metabolic derangements, such as BW 
gain and WAT expansion, were more severe in ovariectomized than in sham- 
operated female rats and were counteracted by estradiol supplementation (52). 
Recently, androgens were also reported to modulate GR activity in liver and 
adipose tissue of male mice (62). Although some signs/symptoms such as muscle 
wasting, osteoporosis, purple striae, and nephrolithiasis are more frequent in 
male patients with Cushing disease, the prevalence of metabolic derangements 
in Cushing syndrome, such as obesity and glucose abnormalities, does not 
differ between men and women (63-65). In contrast, metabolic derangements 
upon systemic or topical use of corticosteroids appeared slightly more frequent 
in women than in men (66). Thus, despite the irrefutable fact that GCs have 
more metabolically negative effects in male rodents, which can at least partly be 
attributed to differences in sex steroid, the clinical manifestation is unclear and 
requires more dedicated studies.
In conclusion, this study illustrates a sex-dependent insulin resistance 
caused by continuous treatment with high-dose corticosterone. Morphological 
changes upon metabolic challenges and adipokine secretions from adipose tissues 
indicate favorable protective mechanisms in female mice. This result warrants 
more careful evaluation of sex as a factor in the glucose monitoring strategy of 
patients receiving corticosteroid therapy.
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Abstract
Background: The thermoneutral zone (TNZ) is a species-specific range of 
ambient temperature (Ta), at which mammals can maintain a constant body 
temperature with the lowest metabolic rate. The TNZ for an adult mouse is 
between 26 and 34 °C. Interestingly, female mice prefer a higher Ta than male 
mice although the underlying mechanism for this sex difference is unknown. 
Here, we tested whether gonadal hormones are dominant factors controlling 
temperature preference in male and female mice.
Methods: We performed a temperature preference test in which 10-week-old 
gonadectomized and sham-operated male and female C57BL/6J mice were 
allowed to choose to reside at the thermoneutral cage of 29 °C or an experimental 
cage of 26, 29 or 32 °C.
results: All mice preferred a Ta higher than 26 °C, especially in the inactive 
phase. Choosing between 29 °C and 32 °C, female mice resided more at 32 
°C while male mice had no preference between the temperatures. Hence, the 
preferred Ta for female mice was significantly higher (0.9±0.2 °C) than that of 
male mice. However, gonadectomy did not influence the Ta preference.
conclusions: Female mice prefer a warmer environment than male mice, a 
difference not affected by gonadectomy. This suggests that thermal sensing 
mechanisms may be influenced by sex-specific pathways other than gonadal 
factors or that the thermoregulatory set point has already been determined prior 
to puberty.
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Background
Mammals prefer ranges of ambient temperature (Ta) within their 
species-specific thermoneutral zone (TNZ) at which their metabolic rate is at 
its lowest and theoretically equal to their basal metabolic rate. To control the 
core body temperature (Tc) in TNZ, only dry heat loss, i.e., skin blood flow, is 
sufficient. However, metabolic heat production or evaporative heat loss is 
required to regulate Tc at a Ta outside the TNZ [1]. Disturbances in Ta can alter 
normal physiological responses such as dietary requirement, cardiovascular 
functions, and reproduction capacity [2, 3]; thus, it is important to be aware of 
the changes of Ta. The TNZ for an adult mouse is considered to be broad and 
in between 26 and 34 °C, and mice therefore prefer a Ta between 29 °C and 31 
°C [4]. However, general animal facilities apply a Ta for laboratory mice in the 
range of 20–24 °C [5], which matches a thermal comfort of husbandry staffs 
and handling procedures but poses a persistent moderate cold stress to mice [6] 
affecting their physiological processes [7].
Many factors contribute to distinct patterns of thermal preference among 
mice. For instance, since mice are nocturnal animals, their motor activity has a 
diurnal rhythm which peaks in the dark phase. An increase in heat production 
related to this physical activity during the active phase results in a preference 
for a lower Ta to maintain Tc at night [6]. In addition, a higher Ta is required 
by neonatal mice due to limitations in their thermal regulatory mechanisms 
[8]. Elderly mice also require higher Ta due to changes in total body surface 
area (BSA). Upon growth, the BSA to body mass ratio decreases resulting in 
less capacity to exchange heat with the environment [4, 9]. Finally, thermal 
differences in mice have a sex-dependent pattern: female mice prefer a slightly 
higher Ta than male mice of the same age, especially in the inactive phase [10].
The mechanism(s) that underlie the differences in thermal regulation 
and preference between sexes are not clearly understood, but gonadal hormones 
such as the female sex hormones estradiol and progesterone and the male sex 
hormone testosterone might be considered dominant factors. The overall Tc of 
post-pubertal female mice is 0.2–0.5 °C higher than that of male mice, especially 
when the levels of progesterone and, to a lesser extent, estradiol are elevated 
during the estrous cycle [11]. Of interest, this higher Tc in female mice is not 
due to the difference in locomotor activity between male and female mice [11]. 
Progesterone shifts the thermoregulatory set point in the central nervous 
system resulting in an increase of basal Tc in the luteal phase of the human 
ovarian cycle [12]. Since the mouse estrous cycle lasts only 4–5 days and does 
not include a true luteal phase, major and prolonged elevations of progesterone 
are only seen during (pseudo)pregnancy [13]. Estradiol influences energy 
balance by increasing the energy expenditure through modulation of central 
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neuronal circuits [14], which includes the production of heat by brown adipose 
tissue (BAT) [15]. BAT is an important source of heat production in rodents, 
especially in the inactive phase. Interestingly, both estradiol and progesterone 
also directly stimulate biogenesis of brown adipocytes while testosterone inhibits 
differentiation of brown adipocytes [16, 17]. However, the effects of gonadal 
hormones on the thermal preferences in mammals are not clearly studied.
To elucidate the effects of gonadal hormones on thermal preference, we 
performed temperature preference tests (TPTs) in adult mice of both sexes, in a 
range of Ta close to their TNZ. The results of the TPTs will reveal whether removal 
of gonadal hormones by gonadectomy (GDX) affects temperature preference.
Methods
Animals and housing conditions
Six-week-old C57BL/6J mice (16 male and 16 female mice) were 
obtained from Charles River Laboratories (Maastricht, the Netherlands). Upon 
arrival, the mice were housed for 1 week in groups of three animals in standard 
laboratory cages (Sealsafe 1145T, Tecniplast, Buguggiate, Italy; 36.9 cm L × 15.6 
cm W × 13.2 cm H) with bedding material (Lignocel BK 8/15, J. Rettenmaier & 
Söhne GmbH, Rosenberg, Germany) and nesting material (facial tissue paper, 
Tork, SCA Hygiene Products, Zeist, the Netherlands) on a 12:12-h light-dark 
cycle (lights on at 8 a.m.), at temperatures of 21–23 °C with 40–70% relative 
humidity. Chow food pellets (801722 CRM (P), Special Diets Services, Essex, 
UK) and water were available ad libitum. After the 1-week acclimatization, the 
mice were housed individually in a cage of the same setting for 3 days before 
the first series of TPTs was started. Thus, the mice were about 8 weeks old 
when enrolled in the experimental setups. All experimental procedures were 
performed with the approval of the Animal Ethics Committee at Erasmus MC, 
Rotterdam, the Netherlands.
Temperature preference test setup 
For the TPT, a setup was designed based on the thermal preference 
apparatus by Gaskill et al. [18]. To connect two cages, an opening was drilled 
in one wall of each cage (4 cm diameter at the position of 7.5 cm from the cage 
floor) and a black corrugated connecting tube was placed, as shown in Fig. 1A,B. 
Water baths, in which electric submersible aquarium heaters and water pumps 
(Superfish Combi Heater and Aqua-Flow, Aquadistri, Cambridgeshire, UK) 
were installed, were used to maintain a constant Ta in the cages. The water bath 
was filled with water to the level of 7.5 cm depth, and the cages were fastened by 
fabric straps to ensure that the water level was 5 cm from the cage bottom. At 
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this water level, the Ta inside the cage (measured at the floor) was less than 0.5 
°C different from the temperature in the water bath. Each cage contained a bottle 
of water, food pellets, nesting material (one sheet of the facial tissue paper, two 
layers per sheet, size 20 cm × 21 cm, weight 1.3 g), and bedding material (0.5 cm 
depth of Lignocel BK 8/15 woodchips). The mice were allowed to freely explore 
both cages. To prevent position bias from adjacent cages, opaque plastic sheets 
were placed as visual barriers between the cages. In total, the setup consisted of 
six TPT sets (Fig. 1B) for studying six mice simultaneously.
Experimental design
The total experimental procedure had a duration of 6 weeks, consisting 
of weeks 1 and 2 for adaptation to the TPT setup, week 3 for surgical procedure 
and recovery, and weeks 4 to 6 for behavioral observation (Fig. 1C). In the 
adaptation period (weeks 1 and 2) and the experimental period (weeks 4, 5, and 
6), we performed the TPT in a total of 96 h after which the mice returned to 
their individual cage for the weekends. On Mondays, the temperature of the 
outer cages (the experimental cages) was set at 23 °C to mimic the general 
animal facility environment, while the temperature of the middle cages (the 
thermoneutral (TMN) cages) was set at 29 °C. The routine care was performed 
daily between 1 and 2 p.m. including replacing of bedding and nesting material, 
weighing mice and food, and adjusting the temperature of the experimental cages 
to 26, 29, and 32 °C on Tuesday, Wednesday, and Thursday, respectively. The 
temperature of the TMN cages was kept at 29 °C throughout the week. After the 
daily routine, the mouse was put back in its experimental cage. The cages and 
water baths were cleaned thoroughly at the end of every week. For the surgical 
week (experimental week 3), the mice were randomized to undergo GDX or sham 
operation on Monday. After the surgery, the mice were allowed to recover for 7 
days in their individual cage. To reduce the effect of position bias, the mice were 
relocated to an adjacent TPT set in the following week.
Gonadectomy
GDX was operated under isoflurane (Isofluraan, Teva Pharmachemie, 
Haarlem, the Netherlands) anesthesia and carprofen (Rimadyl Cattle, Pfizer, 
Capelle a/d IJssel, the Netherlands) analgesia. For the GDX of female mice, 
small incisions were made in both flanks to remove the ovaries. In the male 
mice, small incisions were made in the lower abdomen through which the testes 
were removed. Sham-operated animals underwent the same procedures without 
removal of ovaries or testes. Bleeding was verified and stopped and then the 
muscle layer and skin were sutured.
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Termination of mice
In the week after the last TPT, the mice were euthanized by cardiac 
puncture under isoflurane anesthesia. For the female mice, the uterus was 
dissected and weighed to verify if the ovariectomy was successful.
Behavioral observation, data collection, and analysis
The thermal preference of each mouse was recorded by webcams (Exis, 
Trust, Dordrecht, the Netherlands) with the time-lapse function of Netcam 
Studio software (Moonware Studios) resulting in pictures with a 5-min interval 
that were collected for 23 h, excluding the hour of the daily routine period. In 
the dark period, the photographs were taken under red lights. After a pilot study 
(results not shown), the periods of 9–12 p.m. and 9–12 a.m. (starting 1 hour after 
light off and on, respectively) were selected for the study. Data from the mice 
that failed to explore both the experimental and the TMN cage for the whole 
experimental period were excluded from data analysis.
After weighing the mice and the food in all cages during the routine care, 
the bedding and nesting materials were gathered for further processing. Feces 
were sorted out from the woodchip bedding and weighed. The nesting material 
was unfolded, put on a black board, and photographed for analysis by three 
assessors. The “paperwork score,” modified from Kalueff et al. [19], was assessed 
to quantify how active a mouse was in biting and shredding the paper. This 
score ranges from 1 to 4: 1—without or little paper damage (<5% of destruction 
compared to the total area of the nest), 2—mild paper damage (5–25%), 3—
moderate paper damage (25–50%), and 4—severe paper damage (>50%), as 
shown in Fig. S1. An average overall agreement of the paperwork score by three 
blinded assessors equaled to 84.7% (κ = 0.79), without any more-than-1 ordinal 
score discrepancy. Since the nesting material can be transferred from one cage to 
the other, we also assessed the “nest score” for each cage. This score is calculated 
as follows:
Nest score = ((paperwork score)/4) × (relative amount of nest in the cage).
In this, the relative amount of nest is a proportion of nest weight in that 
cage to the total weight of the nesting material provided to the animal, ranging 
from 0 to 1. For comparison between the experimental and the TMN cage of each 
mouse, the higher paperwork score and the higher nest score were used for data 
analysis.
The BSA of the mice was calculated by Meeh’s formula with the C57BL/6J 
specific constant as described by Cheung et al. [20]:
BSA = 9.822 × BW0.667.
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In this, BW is the body weight in gram and BSA is the surface in square 
centimeter (cm2).
Baseline characteristics of mice taken during the adaptation weeks are 
provided in Table S1.
Statistical analysis
The statistical tests were performed using IBM SPSS Statistics for 
Windows, version 21 (IBM Corp.) with p < .05 considered statistically significant. 
Unless otherwise stated, the effects of experimental Ta, sex of mice, and gonadal 
status were analyzed by repeated three-way ANOVA, and then, the post hoc 
tests were evaluated by two-way ANOVA for the effects of sex and gonadal 
status in each Ta and Tukey tests to determine differences among groups. The p 
values of Ta, sex, and gonadal status are indicated by pT, pS and pG, respectively. 
The proportion of time that a mouse spent in each cage was arcsine transformed. 
The preference to either the TMN cage or the experimental cage in each Ta was 
analyzed by one-sample t test. Correlations between the time-weighted average 
Ta and other factors were calculated by Pearson’s correlation coefficient. All data 
are presented as mean ± SD unless otherwise indicated.
Results
Gonadectomy affected the energy balance pattern mainly in female mice
GDX differentially affected body weight (BW) in male and female mice. 
While ovariectomy increased BW of female mice, orchiectomy did not affect BW of 
male mice during the study period. As a result, the BW of gonadectomized female 
mice was higher than the sham-operated female mice in the last experimental 
week (two-way ANOVA: pS < .001, pG = .011, pS×G = .014; Fig. 2A). In addition, 
the ratio of BSA to BW at the start of the last experimental week depended 
significantly on both sex and gonadal status (female sham 3.57 ± 0.03 cm2/g, 
female GDX 3.43 ± 0.09 cm2/g, male sham 3.32 ± 0.04 cm2/g, and male GDX 3.33 
± 0.07 cm2/g; two-way ANOVA: pS < .001, pG = .013, pS×G = .006; Tukey post hoc 
test revealed p < .05 for all pairs except sham-operated male vs gonadectomized 
male mice).
In general, the experimental Ta influenced the relative daily food intake 
(pT = .003) and female mice ate relatively more than male mice without an effect 
of gonadal status (pS < .001; Fig. 2B). However, the negative correlation of Ta 
on daily food intake was only significant for sham-operated male mice (r = −.54, 
p = .011). In line with the food intake, the experimental Ta was related to the 
relative fecal production (pT = .018). Moreover, the fecal production of female 
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mice was higher than that of male mice, with a significant interaction between 
sex and gonadal status (pS < .001, pS×G = .049; Fig. 2C). Although the general 
trend of daily food intake (energy input) was negatively correlated with the 
experimental Ta, the daily BW change of mice tended to positively correlate with 
the experimental Ta without a significant effect of sex or gonadal status but with 
a significant interaction between Ta, sex, and gonadal status (pT = .002, pT×S×G = 
.002; Fig. 2D). The positive correlations between Ta and daily BW change were 
significant in sham-operated female mice (r = .62, p = .003) and gonadectomized 
male mice (r = .54, p = .007).
Fig. 2  Gonadectomy affected the energy balance pattern mainly in female mice
(A) Gonadectomy increased body weight only in female mice. Weights of mice measured 
at the first day of each experimental week are plotted. (B) Daily food intake and (C) fecal 
production were higher in female mice with negative correlations with the experimental Ta. 
(D) Body weight was unchanged during the 24-h period in the experimental setup when the 
experimental Ta was set at 26 and 29 °C, but some groups of mice gained weight when the 
experimental Ta was set at 32 °C. Two-way ANOVA: $ pS < .05, $$$ pS < .001, + pS×G < .05, ++ 
pS×G < .01, +++ pS×G < .001, and Tukey test: * p < 0.05, *** p < 0.001. Error bar indicates SEM, 
n = 7–8 per group
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Female mice preferred a higher ambient temperature, especially in the inactive 
phase
The time mice spent in the TMN cage was influenced by experimental Ta, 
sex, and the interaction between these factors, but was not altered by gonadal 
status (pT < .001, pS < .001, pT×S = .002, pT×S×G = .004; Fig. 3A). When the Ta of 
the experimental cages was set at 26 °C, all groups of mice preferred to reside in 
the TMN cages rather than the experimental cages (pS = .038, pS×G = .026; Fig. 
3A). Calculated from the cage preference data, the time-weighted average Ta the 
mice were exposed to was slightly higher for male than for female mice, with a 
significant interaction between sex and gonadal status (female sham 28.3 ± 0.3 
°C, female GDX 28.1 ± 0.2 °C, male sham 28.3 ± 0.3 °C, and male GDX 28.5 ± 
0.3 °C; pS = .044, pS×G = .030; Fig. 3B). When the Ta of the experimental cages 
was set the same as of the TMN cages at 29 °C, male mice (both sham-operated 
and gonadectomized) resided more in the TMN cages while female mice had 
no preference to either cage (pS < .001, pS×G = .033; Fig. 3A). When the Ta of 
the experimental cages was set at 32 °C, female mice (both sham-operated and 
gonadectomized) spent more time in the experimental cage than in the TMN 
cage, while sham-operated male mice preferred the TMN cage and gonadecto-
mized male mice had no preference for either the TMN or the 32 °C cage (pS 
< .001; Fig. 3A). Calculated from the cage preference data, the time-weighted 
average Ta the mice were exposed to when able to choose between 29 and 32 °C 
was significantly higher for female mice than male mice, without an effect of 
gonadal status (female sham 31.2 ± 0.2 °C, female GDX 31.1 ± 0.4 °C, male sham 
30.2 ± 0.2 °C, and male GDX 30.4 ± 0.3 °C; pS < .001; Fig. 3B). Thus, in general, 
the female mice preferred a higher Ta than male mice, a difference that was not 
affected by presence of the gonads.
Next, we determined whether Ta preference between the sexes was 
different in the active or inactive phase and found that the sex of mice influenced 
the thermal demand differently between the dark (active) phase (pT < .001, 
pT×S×G = .002; Fig. 3C) and the light (inactive) phase (pT < .001, pS < .001, pT×S = 
.002, pT×G = .013; Fig. 3E). When the experimental Ta was set at 26 °C, sham- 
operated female, gonadectomized female, and gonadectomized male mice 
preferred to stay in the TMN cage in the dark phase, while sham-operated male 
mice had no preference to either cage in the dark phase. In the light phase, all 
groups preferred the TMN cage over the experimental 26 °C cage with a more 
prominent preference in male mice, without an effect of gonadal status. When 
the experimental Ta was set at 32 °C, all groups equally resided in both the 32 
°C and the TMN cages in the dark phase. In the light phase, sham-operated 
and gonadectomized female mice preferred the 32 °C cage over the TMN cage, 
whereas gonadectomized male mice preferred the TMN cage and sham-operated 
male mice showed no preference to either cage.
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It is thus evident that GDX did not alter the sex-dependent thermal 
preferences when analyzing the active and inactive phase independently, except 
only for the male mice in the dark phase at experimental Ta of 26 °C (p = .030). 
In addition, the time-weighted average Ta, calculated from the location where 
the mice resided, was different between the active and inactive phases (Fig. 
3D,F, respectively). The difference between male and female mice was the most 
obvious when they were able to choose between 29 and 32 °C in the inactive 
phase: female mice preferred higher Ta than male mice without an effect of 
gonadal status (female sham 31.7 ± 0.1 °C, female GDX 31.8 ± 0.2 °C, male sham 
30.1 ± 0.6 °C, and male GDX 30.2 ± 0.2 °C; pS < .001; Fig. 3F).
The location of activities was affected mainly by ambient temperature and 
partially by orchiectomy
The experimental Ta and sex influenced the transfer of nesting material 
by the mice (pT < .001, pS < .001, pT×S = .013, pT×G = .021; Fig. 4A). When the 
experimental Ta was at 26 °C, all mice preferred to transfer the nesting material 
to the TMN cage. When the experimental Ta was at 32 °C, female mice transferred 
the nesting material to this warmer cage while male mice did not transfer the 
nesting material at all. This trend of nest transfer to a warmer cage was similar 
to the temperature preference shown in Fig. 3A and was not affected by gonadal 
status. The “paperwork score,” reflecting nest destructions, was only affected by 
the experimental Ta without an effect of sex or gonadal status (pT < .001; Fig. 
4B). The “nest score,” which also takes the relative nest amount into account, 
was solely influenced by the experimental Ta (pT < .001; Fig. 4C). Generally, the 
“nest score” negatively correlated with the experimental Ta, but the correlations 
were only significant for sham-operated female mice (r = −.47, p = .030) and 
gonadectomized male mice (r = −.48, p = .016).
The preference to consume food in the TMN or the experimental cage 
was not affected by experimental Ta, sex, or gonadal status, but there was a 
significant interaction between sex and gonadal status (pS×G = .042; Fig. 4D). 
All mice generally consumed the food equally from both cages except at the 
experimental temperature of 26 °C when sham-operated male mice preferred 
food from the 26 °C experimental cage while the gonadectomized male mice 
preferred food from the TMN cage. The position where mice preferred to defecate 
was dependent on the experimental Ta and the interactions between gonadal 
status and the other factors (pT < .001, pT×G < .001, pS×G = .002; Fig. 4E). When 
the experimental Ta was set at 26 °C, most mice predominantly defecated in the 
26 °C cage, except gonadectomized male mice that had no preference to defecate 
in either cage. When the Ta was equal in both cages at 29 °C, only sham-operated 
male mice preferred the experimental cage while the others defecated equally 
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in both cages. When the experimental Ta was at 32 °C, sham-operated female 
mice defecated more in the TMN cage, while mice of the other groups showed no 
preference. Interestingly, when correlating the nest-building pattern (the cage 
with a higher nest score) with the defecating pattern, it was evident that while 
all other mice defecated in the cage without the nest, gonadectomized male mice 
defecated more in the cage where they had built their nest.
Fig. 4  The location of activities was affected mainly by ambient temperature and 
partially by orchiectomy
(A) At the experimental Ta of 26 °C all groups transferred the nest to the TMN cage, whereas 
at the experimental Ta of 32 °C only female mice transferred the nest to the experimental 
cage. The difference of nest amount found in each cage is represented on the y-axis. Zero 
means the mice did not transfer the nesting material. A positive value means transfer of 
nesting material to the TMN cage while a negative value means transfer to the experimental 
cage, of which the Ta is indicated on the x-axis. Nest-relating activities revealed negative 
correlations of Ta to the (B) paperwork score and (C) nest score without an effect of sex or 
gonadal status. The experimental Ta, sex, or gonadal status did not affect (D) the preferred 
cage for food consumption, but orchiectomy and the experimental Ta altered (E) the preferred 
cage for defecation. Two-way ANOVA: $$ pS < .01, $$$ pS < .001, # pG < .05, + pS×G < .05, ++ 
pS×G < .01, and Tukey test: * p < .05, ** p < .01. Error bar indicates SEM, n = 7–8 per group
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Discussion
The data presented in this paper demonstrate that female mice prefer a 
warmer environment than male mice, in agreement with previous studies [10, 
21]. This article is the first to show that this sex difference in thermal preference 
in adult mice is not altered by GDX, suggesting that gonadal hormones are not 
the main driver of this sex difference in adult mice.
The preference to a higher Ta of female mice could be explained by many 
other mechanisms involving a complex circuit that controls whole body thermal 
and energy homeostasis. The differences in body compositions may affect 
thermal preferences. We found that female C57BL/6J mice had a higher BSA 
to body mass ratio than male mice of the same age. Therefore, the female mice 
likely had a higher heat dissipation rate from the skin to the environment and 
consequently a higher energy demand than male mice which may have resulted 
in the preference to reside at a higher Ta. Moreover, this may have resulted in 
a higher relative daily food intake to match the higher passive heat loss. The 
higher food consumption of female mice was also noted in a previous study [22].
The body composition of C57BL/6J mice is sexually dimorphic: male mice 
have a higher lean body mass [23] with relatively more skeletal muscle mass 
[24] than female mice. Because heat is a byproduct of muscular activities, the 
higher muscle mass in male mice could explain why male mice have generally 
less thermal demand compared to female mice. Paul et al. [24] found that GDX 
abolished the sex-specific pattern of muscle mass leading to a reduction in muscle 
mass in castrated male mice to a comparable amount as found in ovariectomized 
and sham-operated female mice. This effect of castration could also explain the 
higher thermal demand of castrated male mice compared to sham-operated male 
mice in our study, while ovariectomy did not alter the thermal preference of 
female mice in the active phase at Ta of 26 °C.
 Control of Tc is regulated by the brain. The preoptic area of the 
anterior hypothalamus (POAH) is the primary site that integrates afferent 
signals from peripheral thermoreceptors to control the physiological responses 
through projections to other hypothalamic areas that modulate non-shivering 
thermogenesis of BAT to match the overall thermal demand [25–27]. The female 
gonadal steroids estradiol and progesterone differently modulate the thermo-
regulatory set point during the estrous cycle of mammals. A decline of Tc in 
the pre-ovulatory phase is related to estrogen secretion in that phase while 
progesterone secretion at the luteal phase increases Tc [11, 28]. Furthermore, 
there is evidence that estradiol and testosterone differentially affect steroid-sen-
sitive neurons in the POAH of rats [29] and the central set point of temperature in 
different groups of hypothalamic neurons [12, 26]. We found that when the mice 
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were allowed to choose between 32 and 29 °C, the overall average preferred Ta 
was higher for female mice than for male mice in the inactive phase, suggesting 
a sex-dependent regulation of the temperature set point in the mouse brain. 
However, since our study revealed that the removal of gonadal hormones by 
GDX did not affect the thermal preference of both male and female mice, we 
cannot conclude that the sex-dependent regulation of the temperature set point 
in the POAH depends on the different gonadal hormones. Nevertheless, effects of 
gonadal hormones outside the brain might be involved. For instance, estradiol, 
progesterone or testosterone differentially stimulated or inhibited the peripheral 
thermoreceptors [30], and estradiol and progesterone induce while testosterone 
reduces the thermogenesis of BAT [31, 32].
It is highly unlikely that the lack of an effect of GDX on thermal preference 
found in our studies is due to the sustained presence of sex hormones after GDX. 
Steroid hormones, including sex hormones, generally have half-lives of 4–170 
min [33]. In C57BL/6 mice, the half-lives of 17β-estradiol and testosterone are 
less than 1 h [34, 35]. Moreover, locomotor activities and circadian rhythms have 
been shown to be altered as soon as 1 week after GDX [36].
Since we did not find an effect of post-pubertal GDX on thermal preference 
in adult mice, it is plausible that the mechanisms underlying the sex difference 
in thermal preference were generated prior to puberty. Sex hormones have 
permanent organizational effects on brain development during two sensitive 
periods [37]. Perinatally, testosterone secreted from the testes masculinizes 
the neural circuit in male mice while androgen absence in female rodents 
feminizes the nervous system. During puberty, elevations of gonadal hormones 
due to maturation of the hypothalamic-pituitary-gonadal axis strengthen the 
sex-dependent behaviors. In addition, it is reported that the POAH is a sexually 
dimorphic region in which morphological changes develop during puberty and 
that exposure to estrogenic compounds at puberty disturbs the development of 
neuronal circuits [38, 39]. 
Conclusions
In summary, we found that adult female mice preferred a warmer 
environment than male mice of the same age, a difference that was especially 
apparent in the inactive phase. However, this sex difference did not depend on 
the presence of gonads. The sex difference in thermal preference in adult mice 
might be influenced by other sex-specific pathways rather than the gonadal 
factors or the central set point that controls the thermal balance has already 
been established at pre-pubertal stages.
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Fig. S1  Paperwork score
Table S1  Baseline characteristics
Characteristic
Female sham 
before surgery 
(n = 7)
Female GDX 
before surgery 
(n = 7)
Male sham 
before surgery 
(n = 7)
Male GDX 
before surgery 
(n = 8)
Initial body weight (g)
Daily body weight gain (g)
19.1 ± 0.7
0.12 ± 0.13
19.5 ± 1.3
0.08 ± 0.05
23.9 ± 0.8
0.13 ± 0.05
24.0 ± 1.0
0.19 ± 0.07
Daily food intake (g)
Food intake in TMN cage (%)
3.26 ± 0.44
45.7 ± 9.7
3.10 ± 0.47
47.2 ± 10.5
3.57 ± 0.63
42.9 ± 6.9
3.48 ± 0.43
46.8 ± 16.8
Daily fecal production (mg)
Fecal weight in TMN cage (%)
558 ± 56
47.4 ± 10.8
576 ± 77
44.6 ± 8.5
618 ± 86
38.2 ± 9.0
593 ± 38
30.9 ± 10.6
Total time in TMN cage (%) 
   29 °C vs 26 °C day 
   29 °C vs 29 °C day 
   29 °C vs 32 °C day
Preferred temperature (˚C) 
   29 °C vs 26 °C day 
   29 °C vs 32 °C day
 
79.1 ± 9.7 
55.2 ± 26.4 
46.3 ± 13.9
 
28.37 ± 0.29 
30.61 ± 0.42
 
79.0 ± 9.9 
61.3 ± 25.7 
43.8 ± 20.6
 
28.37 ± 0.30 
30.68 ± 0.62
 
70.9 ± 5.1 
64.3 ± 16.5 
54.9 ± 15.2
 
28.13 ± 0.15 
30.35 ± 0.46
 
76.6 ± 11.1 
78.6 ± 17.0 
53.1 ± 22.7
 
28.30 ± 0.33 
30.41 ± 0.68
All variables are described by the mean ± SD. No difference between sham and GDX groups 
of the same sex. (All p values > .05, unpaired t tests).
Abbreviations: TMN = Thermoneutral (29 ˚C), GDX = Gonadectomy
Supplementary data
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Abstract
To maintain a thermal balance when experiencing cold, humans reduce 
heat loss and enhance heat production. A potent and rapid mechanism for heat 
generation is shivering. Research has shown that women prefer a warmer 
environment and feel less comfortable than men in the same thermal condition. 
Using the Blanketrol® III, a temperature management device commonly used 
to study brown adipose tissue activity, we tested whether the experimental 
temperature (TE) at which men and women start to shiver differs. Twenty male 
and 23 female volunteers underwent a cooling protocol, starting at 24 °C and 
gradually decreasing by 1–2 °C every 5 min until an electromyogram detected 
the shivering or the temperature reached 9 °C. Women started shivering at a 
higher TE than men (11.3 ± 1.8 °C for women vs 9.6 ± 1.8 °C for men, P = 0.003). 
In addition, women felt cool, scored by a visual analogue scale, at a higher TE 
than men (18.3 ± 3.0 °C for women vs 14.6 ± 2.6 °C for men, P < 0.001). This 
study demonstrates a sex difference in response to cold exposure: women require 
shivering as a source of heat production earlier than men. This difference could 
be important and sex should be considered when using cooling protocols in 
physiological studies.
Highlights
• Women start shivering at a higher experimental temperature than men.
• Women feel colder and less comfortable than men during the same 
cooling protocol.
• Thermal perception at room temperature and sex are determinants of 
shivering onset.
• Sex of a participant should be considered for thermoregulation studies.
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Introduction
Humans tightly control their core body temperature (Tc) by balancing 
heat loss and heat production (Costanzo, 2017). When exposed to mild cold, 
humans first reduce heat loss by energy-inexpensive mechanisms such as the 
constriction of blood vessels supplying the peripheral tissues. This peripheral 
vasoconstriction not only reduces the heat transfer from the isothermal core 
to the non-isothermal shell, but also increases the insulating capacity of the 
skin and subcutaneous tissues. The shift of blood from superficial layers to 
deeper vessels results in an increased total body insulation since the bloodless 
layer, where the convective heat loss substantially diminishes, becomes thicker 
(Anderson, 1999). However, if the thermal balance cannot be accomplished by a 
reduction in heat loss, heat production is required (Tansey and Johnson, 2015).
Heat production can be achieved by many mechanisms (Castellani and 
Young, 2016; Hall, 2015). Exposure to cold activates the sympathetic nervous 
system (SNS), immediately increasing the metabolic rates of all cells in the 
body that consequently generate heat as a by-product of metabolism. The direct 
stimulation of β-adrenergic receptors by the SNS also activates brown adipose 
tissue (BAT), a specialized metabolic tissue that can convert energy into heat (Lee 
et al., 2013). When the metabolic heat production (non-shivering thermogenesis) 
together with the cutaneous vasoconstriction is not sufficient to maintain the 
optimal Tc, shivering begins.
Shivering, which is the involuntary rhythmic contraction of skeletal 
muscles, is the most potent and rapid mechanism to generate heat in response to 
cold stress. When the skin senses cold via the transient receptor potential cation 
channel subfamily M member 8 (TRPM8) on the sensory nerves (Voets et al., 
2004), it signals to the temperature center in the hypothalamus. The primary 
motor center for shivering in the posterior hypothalamus is then activated 
and transmits signals to the skeletal muscles to initiate shivering throughout 
the body (Hall, 2015). At the maximum intensity of shivering, metabolic heat 
production can rise to five times of the resting levels (Eyolfson et al., 2001).
Various cooling techniques have been used to study the physiological 
responses to cold environment, especially after the rediscovery of BAT in adult 
humans in the last decade (Nedergaard et al., 2007) because cold is a well-known 
stimulant for the thermogenic function of BAT. The cooling methods include 
cold-water immersion, cold-air exposure, cold-air exposure combined with 
localized cooling e.g. feet cooling in ice water, and water-filled cooling blankets or 
suits (Castellani and Young, 2016; van der Lans et al., 2014). The cooling blanket 
with temperature of the filling water set at 1–2°C above the shivering point (also 
known as a personalized cooling protocol) is likely the method that maximally 
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activates BAT (Bahler et al., 2017). Using this cooling method, conduction will 
be the mode of heat transfer at those body areas that are covered and in direct 
contact with the cooling blankets whereas convection will occur at areas without 
direct contact with the blankets. One of the frequently used cooling blankets 
is the Blanketrol® III, a temperature management device that can control the 
temperature of the circulating water in a range from 4 °C to 42 °C.
Research has shown that sex is one of the important factors that 
influence thermal perception and physiological responses to cold. Karjalainen 
(2007) demonstrated that women prefer a higher ambient temperature and feel 
less comfortable than men in the same thermal environment, especially during 
the winter season. Furthermore, Kingma and van Marken Lichtenbelt (2015) 
showed that women require more heat production than men in the standard 
indoor climate setting that was mainly based on male metabolic rates. Castellani 
and Young (2016) revealed that the primary source of the variable capability to 
maintain a normal Tc between men and women during whole-body cold exposure 
is body anthropometric and body composition characteristics. At the same body 
mass and surface area, women generally have a higher subcutaneous fat content 
than men that enhances insulation (Anderson, 1999; Castellani and Young, 
2016; Kuk et al., 2005). On the other hand, when the subcutaneous fat thickness 
is equal between a man and a woman, the latter in general will have a larger 
body surface area (BSA) and a smaller body mass contributing to a greater total 
heat loss and a lower heat-production capacity during resting cold exposure 
(Castellani and Young, 2016; Graham, 1988).
Understanding sex differences in thermal regulation and cold-induced 
physiological responses is beneficial in many aspects. For instance, Iyoho et al. 
(2017) proposed a sex-specific modification of the thermoregulation model for 
predicting thermal response in a wide range of the operational conditions for 
military relevant tasks, especially in the cold-stress responses. Chaudhuri et 
al. (2018) showed that different physiological parameters from male and female 
occupants were needed to accurately predict the thermal comfort status in a 
range of the general indoor climate setting. Graham (1988) demonstrated that 
men and women respond differently in many physiological parameters when 
exercising or resting in either a cold room or cold water, which frequently could 
not be explained solely by sex-specific morphological differences. A review 
of chamber experiments and field studies to identify the factors influencing 
individual differences on thermal comfort by Wang et al. (2018) revealed that 
women are more critical about indoor thermal settings and more sensitive to 
deviations of thermal environment than men, but a consistent conclusion on sex 
differences in thermal comfort could not be drawn. Moreover, it has not been 
addressed whether men and women differ in the shivering onset after a gradually 
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cold exposure using the Blanketrol® III, a common method for studying BAT 
activation. To test this, we exposed healthy volunteers to cold progressively and 
determined the experimental temperature (TE) at which the volunteers started 
to shiver. This study demonstrates sex differences in the physiological responses 
to a gradual cold exposure.
Methods
Participants
We recruited 43 participants (20 men and 23 women) who met the 
inclusion criteria: age 16–35 years; being physically healthy; Caucasian 
ethnicity; body mass index (BMI) 18.5–29.9 kg/m2 for participants aged more 
than 20 years old, or BMI standard deviation score (BMI-SDS) between −2 and 
+2 for participants aged 16–19 years old. The following exclusion criteria were 
used: diabetes mellitus, thyroid disorders, substance use disorders, pregnancy, 
breastfeeding, and using β-adrenergic blocking medication. Participants were 
requested to eat, drink, and sleep as their usual routines, and requested not to 
smoke, eat, or drink any caffeinated or alcohol beverage within one hour before 
an appointment.
Since female sex hormones fluctuate during the reproductive cycle and 
could potentially influence the thermal balance (Charkoudian and Stachenfeld, 
2014), female participants were included as follows. When a female participant 
was using contraceptive pills, she could only participate on a day she was 
taking a hormone-containing pill. When the female participant was not using 
contraceptive pills, she could not participate in the early follicular phase of her 
menstrual cycle, i.e. her menstruation period. In addition, we asked the female 
participants about their menstrual history to identify the phase of reproductive 
cycle at the day of experiment.
The experiment was performed after the participants had signed the 
written informed consent. The study was conducted according to the principles of 
the Declaration of Helsinki (version 19 October 2013). The procedures had been 
approved by the IRB of Erasmus MC, University Medical Center Rotterdam, the 
Netherlands.
Study design
To limit the influence of the environmental temperature on thermal 
perception (Makinen et al., 2004), the experiment was performed during the 
summer (July–September 2017). Daily mean temperatures of Rotterdam, the 
city where the experiment was performed, were obtained from the Royal Dutch 
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Meteorological Institute (KNMI) via a publicly accessible database (KNMI, 
2017). For further analysis, the outside temperature for each individual was 
calculated from three-day daily-mean-temperatures (2 days before and the day 
of the experiment).
The experiment was performed in the same laboratory with a standard 
heating, ventilation and air-conditioning system at a spot without direct air 
flow. The overall experimental design is illustrated in Fig. 1. Room temperature 
was recorded to verify the thermal condition. After arriving at the laboratory, 
participants acclimatized to the thermal setting of the room for at least 30 min. 
During the acclimatization period, participants changed their clothing to shorts 
and a T-shirt, filled in a questionnaire (Fig. 2A), rated their thermal perception, 
and were measured for anthropometric characteristics.
Fig. 1  Overall experimental procedure
The primary outcome is to identify a shivering TE: the experimental temperature at which 
shivering started.
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To assess the thermal perception, we used the visual analogue scales 
(VAS; Fig. 2B) for thermal sensation (VASsensation) and thermal comfort (VAScomfort), 
adapted from Zhang and Zhao (2008). VASsensation is reported on ASHRAE 7-point 
scales: hot (+3), warm (+2), slightly warm (+1), neutral (0), slightly cool (−1), 
cool (−2), and cold (−3). VAScomfort includes 6-point scales: very comfortable (+3), 
comfortable (+2), just comfortable (+1), just uncomfortable (−1), uncomfortable 
(−2), and very uncomfortable (−3). Of note, the VAScomfort score does not contain 
‘neutral’, to make a clear determination to either the ‘comfortable’ or ‘uncomfort-
able’ category.
We followed the American College of Sports Medicine (ACSM)’s Guidelines 
For Exercise Testing and Prescription (ACSM, 2013) for anthropometric 
measurement. In brief, body mass was measured with a 0.5-kg based scale, and 
body height was measured with a 0.5-cm based stadiometer. Waist circumference 
was measured at the height of the iliac crest, and hip circumference was 
measured at the maximal circumference of buttocks with the subject standing 
upright. BSA was calculated by the formula (Reading and Freeman, 2005):
BSA = 1/6·(W·H)0.5.
In this formula, BSA is in m2, W is weight in kg, and H is height in m. 
Skinfold thickness was measured in mm at three sites, depending on the sex of 
the participant (Nieman, 2011). For men, skinfolds were measured at the chest 
(diagonal fold, halfway between the anterior axillary line and the nipple), the 
abdomen (vertical fold, 2 cm to the right side of the umbilicus), and the thigh 
(vertical fold, on the anterior midline, halfway between the proximal border of 
the patella and the inguinal crest). For women, skinfolds were measured at the 
triceps (vertical fold, halfway between the acromion and olecranon processes, 
with the arm held freely to the side of the body), the suprailiac site (diagonal 
fold, at the anterior axillary line immediately superior to the iliac crest), and the 
abdomen (as described above). Body density (BD) and body fat percentage (%BF) 
were calculated by the following formulas (ACSM, 2013).
BDmen = 1.10938 − 0.0008267·(sum of skinfolds) + 0.0000016·(sum of 
skinfolds)2 − 0.0002574·age
BDwomen = 1.089733 − 0.0009245·(sum of skinfolds) + 0.0000025·(sum of 
skinfolds)2 − 0.0000979·age
%BF = (457/BD) − 414.2
For the mentioned formulas, sum of skinfolds is in mm, and age is in years.
After the acclimatization period, two surface electromyography (EMG) 
electrodes (Nutrode Mini-P10MO, O&R Medical) for monitoring the electrical 
activity of the rectus femoris muscle were placed at anterior mid-thigh with an 
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inter-electrode center-to-center distance of 4 cm. The rectus femoris muscle was 
chosen for monitoring since it is one of the muscle groups recruited at onset 
of the shivering (Blondin et al., 2011; Tikuisis et al., 1991) and the movement 
artefact of the leg is easily detected by an investigator. The other electrode was 
placed on an ankle as a ground. EMG signals were transmitted using the Bio 
Amp Cable (model MLA2540, ADInstruments) to the PowerLab 26T (model 
ML856, ADInstruments). The signals were monitored on LabChart software 
(version 7, ADInstruments) with a sampling rate of 1,000 Hz, band-pass 
filters of 10 Hz and 500 Hz, a notch filter of 50 Hz, and an amplification range 
between ±1 mV to ±5 mV depending on the resting activity of each individual 
[modified from Blondin et al. (2011)]. Next, three Thermochron iButton® digital 
thermometers (model DS1921H, Maxim Integrated) were applied at the 
supraclavicular area, the midsternal area, and the dorsum of the hand with 
medical adhesive tapes (Micropore, 3M) for continuous measuring of skin 
temperature (Tsk) with a one-minute interval. Then, the cooling protocol started.
Cooling protocol
The Blanketrol® III Hyper-Hypothermia System (model 233, Cincinnati 
Sub-Zero), the Maxi-Therm® Lite Patient Vest (model 800, Cincinnati Sub-Zero), 
and the Maxi-Therm® Lite Blanket (model 876, Cincinnati Sub-Zero) were used 
as a temperature management system. The Blanketrol regulates the temperature 
of the water that circulates through the Vest and the Blanket. The Vest covered 
shoulders, chest, abdomen, and back of the participant who was lying supine 
on a bed. The Blanket covered hip, groin, buttock, and anterior and posterior of 
thighs. Calculated with the Lund and Browder chart that is normally used to 
estimate the burn areas in patients (Hettiaratchy and Papini, 2004), the Vest 
and Blanket covered more than 50% of total BSA.
The cooling protocol started with the Blanketrol set at 24 °C after 
which the TE was reduced by 1–2 °C every 5 min (a detailed setting is shown 
in Fig. 2C). During the cooling protocol, a participant was requested to lie still 
without any leg movement. When the EMG detected an onset of shivering burst 
(EMG amplitudes exceeded the resting values with a duration of > 0.2 s and an 
interburst interval of > 0.75 s; without any active movement of the leg observed 
by an investigator), the cooling protocol was terminated and the temperature 
of the Blanketrol was recorded as the shivering TE. However, if the participant 
did not shiver after 50 min of the cooling protocol (at 9 °C), the experiment was 
also stopped and the shivering TE of that participant was assumed to be 8 °C. 
Subsequently, the Blanketrol was set at 30 °C to warm up a participant for at 
least 10 min or until the participant was satisfied with the thermal comfort.
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During the cooling protocol, a participant rated the VASsensation score every 
5 min before the next-step TE setting and rated the VAScomfort score every 15 min 
at the 5th, 20th, 35th, and 50th minutes. At the end of the cooling protocol, we 
asked a participant to rate his or her shivering intensity as either no shivering, 
minimal shivering, moderate shivering, or profound shivering. 
Data analysis & Statistics
The statistical tests were performed using IBM SPSS Statistics for 
Windows (version 24, IBM Corp.) and GraphPad Prism for Windows (version 
6, GraphPad Software Inc.). A difference between groups was analyzed by an 
unpaired t test or a Mann–Whitney U test when the data were not normally 
distributed. For categorical data, a difference between groups was analyzed 
with a Fisher's exact test. The effects of sex and TE on VASsensation score, VAScomfort 
score, and Tsk were analyzed using 2-way repeated measures analysis of variance 
(RM-ANOVA) with a Bonferroni’s multiple comparisons test when appropriate. 
Stepwise linear regression was used to identify factors influencing the shivering 
TE. Statistical significance is considered when P < 0.05. Unless otherwise 
indicated, data are presented as mean ± SD.
Results
The characteristics and the anthropometric data of the recruited 
participants are shown in Table 1. The age was not different between the sexes 
(P = 0.67). Men were taller and heavier than women (P < 0.001 for both height 
and weight). When calculating BMI and categorizing to normal or overweight 
subgroups, there was no difference between the sexes (P = 0.90 for BMI and 
P = 1.00 for BMI category). Men had a larger BSA than women (P < 0.001) 
while women had a higher BSA-to-mass ratio than men (P < 0.001). Men had 
a larger waist circumference than women (P < 0.001) but they had equal hip 
circumferences (P = 0.96); hence, waist-to-hip ratio is higher for men than for 
women (P < 0.001). Women tended to have a greater sum of skinfold thickness (P 
= 0.08) and had a significantly higher body fat percentage than men (P < 0.001). 
Concerning the five behavioral data collected from the questionnaire (Fig. 2A), 
four of them revealed no significant difference between men and women, except 
that women reported more discomforts than men at their home or workplace 
thermal condition (P = 0.01). The outside temperature when the experiment 
was performed was slightly higher for women than for men (P = 0.04; Table 1). 
However, the room temperature at which all participants acclimatized before 
the cooling protocol was not different between men and women (P = 0.09).
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Table 1  Characteristics of participants and ambient temperatures
Parameters Men (n = 20) Women (n = 23)
Age (year) 23.5 (8.8) 22.0 (9.0)
Height (cm) * 184.4 (6.9) 170.9 (4.8)
Weight (kg) * 76.0 (9.8) 64.8 (9.0)
BMI (kg/m2) 22.4 (2.7) 22.2 (3.4)
Normal 
Overweight
16 (80%) 
4 (20%)
19 (83%) 
4 (17%)
BSA (m2) * 1.97 (0.14) 1.75 (0.12)
BSA-to-mass ratio (×10−2 m2/kg) * 2.61 (0.15) 2.72 (0.18)
Waist circumference (cm) * 83.7 (7.7) 74.7 (6.3)
Hip circumference (cm) 100.9 (4.5) 100.8 (7.0)
Waist-to-hip ratio * 0.83 (0.06) 0.74 (0.04)
Sum of skinfolds (cm) 46.0 (20.3) 56.9 (18.9)
Body fat percentage (%) * 13.1 (5.6) 23.6 (4.8)
Smoking history
Never 
Rarely/sometimes 
1–10 cigarettes per day 
> 10 cigarettes per day
16 (80%) 
3 (15%) 
– 
1 (5%)
22 (96%) 
– 
1 (4%) 
–
Alcohol consumption
Never 
Rarely/sometimes 
One drink per day
4 (20%) 
13 (65%) 
3 (15%)
4 (17%) 
16 (70%) 
3 (13%)
Caffeine consumption
Never 
Rarely/sometimes 
One cup per day 
2–3 cups per day 
≥ 4 cups per day
2 (10%) 
6 (30%) 
3 (15%) 
5 (25%) 
4 (20%)
– 
10 (43%) 
7 (30%) 
6 (26%) 
–
Exercise/sports frequency
Never 
Rarely/sometimes 
once per week 
2–3 days per week
2 (10%) 
6 (30%) 
8 (40%) 
4 (20%)
– 
8 (35%) 
11 (48%) 
4 (17%)
Thermal complaint/discomfort *
No 
Sometimes 
Often
20 (100%) 
– 
–
16 (70%) 
5 (22%) 
2 (9%)
Outside temperature (°C) * 16.3 (4.7) 18.0 (1.8)
Room temperature (°C) 23.7 (0.7) 24.0 (0.7) 
For BMI category, normal indicates BMI 18.5–24.9 kg/m2 for adult (≥ 20 years) and BMI-SDS 
from −2 to 1 for adolescent (16–19 years); overweight indicates BMI 25.0–29.9 kg/m2 for adult 
and BMI-SDS 1–2 for adolescent.
Data are shown as mean (SD), except age and outside temperature are shown as median 
(IQR), and BMI category and behavioral data are shown as n (%).
* indicates a statistically significant difference between male and female participants.
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Experiencing the identical cooling protocol, women started shivering at 
a higher TE than men (shivering TE: 11.3 ± 1.8 °C for women vs 9.6 ± 1.8 °C for 
men, P = 0.003; Fig. 3A). At the average shivering TE for women, 65% (15/23) 
of women shivered while only 25% (5/20) of men started shivering (P = 0.014). 
Throughout the cooling protocol, all participants felt colder when the TE declined 
with women perceiving the TE colder (lower VASsensation score) than men (PSex×Temp 
< 0.001, PSex = 0.004, PTemp < 0.001; Fig. 3B). Remarkably, the difference in 
VASsensation score between men and women was statistically significant when the 
TE was between 14 °C and 20 °C. Furthermore, women felt more uncomfortable 
(lower VAScomfort score) than men during the experiment, and both groups felt 
more uncomfortable when the TE declined (PSex×Temp = 0.006, PSex = 0.01, PTemp < 
0.001; Fig. 3C).
Concerning thermal sensation and thermal comfort at room temperature 
before the cooling protocol started, female and male participants did not differ 
in both VASsensation score (P = 0.98) and VAScomfort score (P = 0.61). Interestingly, 
women started to feel ‘colder than neutral’ (VASsensation score < 0) at a higher TE 
than men (22.1 ± 1.9 °C for women vs 20.3 ± 3.5 °C for men, P = 0.04; Fig. 3D). 
Women also started to feel ‘cool’ (VASsensation score ≤ −2) at a higher TE than men 
(18.3 ± 3.0 °C for women vs 14.6 ± 2.6 °C for men, P < 0.001; Fig. 3E). At the 
average ‘cool’ TE for women, 65% (15/23) of women felt cool whereas only 20% 
(4/20) of men did (P = 0.005). At the end of the cooling protocol, when shivering 
was detected or TE reached 9 °C, women felt colder than men (VASsensation score 
−3 ± 0 for women vs −3 ± 1 for men [median ± IQR], P = 0.03), but both sexes 
perceived the thermal discomfort equally (VAScomfort score −2 ± 1 for women vs 
−2 ± 1.25 for men [median ± IQR], P = 0.29). Women, moreover, perceived the 
shivering more intense than men at the end of cooling protocol (P = 0.009; Fig. 
3F).
Factors that could possibly influence the shivering TE are listed in 
Table 2. Only sex of the participants, VAScomfort score at room temperature, and 
VASsensation score at room temperature were statistically significant predictors 
of the shivering TE (stepwise linear regression: F(3,39) = 9.352, P < 0.001, R2 
= 0.418). Interestingly, when sex of the participants was removed from the 
analysis, the statistically significant predictors of the shivering TE consisted 
of BSA-to-mass ratio, VAScomfort score at room temperature, and an amount of 
caffeine consumption (stepwise linear regression: F(3,39) = 7.026, P = 0.001, R2 
= 0.351).
Since body composition was different between men and women, we 
performed a subgroup analysis of 19 men and 16 women by using the lowest 
BSA-to-mass ratio of the female participants as a minimal cut-off value and the 
highest BSA-to-mass ratio of the male participants as a maximal cut-off value 
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(BSA-to-mass ratio 0.0263 ± 0.0014 m2/kg for men vs 0.0264 ± 0.0016 m2/kg for 
women, P = 0.70). The results showed the same pattern that women started 
shivering at a higher TE than men (11.1 ± 1.9 °C for women vs 9.6 ± 1.8 °C for 
men, P = 0.03). Women also started to feel ‘cool’ (VASsensation score ≤ −2) at a higher 
TE than men (17.6 ± 2.7 °C for women vs 14.6 ± 2.7 °C for men, P = 0.002) whereas 
the TE at which a participant started to feel ‘colder than neutral’ (VASsensation score 
< 0) was not statistically significant (21.8 ± 1.9 °C for women vs 20.4 ± 3.5 °C for 
men, P = 0.18).
Table 2  Factors that could influence the shivering TE
Factors
All factors Excluding Sex
Beta Sig. Beta Sig.
Sex 0.444 0.001 ** –
Age (year) 0.049 0.71 ns 0.154 0.44 ns
BSA-to-mass ratio (m2/kg) 0.148 0.31 ns 0.480 0.002 **
Body fat percentage (%) −0.325 0.08 ns 0.231 0.08 ns
Sum of skinfolds (cm) −0.239 0.07 ns 0.101 0.52 ns
Abdominal skinfold (cm) −0.230 0.08 ns −0.100 0.55 ns
Smoking −0.072 0.57 ns −0.212 0.15 ns
Alcohol consumption 0.156 0.21 ns 0.189 0.17 ns
Caffeine consumption 0.238 0.06 ns 0.299 0.04 *
Exercise frequency 0.056 0.66 ns 0.011 0.93 ns
Thermal complaint 0.240 0.07 ns 0.253 0.08 ns
VASsensation score at room 
temperature
−0.282 0.03 * −0.171 0.23 ns
VAScomfort score at room 
temperature
−0.339 0.009 ** −0.284 0.04 *
Baseline 3-site average Tsk 0.092 0.49 ns −0.177 0.19 ns
Outside temperature (°C) −0.087 0.53 ns 0.120 0.42 ns
Room temperature (°C) −0.161 0.21 ns −0.086 0.52 ns
Time of experiment 0.206 0.10 ns 0.239 0.08 ns
Stepwise linear regression was analyzed to predict the shivering TE from indicated factors. 
Time of experiment indicates the period of the day when the experiment was performed, 
dividing into 3 periods: 09:00–11:59, 12:00–14:59, and 15:00–17:59. Sig. (statistical signifi-
cance) indicates by P values: P > 0.05 (ns), P < 0.05 (*), and P < 0.01 (**).
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Throughout the cooling experiment, Tsk was monitored at 3 areas of 
the body. The Tsk at the supraclavicular area decreased with the declining TE 
without a statistically significant difference between men and women (PSex×Temp 
= 1.00, PSex = 0.14, PTemp < 0.001; Fig. 4A). The Tsk at the midsternal area was 
not different between men and women; however, it was statistically significantly 
increased during the first few minutes of the cooling protocol, and remained 
stable until the end of the protocol (PSex×Temp = 0.64, PSex = 0.65, PTemp < 0.001; 
Fig. 4B). The Tsk at the dorsum of the hand decreased with the declining TE 
and, interestingly, male participants had higher hand temperatures than female 
participants during the cooling protocol (PSex×Temp < 0.001, PSex = 0.02, PTemp < 
0.001; Fig. 4C).
Concerning the 5-min average Tsk at each stage of the cooling protocol, 
women tended to have a lower baseline Tsk at the dorsum of the hand and 
supraclavicular area than men while the Tsk at the midsternal area was similar 
in both sexes (Table 3 and Fig. 4). The average Tsk from the 3 sites at baseline 
was significantly lower in women than in men. However, when the baseline 3-site 
average Tsk was added into the stepwise linear regression analysis, it was not a 
significant predictor for the shivering TE (Table 2). When participants started 
to feel ‘colder than neutral’ (VASsensation score < 0) or ‘cool’ (VASsensation score ≤ −2), 
all of the measured Tsk’s and the declines of Tsk’s from the baseline values (∆Tsk) 
were not different between the sexes (Table 3). At the end of the cooling protocol 
(shivering started or TE reached 9 °C), women had a significantly lower hand 
Tsk than men while the supraclavicular and midsternal Tsk’s were not different 
between the sexes. The 3-site average Tsk at the end of cooling protocol was also 
significantly lower in women than in men; however, the decline in average Tsk 
(∆Tsk) at the end of the cooling protocol was similar in both sexes. Interestingly, 
the midsternal Tsk did not differ between the sexes and remained unchanged 
during the cooling stages. As a result, the difference between the midsternal 
Tsk and the hand Tsk was greater after cold exposure and tended to be higher 
in women than in men (midsternal Tsk − hand Tsk: 4.5 ± 2.0 °C for women at 
baseline, 3.4 ± 2.6 °C for men at baseline, 6.0 ± 1.4 °C for women at shivering, 
and 4.6 ± 2.1 °C for men at shivering; PCold×Sex = 0.42, PCold < 0.001, PSex = 0.07).
Discussion
This study revealed that women and men respond differently when 
experiencing cold. Female participants felt cold at a higher TE and started 
shivering at a higher TE than male participants upon the gradually cold exposure 
using the water-filled cooling blanket, a commonly used device to study the BAT 
activity in humans.
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Fig. 4  Skin temperatures during the cooling protocol
Skin temperatures (Tsk) measured by the iButton digital thermometers at (A) the supraclavic-
ular area, (B) the midsternal area, and (C) the dorsum of the hand. Statistical significance 
indicates by P values: P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***). Thin lines show the data 
of individual participants, and thick lines indicate the mean. The deviation in mean Tsk between 
men and women at TE lower than 14 °C is mainly driven by the decreasing number of female 
participants that started shivering beyond this TE.
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Shivering can be considered an indicator of cold stress since it is activated 
only if energy-inexpensive mechanisms are not sufficient to maintain a constant 
Tc (Daanen and Van Marken Lichtenbelt, 2016). The stimulus for shivering 
is not only a drop in Tc, but also a cold stimulus that contacts the skin. The 
decrease in Tsk is transmitted as a cold signal by TRPM8, a temperature-sensitive 
receptor that can be activated when an ambient temperature is lower than 
25 °C (Patapoutian et al., 2003). In mice, Caudle et al. (2017) found that TRPM8 
receptors in females had a higher sensitivity to low temperatures than receptors 
in males. Our finding that women perceived the same cooling protocol colder 
than men might therefore partly be explained by a different sensitivity of the 
TRPM8 receptors.
Anderson et al. (1995) demonstrated that there was not a significant 
difference between men and women in the shivering threshold, which was defined 
by the deviation of the esophageal Tc from an individual baseline value when 
resting after exercise in 28 °C water. We could not address the shivering threshold 
in terms of the change of Tc because a lack of Tc monitoring is a limitation of our 
study. A study by Boon et al. (2014), which used the same cooling method as in 
this study to study the BAT activation, showed that Tc was unchanged after the 
2-hour cooling protocol. Moreover, Xu et al. (2013) showed that the Tsk measured 
from the sternum are best correlated with the Tc. Thus, it is likely that the Tc of 
the participants in this study was not remarkably affected since the midsternal 
Tsk remained unchanged during the cooling protocol. Interestingly, Boon et al. 
(2014) also found that the gradient between the proximal and the distal Tsk was 
greater after cold exposure, which was confirmed in our study. A decline in distal 
Tsk together with a greater gradient between the proximal and the distal Tsk 
reflects the vasoconstriction capacity of the peripheral tissues to conserve heat 
during an exposure to cold. Overall, our results suggest that women approach 
the maximal capacity of vasoconstriction earlier, and thus need shivering as a 
source of heat production sooner than men.
The BSA-to-mass ratio is an important factor explaining differences in 
the net heat transfer in cold conditions (Castellani and Young, 2016; Parsons, 
2014). An increase in BSA results in a higher heat loss from the body to the 
environment. On the other hand, an increase in total body mass contributes to 
a higher heat production capacity (Arciero et al., 1993). A combination of high 
BSA and low body mass causes a low capability to maintain a proper thermal 
balance for a constant Tc during cold stress. In general, the body composition 
of adult men and women shows a sexually dimorphic pattern (Kuk et al., 2005; 
Wells, 2007), which is the same pattern observed in this study cohort. Female 
participants in our study cohort had a slightly higher BSA-to-mass ratio than 
male participants and the BSA-to-mass ratio was a statistically significant 
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determinant for the shivering TE. Hence, the BSA-to-mass ratio is likely a 
principal factor determining this sex difference (Castellani and Young, 2016; 
Tikuisis et al., 2000). However, this anthropometric characteristic is not the only 
factor underlying the sex difference in our cohort since the subgroup analysis 
of an equivalent BSA-to-mass ratio between the sexes still showed the sex- 
dependent pattern. Further research is needed to identify why women need 
shivering as a source of heat production earlier than men to maintain their 
thermal balance when experiencing the same cold stress.
Concerning the thermal sensation and thermal comfort over the whole 
cooling period as a subjective method to evaluate cold perception, we found that 
women did feel colder and less comfortable than men. Intriguingly, the TE’s at 
which the participants started to feel ‘colder than neutral’ (VASsensation score < 
0) and ‘cool’ (VASsensation score ≤ −2) were both higher for women than for men. 
Karjalainen (2012) and Wang et al. (2018) illustrated that women feel colder 
and are less comfortable than men in a standard indoor climate setting. Our 
results, however, did not find a difference in thermal sensation or thermal 
comfort between men and women at the acclimatization period before the cooling 
protocol started. We previously performed a behavioral mouse study to identify 
sex differences in thermal preference of adult mice (Kaikaew et al., 2017) and 
found that female mice preferred to reside at a higher ambient temperature than 
male mice. Overall, our data of both the previous mouse study and this current 
human study confirmed the sex difference in thermal perception.
Since our institutionally approved cooling protocol allowed us to study 
the effect of cold exposure in a healthy individual up to a minimum TE of 9 °C 
only, we assumed a shivering TE of 8 °C in those participants that failed to shiver 
at this minimum TE. Using this assumption, we found that male participants 
started shivering at a statistically lower TE than female participants. It is very 
unlikely that this assumption led to a false conclusion since 89% (8 out of 9) of 
the participants with undetectable shivering at 9 °C were male participants. 
Thus, this assumption may even underestimate the effect size in the difference 
in shivering TE between the sexes. Although this conclusion is based on a rather 
small cohort (20 men and 23 women), our power analysis to determine a potential 
sex difference in shivering TE indicated that this sample size is sufficient as a 
minimum of 16 participants per sex was needed.
Cold-induced activation of BAT, the thermogenic organ that utilizes 
energy to generate heat, can be detected in many regions of the body, including 
the supraclavicular area (van der Lans et al., 2014). The current ‘gold standard’ 
method to study the activity of human BAT is the 18F-fluorodeoxyglucose 
(18F-FDG) positron emission tomography integrated with computed tomography 
(PET/CT) imaging (Blondin and Carpentier, 2016). 18F-FDG uptake in BAT was 
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detected in only ∼6% of individuals when the PET/CT scan was performed in 
unstimulated conditions, with a significantly higher prevalence in women than 
in men (Cypess et al., 2009; Ouellet et al., 2011). Nevertheless, when participants 
were exposed to 19 °C for 2 hours before the scan, 18F-FDG uptake in BAT was 
observed in 52% of young participants (aged 23–35 years), without an apparent 
sex difference (Saito et al., 2009). Thus, an individualized cooling protocol could 
be beneficial for studying BAT activity.
18F-FDG-PET/CT imaging has limitations such as underestimating a 
weakly activated BAT in normal physiological conditions, requiring expensive 
equipment, and exposing a subject to ionizing radiation (Cypess et al., 2014). A 
proposed non-invasive method to determine the activity of BAT is measurement 
of the Tsk at the supraclavicular area. Unlike previous reports that cold exposure 
enhanced the supraclavicular Tsk suggesting activation of BAT (Boon et al., 
2014; van der Lans et al., 2016), our cooling protocol did not increase the supra- 
clavicular Tsk. This conflicting result is likely explained by the shorter duration 
of cold exposure in our protocol compared to those published previously, which is 
possibly not potent enough to stimulate BAT to a detectable level.
Conclusions
This study demonstrates that women and men respond differently to 
low temperatures. Women not only started shivering at a higher TE than men, 
they also felt colder and less comfortable than men throughout the same cooling 
protocol using the Blanketrol® III. These sex differences could be important for 
studying the physiological responses at temperatures lower than the thermo- 
neutral zone, such as those using cooling protocols for radiologic diagnostic 
imaging in patients or those studying BAT activity in the general population.
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Overview
Adipose tissue is a multifunctional organ essential for maintaining 
whole-body energy homeostasis. The first known function of adipose tissue is 
an energy reservoir for the body by storing excess energy as triglycerides in 
intracellular lipid droplets which can be supplied in energy-deprived conditions. 
Second, adipose tissue acts as an endocrine organ since it secretes a variety 
of adipokines that systematically reflect the metabolic status. Apart from the 
classical type of adipose tissue [white adipose tissue (WAT)] which serves the 
above-mentioned functions, brown adipose tissue (BAT) is another specialized 
adipose tissue that can utilize energy substrates for non-shivering thermo- 
genesis. In this latter process, the uncoupling protein 1 (UCP1) plays a crucial 
role (1). Currently, increasing energy expenditure by BAT activation or by 
“browning” of WAT is considered a promising tool for the treatment of obesity 
and metabolic diseases (2).
Despite being relatively overlooked, studies in rodents and humans 
have shown that males and females display many sex-dependent characteristics 
in WAT and BAT (3). Although the precise mechanisms underlying these sex 
differences are still not completely understood, studies have revealed crucial 
roles for sex hormones, particularly estrogens and androgens herein. This thesis 
broadens the understanding of sex differences in adipose tissue function upon 
modulation by corticosterone [an endogenous rodent glucocorticoid (GC)] or 
progesterone [a circulating female sex steroid that has been limitedly investi-
gated]. Furthermore, this thesis also demonstrates sex differences in thermal 
perception, the sensory signal for whole-body thermoregulatory system, in which 
activation of BAT thermogenesis is its major autonomic response.
Factors affecting sex differences in WAT
The most prominent characteristic of sex differences in WAT is sexual 
dimorphism in fat distribution. Men and male rodents are prone to accumulate 
fat in visceral depots, known as the apple-shaped or android fat distribution 
which correlates to worsened metabolic health, whereas women and female 
rodents store fat in subcutaneous depots, known as the pear-shaped or gynoid 
fat distribution which is relatively protective against metabolic diseases (4). The 
sex-differential fat distribution is principally driven by sex steroids because it 
becomes apparent during puberty and reverses at menopause when women gain 
more visceral fat (4-6).
WAT expansion is a coordinated response by multiple cells in the adipose 
tissue, namely adipocytes, endothelial cells, fibroblasts, and immune cells (7). 
A healthy adipose tissue expansion is accomplished by four reciprocal steps: 
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1) transient hypoxic stress caused by a limitation in oxygen diffusion of enlarged 
adipocytes, 2) sufficient angiogenesis induced by local hypoxia and upregulations 
of angiogenic factors, such as vascular endothelial growth factors, 3) formation 
of new adipocytes through recruitment and differentiation of the perivascular 
adipose progenitors, and 4) remodeling of the extracellular matrix to promote 
further expansion (7,8). Studies in rodents have shown that female WAT depots 
exhibit a higher angiogenic induction, a greater differentiation capacity of 
adipose progenitor cells, and more optimal remodeling in extracellular matrix 
proteins than male WAT depots (9,10).
Endogenous GCs are adrenal hormones crucial for diverse physiological 
processes, including regulation of glucose homeostasis. Exogenous GCs are widely 
used due to their anti-inflammatory properties. Elevated endogenous or chronic 
exposure to exogenous GCs can cause many adverse effects in a variety of organ 
systems leading to Cushing syndrome that includes weight gain, fat redistri-
bution towards truncal obesity (Cushingoid appearance), increased insulin 
resistance, and worsening of glycemic control or new-onset diabetes mellitus 
(11,12). GC-induced diabetes or insulin resistance predominantly presents with 
postprandial hyperglycemia through increased hepatic gluconeogenesis and 
reduced glucose uptake in skeletal muscle and adipose tissue (13). Although 
male sex has been suggested to be a risk factor to develop GC-induced diabetes 
(14), other studies have reported that the GC-induced insulin resistance was not 
sexually dimorphic (12,15,16). The study in Chapter 2, therefore, investigated 
the glucometabolic effects of a high dose of corticosterone in male and female mice. 
The results of this study demonstrate that corticosterone induces nonfasting 
hyperglycemia only in male mice but the compensatory hyperinsulinemia is 
profound in both sexes. Upon corticosterone treatment, serum total adiponectin 
and high-molecular-weight adiponectin levels, which are tightly correlated with 
improved insulin sensitivity (17), were higher in female mice than in male mice. 
In addition, the hyperplastic expansion of adipose tissue, which is associated 
with better insulin sensitivity compared with the hypertrophic expansion (8), 
was more evident in female adipocytes than in male adipocytes. Altogether, 
Chapter 2 suggests a more beneficial adaptation in WAT depots of female mice 
upon GC administration than that of male mice.
Factors affecting sex differences in BAT and browning of WAT
GCs are known to suppress BAT thermogenesis, likely through the 
glucocorticoid receptor (GR) (18,19), but interestingly most studies have only 
been performed in males. Whether GCs affect BAT in a sex-dependent manner 
has not been extensively studied. The study in Chapter 2 also demonstrates 
that treatment with a supraphysiological dose of corticosterone reduced Ucp1 
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mRNA expression and induced lipid accumulation in BAT in a sex-independent 
manner. In contrast, Gasparini et al. (20) found that corticosterone treatment 
induced lipid accumulation (whitening) in BAT only in male mice, not in female 
mice, but corticosterone treatment marginally reduced the amount of UCP1 in 
BAT. The discrepancy between findings in this thesis and the study of Gasparini 
et al. (20) is likely due to a higher dose of administered corticosterone and 
higher circulating corticosterone levels after treatment in our study, suggesting 
a sex difference in dose-sensitivity. Nevertheless, a recent study in mice with 
BAT-specific GR knockdown presented contradictory findings, i.e., GR signaling 
for BAT thermogenesis and metabolic activity was negligible upon cold exposure 
or high-fat diet–induced obesity (21). This observation could suggest that the 
deleterious effect of systemic GC administration on BAT in vivo is an indirect 
consequence of systemic metabolic disturbances via modulation of efferent signals 
from the central nervous system to BAT, or that the direct effect of GCs on BAT 
is signaled through other receptors or modulated by the interaction of GR and 
those receptors. Hence, the GC-GR-BAT axis still requires further validation.
A major plausible explanation for sexual dimorphism in BAT activity is 
likely a difference in circulating sex hormones. Detection of active BAT in adults 
by the positron emission tomography/computed tomography (PET/CT) imaging 
suggests that BAT is more prevalent in women than in men and that its presence 
is inversely correlated with outdoor temperatures, underscoring its thermogenic 
function (22). Another PET/CT study under thermoneutral conditions confirmed 
that women have higher BAT activity and BAT mass than men (23). This study 
also reported that BAT activity declines with age, which might be due to a decline 
in sex hormones (23). A similar sex difference is found in rodents: female rats have 
a larger BAT depot, a higher Ucp1 mRNA expression in BAT, as well as greater 
lipolytic and thermogenic activation by β3-adrenergic receptor (β3-ADR) agonists 
than male rats (24). An in vitro study in primary brown adipocytes isolated from 
adult mice also supported direct effects of sex steroids on brown adipocytes. 
Testosterone dose-dependently inhibited norepinephrine-induced Ucp1 mRNA 
expression, while 17β-estradiol (E2) and progesterone had no significant effects 
or slightly upregulated Ucp1 mRNA expression (25). Moreover, E2 and proges-
terone were shown to reduce the α2A/β3-ADR protein ratio in primary brown 
adipocytes, reflecting a greater thermogenic and lipolytic capacity, whereas 
testosterone did not alter the α2A/β3-ADR ratio (26). Concerning the browning 
of WAT to reach a maximal thermogenic capacity, female sex hormones are 
important factors to induce WAT browning since CL316,243 (a β3-ADR agonist) 
stimulation was able to induce browning of gonadal WAT only in female but not 
male C57BL/6J mice (27). This is remarkable since this depot is considered the 
most refractory WAT depot for browning in this mouse strain (28,29). Moreover, 
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the CL316,243-induced gonadal WAT browning was abolished when female 
mice had chemically induced ovarian failure (27), suggesting an interaction with 
female gonadal factors.
To uncover more sex-specific features in BAT, gene expression profiling 
was performed on BAT of male and female mice of which the data are described 
in Chapter 3. This study reveals that BAT gene expression profiles of male 
and female mice were indeed different, especially for genes encoding proteins 
involved in cellular structure, cell-cell contact, and cell adhesion. As expected, 
E2, progesterone, and dihydrotestosterone (DHT; a potent and active form 
of testosterone) were identified as possible upstream regulators for the sex- 
differential expression profile. Although expression of thermogenic markers 
Ucp1 and Ppargc1a (the transcription factor of Ucp1) in BAT and primary brown 
adipocytes were not significantly sex-dependent, they show a tendency to be 
higher in female brown adipocytes.
In literature, the effects of progesterone on BAT activities are conflicting. 
Some studies have shown a stimulatory effect of progesterone on brown 
adipocytes (25,26), whereas in vivo observations show that BAT becomes inactive 
and atrophied during pregnancy (when progesterone concentrations are high), 
likely to conserve maternal energy for fetal growth (1). BAT of pregnant mice 
showed whitening morphological changes (enlarging intracellular lipid droplets) 
with decreased expression of thermogenic genes and increased expression of 
WAT markers (30). In Chapter 3, high concentrations of progesterone inhibited 
basal and norepinephrine-stimulated Ucp1 and Ppargc1a mRNA expression in 
T37i cells, a female brown adipocyte cell line, in accordance with the findings of 
McIlvride et al. (30). The studies described in Chapter 3 also test the effects of 
progesterone on primary brown adipocytes differentiated from stromal vascular 
fraction cells in BAT of male and female mice. In contrast to data in T37i cells, 
progesterone stimulation did not significantly affect Ucp1 and Ppargc1a mRNA 
expression in primary brown adipocytes, but it dose-dependently reduced mRNA 
expression of Adipoq, the gene encoding the metabolically favorable adipokine 
adiponectin. Interestingly, the inhibitory effect of progesterone was likely due to 
the enhanced GR signaling. This suggests an interesting interaction between sex 
steroid and glucocorticoid signaling that requires further research to unravel the 
full physiological consequences. In addition, female primary brown adipocytes 
tended to express thermogenic genes and some cell-cell contact or structural 
genes at higher levels than male adipocytes although the cells were maintained 
in similar culture conditions, including sex steroid concentrations. This suggests 
intrinsic roles for the sex origin of the cells, driven by epigenetic programming or 
sex chromosomes. This finding stresses the need for stable cell lines generated 
from BAT of both male and female mice, which are currently lacking, in order 
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to understand these additional mechanisms beyond or in interaction with sex 
steroids.
At 22 °C (a usual temperature for housing conditions of laboratory 
animals), female rats have been reported to have higher Ucp1 mRNA expression 
levels and higher mitochondrial activity in BAT than male rats (31). Surpris-
ingly, this sex difference disappeared when the thermogenic capacity of BAT 
was maximally stimulated by exposing animals to cold (4 °C) since Ucp1 mRNA 
expression was upregulated to a similar level in both sexes (31). These data 
suggest that a sex difference in thermal perception at 22 °C might result in 
sexually dimorphic BAT activity, a plausible explanation that will be discussed 
in the following section.
Factors affecting sex differences in thermal perception
Males and females pose many differences in the thermoregulatory 
system to achieve optimal thermal homeostasis. The major contributing factors 
are sexual dimorphisms in body composition and anthropometric character-
istics implicating that women (or female rodents) generally have larger body 
surface area (BSA)-to-mass ratios, which result in greater net heat loss to the 
surroundings, than men (or male rodents) (32,33). Since mice are >3,000-fold 
smaller in body mass and have a larger BSA-to-mass ratio than humans, mice 
present some unique characteristics in thermoregulation. Compared to humans, 
mice prefer higher ambient temperatures (Ta) with a thermoneutral zone (TNZ) 
around 30–32 °C and mice have a lower vasomotor dependency, higher metabolic 
rates, larger BAT relative to body mass, and more diurnal variations in the core 
body temperature (Tc) (34,35).
Thermal perception is a broader term than thermal sensation since it 
incorporates thermal sensation (neural thermal reception), individual interpre-
tation of thermal sensation (e.g. cold, cool, neutral, warm, or hot), and thermal 
comfort or satisfaction (comfortable vs. uncomfortable or satisfied vs. dissatisfied) 
(36). Many experimental and field studies indicate that women are more sensitive 
to deviations from a preferred Ta and women experience more dissatisfaction 
in a similar thermal environment than men (37,38). Some studies demonstrate 
that women prefer a higher Ta than men to achieve their thermal comfort (39); 
however, this observation is not always consistent since some studies show no 
sex-dependency in thermal preference (37,38).
To study thermal perception in animals, temperature preference tests, 
i.e. behavioral observations to study where animals prefer to reside among a 
range of Ta’s, are usually performed. That is because behavioral thermoregulatory 
responses, i.e. movement to a preferred Ta, are energy-inexpensive mechanisms 
that animals use to optimize thermal needs (34). The temperature preference test 
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in adult mice presented in Chapter 4 shows that female mice spend more time 
in cages with a higher Ta than male mice, especially during the light (inactive) 
phase, which is in line with a previous study (40). More specifically, the study in 
Chapter 4 is the first to demonstrate that females prefer a Ta close to an upper 
limit of TNZ (32 °C) whereas male mice show no preference to either an upper 
limit (32 °C) or lower limit (29 °C) of TNZ.
The cool-sensitive thermoreceptor TRPM8 of females has been reported 
to be more sensitive than that of males and the ex vivo study in isolated dorsal 
root ganglion neurons showed that this difference was depended on the presence 
of E2 and testosterone (41). Surprisingly, the study in Chapter 4 reveals that 
gonadectomy in adult mice does not affect the sex-specific thermal preference. 
This might suggest that an effect of gonadal hormones on thermal sensory inputs 
alone cannot explain the sex difference in thermal preference of adult mice and/
or that sex hormones may have influenced the thermal neural circuits during 
earlier stages of life, such as the two most critical periods of brain development: 
pubertal and neonatal stages (42). In literature, it has been demonstrated that 
the preoptic area (POA) of the anterior hypothalamus (the thermoregulatory 
integration area) is responsive to gonadal hormones during development 
and shows striking sexual dimorphism in both molecular and morphological 
components, and hence causes several sex-specific behaviors in adults (42). 
Hence, it would be of interest to repeat this study using mice at prepubertal age. 
The study in male and female volunteers in Chapter 5 supports the 
findings in mice. Experiencing a gradually cooling protocol using a temperature- 
controlled water-perfused blanket, women start shivering at a higher 
temperature (a quantitative outcome for cold sensation) and sense/perceive a 
similar temperature colder and less comfortable than men. A subgroup analysis 
that matches the BSA-to-mass ratio between men and women does not change 
the sex-dependent outcomes, suggesting that body composition is not the only 
factor for the sex difference in thermal demand and that thermal preference 
has been determined in a sex-specific fashion. Hence, further (animal) studies 
investigating the roles of sex hormones before puberty are needed to obtain 
further insight into the underlying mechanism of the sex-dimorphic thermal 
preference.
Future perspectives for studies of sex difference in adipose tissue 
function
Apart from sex hormones, sex chromosomes are likely independent 
factors regulating adiposity (43). The four core genotypes (FCG) mouse model 
in which the testis-determining gene Sry is relocated from the Y chromosome to 
an autosome, has been used to investigate the segregation of the effects of the 
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gonadal sex and gonad-secreting factors from the sex chromosome complement 
(44). Comparing mice with a similar gonadal type in early adulthood, mice with 
XX chromosomes were slightly but significantly heavier than those with XY 
chromosomes (45). When gonadectomy was performed to remove acute effects 
of sex hormones, the XX mice had a substantial increase in total fat mass and 
plasma leptin levels, compared to XY mice, regardless of their original gonads 
(45). This suggests that the sex chromosomes themselves have effects on 
adipose tissue function. Indeed, an increase in adiposity by the number of X 
chromosomes was also observed in the XY* mouse model in which the paternal 
unusual Y* chromosome produces offspring equivalent to XO, XX, XY, and 
XXY genotypes (44,45). Metabolic challenges with a high-fat diet revealed sex- 
chromosomal effects on fat distribution: XX mice had a larger inguinal WAT depot 
whereas XY mice had a larger gonadal WAT depot, independent of gonads (45). 
All these studies were performed with mice of the C57BL/6J strain, but similar 
genetic models in mice of the MF1 strain confirmed a role of the total number of 
sex chromosomes on adiposity and metabolism (46), but showed no differential 
effects whether these were X or Y chromosomes. Thus, animal studies indicate 
that the number of the sex chromosome is an independent factor for body fat 
accumulation. In humans, men with Klinefelter syndrome (47,XXY) and women 
with Turner syndrome (e.g. 45,X) have increased risks of abdominal obesity and 
metabolic diseases relative to their normal karyotype controls (47,48). Because 
patients with Klinefelter and Turner syndromes also suffer from hypogonadism, 
effects of sex chromosomes and sex hormones on adiposity in humans cannot be 
individually evaluated.
The effect of sex chromosomes on BAT function has not been studied in 
detail. Thus far, there has been only one study investigating BAT of the FCG 
mice, in which no effect of sex chromosomes on Ucp1 and Ppargc1a mRNA 
expression in BAT at 4 weeks or 10 months after gonadectomy was described (45). 
Interestingly, in a similar sex-chromosomal status at 4 weeks after gonadectomy, 
orchiectomized gonadal male mice had a slightly higher Ucp1 mRNA expression 
level in BAT than ovariectomized gonadal female mice (45), stating a role of 
gonadal hormones rather than sex chromosome complements. Nevertheless, 
since the study in Chapter 3 reveals sex-dependent gene expression patterns 
in primary brown adipocytes independent of sex steroids, further analysis of 
the role of sex chromosomes and their interaction with sex steroids, particularly 
in pathological conditions in which cells are exposed to sex steroids opposite to 
their sex-chromosomal status, is warranted.
Genome-wide association studies (GWAS) of genetic variants, such as 
single-nucleotide polymorphisms (SNPs) and short deletions or insertions, 
revealed many genetic loci associated with body mass index (BMI; a surrogate 
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for obesity) and waist-to-hip ratio adjusted for BMI (WHRadjBMI; an index for 
abdominal obesity) (49). A study in 339,224 individuals identified 97 autosomal 
genetic loci associated with BMI of which only 2 loci were marginally sex- 
dependent (50). Another study in 224,459 individuals identified 49 loci associated 
with WHRadjBMI of which 20 loci were sex-dependent (51). Interestingly, there 
was no overlap in the identified loci for general and abdominal obesity [see a 
comprehensive list in (49)]. A subsequent study in 320,485 individuals revealed 
that 15 BMI-associated loci showed age-specific effects and 44 WHRadjBMI- 
associated loci showed sex-specific effects, but interestingly there was neither a 
sex-specific effect on BMI-associated loci nor an age-specific effect on WHRadjBMI- 
associated loci (52). Therefore, these GWAS data suggest that genetic variants 
in autosomal DNA might contribute to sex dimorphisms in the fat distribution 
pattern, but not for general obesity. Of note, variants in sex chromosomes were 
excluded from these GWAS due to technical reasons.
Epigenetic modifications, such as DNA methylation, histone modifica-
tions, and environmental factors, have been shown to play an important role 
in WAT programming (53), which includes some sex-differential features. For 
example, a single injection of testosterone in female mice and rats during the 
early postnatal period resulted in obesity, increased visceral fat accumulation, 
and insulin resistance at adult age (54,55). These phenotypes likely resulted 
from imprinting or epigenetic programming due to neonatal testosterone 
exposure. The epigenetic effect of androgens is supported by a study in women 
with polycystic ovary syndrome (PCOS) whose classical manifestations include 
hyperandrogenism (56). Several DNA methyltransferases (DNMTs; major 
enzymes that maintain methylation patterns upon DNA replication) were 
differentially methylated and DMAP1 (DNMT1 associated protein 1; a protein 
involved in DNA methylation and obesity-related inflammation) was differentially 
expressed in abdominal subcutaneous WAT of women with PCOS compared to 
those of healthy controls. In addition, 30 differentially expressed genes were 
identified with changes in DNA methylation sites (56), suggesting the potential 
influence of DNA methylation on corresponding gene expression.
Epigenetic regulation is also important for BAT function at many levels 
(57). For example, a retrospective study found that individuals with active BAT 
in PET/CT imaging were more likely to have been conceived in the colder period 
of the year (October–February) than in the warmer period (April–September) 
(58). Studies in mice showed that paternal cold exposure before mating led to 
upregulated basal and cold-stimulated UCP1 protein levels in BAT and inguinal 
WAT in the offspring of both sexes, which is likely due to a differential methylation 
status in the sperm of the cold-exposed males compared to control fathers (58). 
Some histone deacetylases (HDACs), which remove acetyl groups from histones, 
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compact the chromatin structure, and generally suppress gene transcription, 
are recognized as negative regulators for BAT thermogenesis (57). For instance, 
acute cold exposure or an injection of CL316,243 in mice downregulated Hdac1 
mRNA expression in BAT and inhibitions of HDAC1 upregulated Ucp1 mRNA 
and UCP1 protein levels in cultured brown adipocytes (59). Another relevant 
observation is that a single injection of testosterone during the neonatal period 
in female mice increased lipid accumulation and reduced mRNA expression 
of Ucp1 and other BAT-specific genes in BAT in later life (55), suggesting 
lifelong epigenetic modulation by postnatal sex steroid exposure. However, our 
preliminary unpublished study observed no apparent sex difference in the global 
methylation pattern in BAT of adult male and female mice housed at normal 
housing conditions. Hence, whether sex-dependent epigenetic programming in 
BAT at physiological conditions exists and whether it affects sex differences in 
BAT function warrants further studies.
Concerning the secretory function of adipose tissue apart from conven-
tional adipokines, WAT and BAT produce and secrete exosomes containing 
microRNAs (miRNAs) which are 19–22-nucleotide long non-coding RNAs that 
regulate gene expression and translation in other tissues, such as liver (60). 
A study in the FCG mice revealed that sex differences in miRNA expression 
levels in gonadal WAT were mainly driven by the gonadal type, thus likely by 
sex hormones (61). When gonadectomy was performed to eliminate the acute 
effects of sex hormones, sex chromosome complements were also found to play 
a role in miRNA profiles, but to a lower extent than sex hormones (61). To the 
best of my knowledge, sex differences in miRNA expression levels in BAT have 
not been investigated. It is worth mentioning that circulating levels of exosomal 
miRNAs, such as miR-34c, miR-92a, and miR-122, are possibly a non-invasive 
biomarker to reflect in vivo BAT activity in mice or humans (62-64). However, 
our preliminary unpublished data and a subsequent study by Okamatsu-Ogura 
et al. (64) could not confirm a correlation of miR-92a levels and BAT activity. 
It would, therefore, be of interest to study the circulating concentrations of 
miRNAs in males and females with an emphasis on the role of sex steroids in the 
circulating miRNA levels.
As mentioned earlier, effects of sex steroids or other factors could 
differ depending on the sex origin of the cells. The human-induced pluripotent 
stem cell (hiPSC) is a promising tool to produce an in vitro functional white or 
brown adipocyte model that is most analogous to in vivo adipocytes to study 
sex-dimorphic features. Somatic cells, such as skin fibroblasts, can be used to 
generate iPSCs (65). Since iPSCs are capable of long-term self-renewal and can 
be expanded into large numbers, many biological or translational tests can be 
performed. In addition, obtaining iPSCs is more feasible than obtaining other 
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primary human cells, namely human embryonic stem cells (which raises ethical 
issues) or adipose-derived stromal vascular cells (which have limited prolifera-
tive potential and may quickly lose differentiation capacities) (66,67). However, 
one might argue that the traditional cell culture in which cells are maintained 
in monolayer cultures is not an ideal model for adipose tissue structure. To 
mimic the natural structure, three-dimensional cultures may be preferred and 
this would also allow studying interactions with additional cell types such as 
endothelial cells and immune cells. Protein scaffolds of biomaterials, e.g. silk 
or elastin-like polypeptides conjugated to polyelectrolytes, have been shown to 
enhance long-term tissue sustainability, structural organization, and functional 
activities (68,69). Three-dimensional cultures may facilitate the understanding 
if sex difference in adipose tissue structure persists ex vivo and whether this 
leads to the functional discrepancy.
WAT shows many sex- and depot-specific morphology and composition 
in its microenvironment, an aspect that has been limitedly studied in BAT. Our 
transcriptional data in Chapter 3 suggest that the microenvironment also plays 
an important role in regulation of sex-specific BAT function. Our data furthermore 
implicates that interactions of brown adipocytes with various cells present in the 
BAT depot contribute to sex-specific BAT function. Compared to WAT, BAT has 
a higher number of endothelial cells and denser vasculature in the tissue (70,71), 
as well as a higher norepinephrine turnover rate per depot, which indicates a 
dense innervation of sympathetic nerves (72,73). These features of BAT facilitate 
its thermogenic function in both mice and humans, as blood flow to BAT, uptake 
of glucose or fatty acids in BAT, and skin temperature overlaying BAT depots 
are markedly increased by norepinephrine injection or cold exposure (71,74,75). 
Female BAT is more responsive to adrenergic stimulation than male BAT (24), 
but whether the adrenergic innervation or the blood supply to BAT is sexually 
dimorphic has not been studied. Our data showing sex-dimorphic expression of 
structural genes in BAT, not being expressed in primary adipocytes, suggest 
that these additional features may be interesting targets to activate BAT. 
Steroid hormone receptors such as the GR, mineralocorticoid receptor 
(MR), estrogen receptor (ER), progesterone receptor (PR), and androgen receptor 
(AR) are members of the nuclear receptor superfamily 3 and they therefore 
share several molecular and functional characteristics. Upon ligand binding, the 
ligand-receptor complex is translocated from the cytoplasm to the nucleus, binds 
to the response elements and/or interacts with coregulatory proteins, and hence 
activates or inhibits transcription of target genes (76,77). The coregulatory 
proteins, e.g. the steroid receptor coactivator (SRC) family, also known as the 
nuclear receptor coactivator (NCoA), have been shown to regulate adipocyte 
differentiation and energy expenditure (78). However, whether coregulatory 
186
6
Chapter 6
proteins influence sex-dependent transcriptional profile in adipose tissue has 
not been systematically evaluated. Since studies in Chapters 2–3 suggest 
interactions of sex hormones and GR signaling on adipose tissue functional 
activities, nuclear receptor coregulatory complexes, as well as crosstalk among 
sex hormones and nuclear receptors, should be investigated. The most relevant 
study of hormonal crosstalk described so far in literature was performed only 
in male mice. Upon corticosterone treatment, DHT cotreatment potentiated 
transcription of GR-target genes in WAT and BAT, and cotreatment with 
the AR antagonist enzalutamide attenuated the GR signaling in WAT (79). 
The GR-inhibiting effect of enzalutamide in WAT is likely driven by reduced 
activity of the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1; an 
intra-tissue GC reactivating enzyme) (79).
Summary
Altogether, this thesis has broadened our understanding of sex differences 
in control of WAT and BAT function in various aspects, namely sex-dependent 
adaptation of WAT upon corticosterone exposure, sex-specific transcriptional 
profile in BAT at basal conditions, and sex-biased thermal perception (the 
afferent signals essential for BAT activation and WAT browning). These findings 
generally support that inclusion of sex should be considered as an independent 
risk factor when considering individualized treatment options for patients with 
obesity. However, more studies are warranted to fully understand this complex 
picture of sexual dimorphisms in adipose tissue biology.
References
1. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol 
Rev. 2004;84(1):277-359.
2. Loh RKC, Kingwell BA, Carey AL. Human brown adipose tissue as a target for obesity 
management; beyond cold-induced thermogenesis. Obes Rev. 2017;18(11):1227-1242.
3. Valencak TG, Osterrieder A, Schulz TJ. Sex matters: The effects of biological sex on adipose 
tissue biology and energy metabolism. Redox Biol. 2017;12:806-813.
4. Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues 
- the biology of pear shape. Biol Sex Differ. 2012;3(1):13.
5. Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 
2007;21(3):415-430.
6. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased 
energy expenditure during the menopausal transition. Int J Obes (Lond). 2008;32(6):949-
958.
7. Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, 
fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127(1):74-82.
8. Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose Tissue Remodeling: Its Role in Energy 
Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne). 2016;7:30.
9. Rudnicki M, Abdifarkosh G, Rezvan O, Nwadozi E, Roudier E, Haas TL. Female Mice Have 
Higher Angiogenesis in Perigonadal Adipose Tissue Than Males in Response to High-Fat Diet. 
Front Physiol. 2018;9:1452.
10. Wu Y, Lee MJ, Ido Y, Fried SK. High-fat diet-induced obesity regulates MMP3 to modulate 
187
6
General Discussion
depot- and sex-dependent adipose expansion in C57BL/6J mice. Am J Physiol Endocrinol Metab. 
2017;312(1):E58-E71.
11. Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, 
Kim H. A practical guide to the monitoring and management of the complications of systemic 
corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30.
12. Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A. Complications of 
Cushing's syndrome: state of the art. Lancet Diabetes Endocrinol. 2016;4(7):611-629.
13. Perez A, Jansen-Chaparro S, Saigi I, Bernal-Lopez MR, Minambres I, Gomez-Huelgas R. 
Glucocorticoid-induced hyperglycemia. J Diabetes. 2014;6(1):9-20.
14. Bonaventura A, Montecucco F. Steroid-induced hyperglycemia: An underdiagnosed problem or 
clinical inertia? A narrative review. Diabetes Res Clin Pract. 2018;139:203-220.
15. Binnert C, Ruchat S, Nicod N, Tappy L. Dexamethasone-induced insulin resistance shows no 
gender difference in healthy humans. Diabetes Metab. 2004;30(4):321-326.
16. Katsuyama T, Sada KE, Namba S, Watanabe H, Katsuyama E, Yamanari T, Wada J, Makino H. 
Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin 
Pract. 2015;108(2):273-279.
17. Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on 
adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. 2014;43(1):75-
102.
18. Kroon J, Koorneef LL, van den Heuvel JK, Verzijl CRC, van de Velde NM, Mol IM, Sips HCM, 
Hunt H, Rensen PCN, Meijer OC. Selective Glucocorticoid Receptor Antagonist CORT125281 
Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice. Endocrinology. 
2018;159(1):535-546.
19. Moriscot A, Rabelo R, Bianco AC. Corticosterone inhibits uncoupling protein gene expression in 
brown adipose tissue. Am J Physiol. 1993;265(1 Pt 1):E81-87.
20. Gasparini SJ, Swarbrick MM, Kim S, Thai LJ, Henneicke H, Cavanagh LL, Tu J, Weber MC, 
Zhou H, Seibel MJ. Androgens sensitise mice to glucocorticoid-induced insulin resistance and 
fat accumulation. Diabetologia. 2019;62(8):1463-1477.
21. Glantschnig C, Mattijssen F, Vogl ES, Ali Khan A, Rios Garcia M, Fischer K, Muller T, et al. 
The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis. 
EMBO Rep. 2019;20(11):e48552.
22. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, et al. Identification 
and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509-
1517.
23. Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, Schmadl M, Reimold M, Haring HU, 
Claussen CD, Stefan N. Impact of age on the relationships of brown adipose tissue with sex and 
adiposity in humans. Diabetes. 2010;59(7):1789-1793.
24. Rodriguez-Cuenca S, Pujol E, Justo R, Frontera M, Oliver J, Gianotti M, Roca P. Sex-dependent 
thermogenesis, differences in mitochondrial morphology and function, and adrenergic response 
in brown adipose tissue. J Biol Chem. 2002;277(45):42958-42963.
25. Rodriguez AM, Monjo M, Roca P, Palou A. Opposite actions of testosterone and progesterone 
on UCP1 mRNA expression in cultured brown adipocytes. Cell Mol Life Sci. 2002;59(10):1714-
1723.
26. Monjo M, Rodriguez AM, Palou A, Roca P. Direct effects of testosterone, 17 beta-estradiol, and 
progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for 
gender-dependent thermogenesis. Endocrinology. 2003;144(11):4923-4930.
27. Kim SN, Jung YS, Kwon HJ, Seong JK, Granneman JG, Lee YH. Sex differences in sympathetic 
innervation and browning of white adipose tissue of mice. Biol Sex Differ. 2016;7:67.
28. Guerra C, Koza RA, Yamashita H, Walsh K, Kozak LP. Emergence of brown adipocytes in 
white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest. 
1998;102(2):412-420.
29. de Jong JM, Larsson O, Cannon B, Nedergaard J. A stringent validation of mouse adipose tissue 
identity markers. Am J Physiol Endocrinol Metab. 2015;308(12):E1085-1105.
30. McIlvride S, Mushtaq A, Papacleovoulou G, Hurling C, Steel J, Jansen E, Abu-Hayyeh S, 
Williamson C. A progesterone-brown fat axis is involved in regulating fetal growth. Sci Rep. 
2017;7(1):10671.
31. Quevedo S, Roca P, Pico C, Palou A. Sex-associated differences in cold-induced UCP1 synthesis 
in rodent brown adipose tissue. Pflugers Arch. 1998;436(5):689-695.
32. Castellani JW, Young AJ. Human physiological responses to cold exposure: Acute responses and 
acclimatization to prolonged exposure. Auton Neurosci. 2016;196:63-74.
188
6
Chapter 6
33. Schile A, Denegre J. Growth curve analysis of 10 strains of mice. MPD:Jaxpheno5. Mouse 
Phenome Database web resource (RRID:SCR_003212). The Jackson Laboratory; 2014. Accessed 
11 November 2019. https://phenome.jax.org/projects/Jaxpheno5.
34. Gordon CJ. The mouse thermoregulatory system: Its impact on translating biomedical data to 
humans. Physiol Behav. 2017;179:55-66.
35. Taylor NAS, Gordon CJ. The origin, significance and plasticity of the thermoeffector thresholds: 
Extrapolation between humans and laboratory rodents. J Therm Biol. 2019;85:102397.
36. Schweiker M, Huebner GM, Kingma BRM, Kramer R, Pallubinsky H. Drivers of diversity 
in human thermal perception - A review for holistic comfort models. Temperature (Austin). 
2018;5(4):308-342.
37. Karjalainen S. Thermal comfort and gender: a literature review. Indoor Air. 2012;22(2):96-
109.
38. Wang Z, de Dear R, Luo M, Lin B, He Y, Ghahramani A, Zhu Y. Individual difference in thermal 
comfort: A literature review. Build Environ. 2018;138:181-193.
39. Maykot JK, Rupp RF, Ghisi E. A field study about gender and thermal comfort temperatures in 
office buildings. Energy Build. 2018;178:254-264.
40. Gaskill BN, Rohr SA, Pajor EA, Lucas JR, Garner JP. Some like it hot: Mouse temperature 
preferences in laboratory housing. Appl Anim Behav Sci. 2009;116(2-4):279-285.
41. Kondrats'kyi AP, Kondrats'ka KO, Skryma R, Prevars'ka N, Shuba Ia M. [Gender differences in 
cold sensitivity: role of hormonal regulation of TRPM8 channel]. Fiziol Zh. 2009;55(4):91-99.
42. Lenz KM, Nugent BM, McCarthy MM. Sexual differentiation of the rodent brain: dogma and 
beyond. Front Neurosci. 2012;6:26.
43. Zore T, Palafox M, Reue K. Sex differences in obesity, lipid metabolism, and inflammation-A role 
for the sex chromosomes? Mol Metab. 2018;15:35-44.
44. Mauvais-Jarvis F, Arnold AP, Reue K. A Guide for the Design of Pre-clinical Studies on Sex 
Differences in Metabolism. Cell Metab. 2017;25(6):1216-1230.
45. Chen X, McClusky R, Chen J, Beaven SW, Tontonoz P, Arnold AP, Reue K. The number of x 
chromosomes causes sex differences in adiposity in mice. PLoS Genet. 2012;8(5):e1002709.
46. Chen X, McClusky R, Itoh Y, Reue K, Arnold AP. X and Y chromosome complement influence 
adiposity and metabolism in mice. Endocrinology. 2013;154(3):1092-1104.
47. Gravholt CH, Jensen AS, Host C, Bojesen A. Body composition, metabolic syndrome and type 2 
diabetes in Klinefelter syndrome. Acta Paediatr. 2011;100(6):871-877.
48. Ros C, Castelo-Branco C. Management of Turner's syndrome in adult life: case-series and 
systematic review. Gynecol Endocrinol. 2012;28(9):726-732.
49. Fall T, Mendelson M, Speliotes EK. Recent Advances in Human Genetics and Epigenetics of 
Adiposity: Pathway to Precision Medicine? Gastroenterology. 2017;152(7):1695-1706.
50. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, et al. Genetic studies of 
body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.
51. Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Magi R, Strawbridge 
RJ, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 
2015;518(7538):187-196.
52. Winkler TW, Justice AE, Graff M, Barata L, Feitosa MF, Chu S, Czajkowski J, et al. The 
Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale 
Genome-Wide Interaction Study. PLoS Genet. 2015;11(10):e1005378.
53. Seki Y, Williams L, Vuguin PM, Charron MJ. Minireview: Epigenetic programming of diabetes 
and obesity: animal models. Endocrinology. 2012;153(3):1031-1038.
54. Nilsson C, Niklasson M, Eriksson E, Bjorntorp P, Holmang A. Imprinting of female offspring 
with testosterone results in insulin resistance and changes in body fat distribution at adult age 
in rats. J Clin Invest. 1998;101(1):74-78.
55. Jang H, Bhasin S, Guarneri T, Serra C, Schneider M, Lee MJ, Guo W, Fried SK, Pencina K, 
Jasuja R. The Effects of a Single Developmentally Entrained Pulse of Testosterone in Female 
Neonatal Mice on Reproductive and Metabolic Functions in Adult Life. Endocrinology. 
2015;156(10):3737-3746.
56. Kokosar M, Benrick A, Perfilyev A, Fornes R, Nilsson E, Maliqueo M, Behre CJ, et al. Epigenetic 
and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome. Sci 
Rep. 2016;6:22883.
57. Sambeat A, Gulyaeva O, Dempersmier J, Sul HS. Epigenetic Regulation of the Thermogenic 
Adipose Program. Trends Endocrinol Metab. 2017;28(1):19-31.
58. Sun W, Dong H, Becker AS, Dapito DH, Modica S, Grandl G, Opitz L, et al. Cold-induced 
189
6
General Discussion
epigenetic programming of the sperm enhances brown adipose tissue activity in the offspring. 
Nat Med. 2018;24(9):1372-1383.
59. Li F, Wu R, Cui X, Zha L, Yu L, Shi H, Xue B. Histone Deacetylase 1 (HDAC1) Negatively 
Regulates Thermogenic Program in Brown Adipocytes via Coordinated Regulation of Histone 
H3 Lysine 27 (H3K27) Deacetylation and Methylation. J Biol Chem. 2016;291(9):4523-4536.
60. Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, et al. 
Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 
2017;542(7642):450-455.
61. Link JC, Hasin-Brumshtein Y, Cantor RM, Chen X, Arnold AP, Lusis AJ, Reue K. Diet, gonadal 
sex, and sex chromosome complement influence white adipose tissue miRNA expression. BMC 
Genomics. 2017;18(1):89.
62. Goody D, Pfeifer A. BAT Exosomes: Metabolic Crosstalk with Other Organs and Biomarkers for 
BAT Activity. Handb Exp Pharmacol. 2019;251:337-346.
63. Chen Y, Buyel JJ, Hanssen MJ, Siegel F, Pan R, Naumann J, Schell M, et al. Exosomal 
microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun. 
2016;7:11420.
64. Okamatsu-Ogura Y, Matsushita M, Bariuan JV, Nagaya K, Tsubota A, Saito M. Association 
of circulating exosomal miR-122 levels with BAT activity in healthy humans. Sci Rep. 
2019;9(1):13243.
65. Yao X, Salingova B, Dani C. Brown-Like Adipocyte Progenitors Derived from Human iPS Cells: 
A New Tool for Anti-obesity Drug Discovery and Cell-Based Therapy? Handb Exp Pharmacol. 
2019;251:97-105.
66. Singh AM, Dalton S. What Can 'Brown-ing' Do For You? Trends Endocrinol Metab. 
2018;29(5):349-359.
67. Volarevic V, Markovic BS, Gazdic M, Volarevic A, Jovicic N, Arsenijevic N, Armstrong L, Djonov 
V, Lako M, Stojkovic M. Ethical and Safety Issues of Stem Cell-Based Therapy. Int J Med Sci. 
2018;15(1):36-45.
68. Abbott RD, Kimmerling EP, Cairns DM, Kaplan DL. Silk as a Biomaterial to Support Long-Term 
Three-Dimensional Tissue Cultures. ACS applied materials & interfaces. 2016;8(34):21861-
21868.
69. Turner PA, Tang Y, Weiss SJ, Janorkar AV. Three-dimensional spheroid cell model of in vitro 
adipocyte inflammation. Tissue engineering. Part A. 2015;21(11-12):1837-1847.
70. Grandl G, Muller S, Moest H, Moser C, Wollscheid B, Wolfrum C. Depot specific differences in 
the adipogenic potential of precursors are mediated by collagenous extracellular matrix and 
Flotillin 2 dependent signaling. Mol Metab. 2016;5(10):937-947.
71. Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, et al. Different 
metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 
2011;14(2):272-279.
72. Bartness TJ, Vaughan CH, Song CK. Sympathetic and sensory innervation of brown adipose 
tissue. Int J Obes (Lond). 2010;34 Suppl 1:S36-42.
73. Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ. Differential activation of the sympathetic 
innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology. 
2007;148(11):5339-5347.
74. Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in 
metabolic studies. J Exp Biol. 2011;214(Pt 2):242-253.
75. van der Lans AA, Wierts R, Vosselman MJ, Schrauwen P, Brans B, van Marken Lichtenbelt 
WD. Cold-activated brown adipose tissue in human adults: methodological issues. Am J Physiol 
Regul Integr Comp Physiol. 2014;307(2):R103-113.
76. Alexander SP, Cidlowski JA, Kelly E, Marrion NV, Peters JA, Faccenda E, Harding SD, et 
al. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors. Br J 
Pharmacol. 2017;174 Suppl 1:S208-S224.
77. Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, et al. 
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear 
receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. 
Pharmacol Rev. 2006;58(4):782-797.
78. Lonard DM, O'Malley BW. Nuclear receptor coregulators: modulators of pathology and 
therapeutic targets. Nat Rev Endocrinol. 2012;8(10):598-604.
79. Spaanderman DCE, Nixon M, Buurstede JC, Sips HC, Schilperoort M, Kuipers EN, Backer 
EA, et al. Androgens modulate glucocorticoid receptor activity in adipose tissue and liver. J 
Endocrinol. 2019;240(1):51-63.

Chapter 7
Summary / Samenvatting
7
192
7
Chapter 7
193
7
Summary
Summary
Obesity and overweight are both conditions of excessive/abnormal fat 
accumulation and are leading risk factors for many metabolic diseases, such 
as insulin resistance and type 2 diabetes mellitus. The principal site of fat 
accumulation in the body is adipose tissue, the organ traditionally defined as a 
quiescent energy reservoir. Nowadays, adipose tissue has gained interests as an 
endocrine organ since its secretory function reflects adaptability to an altered 
systemic metabolic status. In addition to white adipose tissue (WAT), brown 
adipose tissue (BAT) is another specialized adipose tissue that, in contrast 
to WAT, utilizes energy substrates for metabolic heat production, a crucial 
cold-defense mechanism to maintain body temperature in neonates and small 
mammals. After the rediscovery of active BAT in adult humans, activation of 
BAT is considered one of the promising therapeutic targets to increase energy 
expenditure for combating the global obesity pandemic.
Fat distribution physiologically shows a sexually dimorphic pattern: men 
store fat predominantly in visceral (intra-abdominal) WAT depots, resulting in 
an apple-shaped body, whereas women accumulate fat principally in subcuta-
neous WAT depots, e.g. gluteofemoral region, resulting in a pear-shaped body 
contour. In addition, women of reproductive age have a lower incidence of 
metabolic diseases than age-matched men. However, after menopause, women 
are more susceptible to visceral obesity (the male pattern of fat accumulation), 
which is linked to an increased incidence of metabolic diseases. Sex differences 
in BAT abundance and function are also reported. In general, women and female 
rodents have a higher BAT mass and/or greater BAT activity than men and 
male rodents. Altogether, human and rodent studies pinpoint protective effects 
of estrogens on energy balance and metabolic risk factors, while androgens in 
general have a negative effect on metabolic risk factors.
Apart from sex steroids, glucocorticoids (GCs; cortisol for humans and 
corticosterone for rodents), which are adrenal steroid hormones principally 
secreted in response to stress, have also been implicated in the control of energy 
metabolism and hence metabolic risk factors. The main function of endogenous 
GCs is to supply glucose for vital organs through many mechanisms, including 
inhibition of glucose uptake by WAT. Sustained elevated GC levels or chronic 
exposure to exogenous GCs, such as synthetic corticosteroids, result in many 
metabolic adverse effects, including weight gain, truncal obesity, insulin 
resistance, and poor glycemic control. However, whether the adverse effects of 
GCs are expressed in a sex-dependent manner is unclear. The general aim of this 
thesis therefore is to broaden our understanding of sex differences in adipose 
tissue function. 
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Chapter 1 is a general introduction of this thesis and describes 1) basic 
knowledge of adipose tissue biology, including adipogenic programming, lipid 
metabolism in adipocytes, secretory function of WAT, and thermogenic function 
of BAT; 2) roles of sex and stress steroids on the distribution and function of 
adipose tissue; and 3) a general concept of body thermoregulation which is 
important for an understanding of BAT thermogenesis.
In Chapter 2, the effects of a high dose of corticosterone on systemic 
glucose homeostasis and adipose tissue adaptation were studied in male and 
female mice. Upon corticosterone treatment, male mice had nonfasting hyper- 
glycemia, which resembles the pathognomonic sign of steroid-induced diabetes 
in humans. Female mice, in contrast, remained normoglycemic throughout the 
two weeks of treatment. However, both sexes showed normal fasting glucose 
levels and profoundly elevated fasting insulin levels, indicative of insulin 
resistance. Stable isotope-labeled glucose techniques were utilized during the 
glucose tolerance test and confirmed that female mice had a higher basal glucose 
clearance rate than male mice upon corticosterone treatment. WAT and BAT 
depots were enlarged by corticosterone treatment in both sexes, but female mice 
manifested more metabolically protective adaptations than males, i.e., more 
hyperplastic WAT morphology and higher serum adiponectin levels. In vitro 
studies in white and brown adipocyte cell lines suggested that the increased 
adiponectin level in female mice was likely driven by an elevated insulin level 
rather than a direct effect of corticosterone treatment.
Sex differences in BAT prevalence and activity are reported to be 
likely caused by a stimulatory effect of estrogens and/or an inhibitory effect of 
androgens on BAT, or a stimulatory effect of estrogens on the central nervous 
system that regulates BAT thermogenesis. To uncover if molecular mechanisms 
contribute to the sexual dimorphism in BAT function, RNA-sequencing was 
performed to identify sex differences in the murine BAT transcriptome. The 
data presented in Chapter 3 show that sex differences in BAT gene expression 
were evident for genes encoding proteins involved in cellular structure, cell-cell 
contact, and cell adhesion. Interestingly, ovariectomy significantly affected while 
orchiectomy marginally influenced expression levels of the identified genes. 
Moreover, in silico upstream regulator analysis supported that 17β-estradiol 
(E2), progesterone, and dihydrotestosterone were among the top significant 
upstream regulators for these sex-differentially expressed genes. Direct effects 
of progesterone were further tested in primary cultures of brown adipocytes and 
it was found that progesterone inhibited expression of some identified genes, as 
well as common brown adipocyte markers. This inhibitory effect of progesterone 
is likely mediated by the glucocorticoid receptor rather than the progesterone 
receptor. Furthermore, although primary brown adipocytes were maintained in a 
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similar sex steroid milieu, basal expression of many sex-differentially expressed 
genes remained higher in female adipocytes than in male adipocytes, suggesting 
intrinsic roles of sex origin of the cells.
When housed under general laboratory conditions, female rodents have 
a higher thermogenic capacity in BAT than their male counterparts. However, 
this difference is diminished upon cold exposure in which BAT thermogenesis 
is maximally activated. This finding indicates that a difference in thermal 
perception might underlie the sex-dependent thermogenic responses, which 
we studied subsequently in both mouse and human. Chapter 4 describes that 
female mice prefer a higher ambient temperature than male mice, especially 
when physical activities are generally low. Of interest, gonadectomy in adult 
mice did not alter this sex-specific thermal preference, indicating that the neural 
control of thermal sensation is sex-dependently regulated by factors other than 
gonadal factors or that the neural circuit has been determined prior to puberty.
It is documented that males and females pose many differences in the 
thermoregulatory system. One of the principal determining factors is sexual 
dimorphism in body composition. Women (or female rodents) have a larger 
body-surface-area/mass ratio than men (or male rodents) that hence leads to a 
higher rate of net heat loss and greater thermal demand in females. Apart from 
the sex-dependent physical property, women also perceive a temperature lower 
than the thermoneutral zone colder and less comfortable than men, as is shown 
by the study in Chapter 5. This study shows that women start shivering at a 
higher temperature (a quantitative measure for cold sensation) than men during 
a gradually cold exposure protocol by a temperature-controlled water-perfused 
blanket. Interestingly, subgroup analysis which matches the body-surface-area/
mass ratio between men and women did not alter the sex-dependent shivering 
temperature, suggesting that body composition is not the sole factor for sex 
differences in thermoregulation.
Finally, Chapter 6 discusses the findings in this thesis that broaden 
our understanding of sex differences in the control of adipose tissue function. 
However, further studies are required to complete this complex picture of sexual 
dimorphisms in adipose tissue biology and energy metabolism in general.
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Samenvatting
Een toegenomen opslag van vetten in vetweefsel leidt tot overgewicht 
of, in meer extreme mate, obesitas. Overgewicht is een risicofactor voor 
metabole ziekten zoals insuline resistentie en diabetes mellitus type 2. Tot 
voor kort werd aangenomen dat het vetweefsel een relatief passief orgaan is 
met als enige functie de opslag van vet. We weten nu echter dat vetweefsel 
één van de meest actieve endocriene organen is, het scheidt namelijk diverse 
factoren uit en reflecteert daarmee veranderingen in de metabole status van 
het lichaam. Naast het bekende wit vetweefsel, bestaat er ook bruin vetweefsel. 
Waar wit vetweefsel voornamelijk een grote rol speelt in de opslag van vetten, 
is bruin vetweefsel gespecialiseerd in het verbranden van vetten om warmte 
te produceren. Dit proces wordt thermogenese genoemd en is cruciaal bij 
neonaten en kleine zoogdieren om de lichaamstemperatuur op peil te houden. 
Nog niet zo lang geleden is aangetoond dat ook volwassenen bruin vetweefsel 
hebben en sindsdien wordt activering van bruin vetweefsel beschouwd als een 
veelbelovende methode in de strijd tegen overgewicht.
De vetverdeling verschilt tussen mannen en vrouwen: mannen hebben 
over het algemeen meer buikvet terwijl vrouwen meer onderhuids vet hebben. Een 
toename in lichaamsgewicht resulteert daarom bij mannen in een zogenaamde 
‘appelvorm’ en bij vrouwen in een ‘peervorm’. Dit verschil in vetverdeling 
verklaart ook voor een deel waarom vrouwen voor de menopauze, de periode 
waarin er een groot verschil is tussen mannen en vrouwen in de hoeveelheid en 
type geslachtshormonen, beschermd zijn tegen metabole ziekten. Echter na de 
menopauze neemt bij vrouwen de hoeveelheid buikvet over het algemeen toe, 
een effect dat correleert met een toename in de incidentie van metabole ziekten.
Naast een verschil in de verdeling van wit vetweefsel tussen mannen 
en vrouwen is er ook een verschil in bruin vetweefsel tussen de geslachten. 
Vrouwen en vrouwelijke ratten en muizen - dieren die veelvuldig voor metabool 
onderzoek worden gebruikt - hebben over het algemeen meer en actiever bruin 
vetweefsel dan mannen en mannelijke ratten en muizen. Diverse studies hebben 
aangetoond dat oestrogenen (vrouwelijke geslachtshormonen) een positief effect 
en androgenen (mannelijke geslachtshormonen) een negatief effect hebben op de 
vet- en energiehuishouding.
Niet alleen geslachtshormonen, ook glucocorticosteroïden hebben een 
effect op de vet- en energiehuishouding. Glucocorticosteroïden zijn hormonen 
die onder invloed van stress door de bijnieren worden afgescheiden opdat vitale 
weefsels voldoende glucose krijgen, onder andere door de glucose opname door wit 
vetweefsel te remmen. Langdurig verhoogde glucocorticosteroïd concentraties 
zorgen voor diverse metabool ongewenste effecten zoals gewichtstoename, 
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toename van de hoeveelheid buikvet en insuline resistentie. Het is niet bekend 
of mannen en vrouwen verschillend reageren op deze effecten van glucocorti-
costeroïden.
Het overkoepelende doel van dit proefschrift is om meer inzicht te krijgen 
in de geslachtsgebonden verschillen in de functionaliteit van het vetweefsel. 
Hoofdstuk 1 is een algemene introductie en geeft een overzicht van de basale 
kennis van wit en bruin vetweefsel en -cellen. Daarnaast behandelt dit hoofdstuk 
de effecten van geslachtshormonen en glucocorticosteroïden op de vetverdeling 
en de functies van vetcellen. Dit hoofdstuk geeft eveneens een beschrijving van 
de processen die betrokken zijn bij de regulatie van de lichaamstemperatuur, 
hetgeen belangrijk is om de thermogene activiteit van bruin vetweefsel te 
begrijpen.
De geslachtsgebonden effecten van glucocorticosteroïden op het 
vetweefsel en de glucosehuishouding worden beschreven in hoofdstuk 2. 
Mannelijke en vrouwelijke muizen werden gedurende twee weken behandeld met 
een hoge dosis van het knaagdier-specifieke glucocorticosteroïd corticosteron. 
De mannelijke muizen kregen onder invloed van corticosteron in de niet gevaste 
toestand een verhoogde bloedsuikerwaarde, maar opmerkelijk genoeg werd dit 
niet waargenomen in de vrouwelijk muizen. In gevaste toestand hadden zowel 
de mannelijke als de vrouwelijke muizen na corticosteron behandeling een 
normale bloedsuikerwaarde met een verhoogde plasma insuline concentratie: 
een indicatie dat corticosteron in beide geslachten insuline resistentie induceert. 
Met behulp van stabiele isotopen van glucose werd vervolgens aangetoond dat 
de glucose klaring na corticosteron behandeling hoger is in vrouwelijke dan in 
mannelijke muizen. In beide geslachten resulteerde corticosteron behandeling in 
een toename van wit en bruin vetweefsel. In vrouwelijk muizen ging deze toename 
gepaard met metabool relatief gunstige modificaties zoals een verhoogde plasma 
adiponectine concentratie. In vitro experimenten toonden vervolgens aan dat de 
verhoogde adiponectine concentratie waarschijnlijk het gevolg is van de hoge 
insuline spiegels en niet zozeer een direct effect is van corticosteron.
Geslachtsgebonden verschillen in bruin vetweefsel worden waarschijnlijk 
veroorzaakt door een stimulerend effect van oestrogenen en/of een remmend 
effect van androgenen op de activiteit van dit vetweefsel. Het is bijvoorbeeld 
bekend dat oestrogenen de thermogenese stimuleert via een effect op het centrale 
zenuwstelsel. Om de moleculaire mechanismen te achterhalen die betrokken zijn 
bij de geslachtsgebonden verschillen in bruin vetweefsel is de gen expressie van 
dit vetweefsel van mannelijke en vrouwelijke muizen onderzocht met behulp van 
RNA sequencing. De data die in hoofdstuk 3 worden gepresenteerd laten zien 
dat genen die coderen voor eiwitten betrokken bij de cellulaire structuur, cel-cel 
contacten en de celadhesie meer tot expressie komen in bruin vetweefsel van 
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vrouwelijk muizen dan in dat van mannelijke muizen. Het verwijderen van de 
ovaria had een sterk effect op de expressie van deze genen, maar het verwijderen 
van de testes had geen of slechts marginaal invloed. In silico analyses toonden aan 
dat de expressie van de gevonden genen onder andere wordt gereguleerd door het 
oestrogeen 17β-estradiol en het androgeen dihydrotestosteron, maar dat tevens 
progesteron een rol speelt. De effecten van het vrouwelijk geslachtshormoon 
progesteron op vetweefsel en vetcellen zijn slechts in beperkte mate onderzocht. 
Daarom werd besloten om het effect van progesteron in meer detail te 
onderzoeken. Celkweek experimenten met primaire bruine vetcellen geïsoleerde 
uit muizen toonden aan dat progesteron de expressie van enkele van de geïden-
tificeerde genen onderdrukt. Daarnaast onderdrukt progesteron ook enkele 
klassieke markers van bruin vetweefsel, een effect dat zeer waarschijnlijk wordt 
bewerkstelligd door de glucocorticosteroïd receptor en slechts in mindere mate 
door de progesteron receptor. Opvallend was dat bruine vetcellen geïsoleerd uit 
vrouwelijke muizen nog steeds een ander expressie patroon lieten zien dan de 
cellen uit mannelijke muizen, ondanks dat ze dagenlang in hetzelfde medium 
werden gekweekt. Dit suggereert dat niet alleen geslachtshormonen, maar ook 
het geslacht zelf een rol speelt in de geslachtsgebonden verschillen van bruin 
vetweefsel.
Het is gebruikelijk om laboratorium muizen bij circa 22 °C te huisvesten. 
Bij deze temperatuur heeft bruin vetweefsel van vrouwelijke muizen een 
hogere thermogene activiteit dan bruin vetweefsel van mannelijke muizen. Dit 
verschil verdwijnt echter wanneer de muizen worden blootgesteld aan een lage 
temperatuur zoals 4 °C, wat een gebruikelijke methode is om de thermogene 
activiteit van bruin vetweefsel te verhogen. Blijkbaar zorgt een verschil in 
perceptie van temperatuur voor een verschil in de thermogene activiteit van 
bruin vetweefsel van mannelijke en vrouwelijke muizen. Het is te verwachten dat 
een dergelijk verschil ook tussen mannen en vrouwen bestaat. Dit proefschrift 
bevat een tweetal studies waarin dit verschil werd bestudeerd. Hoofdstuk 
4 beschrijft een studie waarin werd gevonden dat vrouwelijk muizen een 
hogere omgevingstemperatuur prefereren dan mannelijke muizen, met name 
gedurende de inactieve fase. Gonadectomie (het verwijderen van de ovaria bij 
vrouwelijke muizen en de testes bij mannelijke muizen) had hierop geen effect, 
wat suggereert dat verschillen in neuronale netwerken die de gevoeligheid 
voor temperatuur reguleren niet afhankelijk zijn van geslachtshormonen. Het 
is echter ook mogelijk dat het verschil tussen de geslachten al is aangelegd 
voordat de pubertijd begint. Het onderzoek in hoofdstuk 5 werd uitgevoerd met 
gezonde vrijwilligers die door middel van een koelvest werden blootgesteld aan 
een geleidelijke verlaging van de omgevingstemperatuur. Deze studie toont aan 
dat vrouwen een bepaalde temperatuur over het algemeen als kouder en minder 
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comfortabel beschouwen dan mannen. Eén van de factoren die betrokken zou 
kunnen zijn bij dit verschil tussen mannen en vrouwen is de lichaamscompositie. 
In vergelijking met mannen hebben vrouwen relatief meer lichaamsoppervlakte 
per lichaamsgewicht wat resulteert in netto meer verlies van warmte. Een 
verschil in lichaamsoppervlakte verklaarde echter niet de waargenomen 
verschillen tussen mannen en vrouwen. Het kan daarom geconcludeerd worden 
dat de lichaamscompositie niet de enige factor is die het verschil in temperatuur 
gevoeligheid tussen mannen en vrouwen verklaart.
Tot slot worden in hoofdstuk 6 de resultaten en conclusies uit dit 
proefschrift besproken. Alhoewel de studies uit dit proefschrift opheldering 
hebben gegeven omtrent geslachtsgebonden verschillen in de functionaliteit van 
het vetweefsel en vetcellen, is het ook duidelijk dat er nog verder onderzoek 
nodig is om meer inzicht te krijgen waarom het vetweefsel, de vetcellen en de 
energiehuishouding verschilt tussen mannen en vrouwen.
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